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12 Chapter 1. Introduction
It is well established that ventricular arrhythmia is the primary mechanism of
sudden death in patients who survive the acute phase of myocardial infarction
[1–3].
For secondary prevention of sudden arrhythmic death, a wide range of thera-
pies has become available. Treatment strategies for malignant postinfarction ven-
tricular tachycardia can be subdivided into three categories: 1) those that prevent
recurrences of ventricular arrhythmia by modulating the properties of the arrhyth-
mogenic substrate; 2) those that prevent the fatal outcome of recurrences of ven-
tricular arrhythmias and 3) those that can be considered curative, since they are
capable of eliminating the arrhythmogenic substrate.
A wide variety of antiarrhythmic drugs has been developed to influence the
electrophysiologic properties of the arrhythmogenic substrate, thereby preventing
recurrences of arrhythmias. Antiarrhythmic drugs can be divided into subclasses
that describe their electrophysiologic mode of action [4, 5]. Unfortunately, by the
current standards, their efficacy in preventing sudden death appears to be low
[6–10]. In addition, it has been reported that antiarrhythmic drugs may increase
the risk for malignant arrhythmias in selected patients [11].
The concept of an implantable cardioverter (ICD) was developed to lower
the risk of fatal outcome caused by recurrent ventricular arrhythmias [12–14].
ICDs are capable of detecting malignant ventricular tachyarrhythmias and can
subsequently terminate the arrhythmia by antitachycardia pacing or internal de-
fibrillation. ICD therapy has been shown to be both superior to antiarrhythmic
drugs as well as cost-effective in secondary prevention of sudden cardiac death
[6–10, 15]. More recently, ICD therapy proved to be effective in preventing sud-
den cardiac death in patients with coronary artery disease and asymptomatic,
non-sustained ventricular arrhythmias [16]. ICD therapy does not prevent life-
threatening rhythm disorders, but merely the utmost consequences of ventricular
arrhythmias for the patient. Major disadvantage of ICD therapy appears therefore
to be its effect on the quality of life of patients, caused by inappropriate shocks
or the prevailing possibility of experiencing cardioversion shocks while still con-
scious [17].
The most definite solution for saving patients from postinfarction ventricular
arrhythmias is the elimination of the substrate itself. In the late 1970’s, antiarrhyth-
mic surgery was introduced for this purpose [18–21]. Antiarrhythmic surgery can
be guided by intraoperative mapping and results in removal of the arrhythmo-
genic substrate. It has proven its efficacy in the past, but major disadvantage of
antiarrhythmic surgery remains that surgical ablation can only be performed dur-
ing open-heart surgery [22]. In the early 1990’s, first attempts to cure patients from
ventricular arrhythmias by means of percutaneous radiofrequency catheter abla-
tion were reported [23, 24]. Efficacy of radiofrequency ablation of postinfarction
VT depends on the stability of the VT, the number of VT morphologies in one pa-
tient, hemodynamic tolerance and intramural depth of the radiofrequency target
site [25, 26].
From the abovementioned considerations, it appears that identification of pa-
tients at risk for life threatening postinfarction ventricular arrhythmias is essential.
1.1. Mechanisms of cardiac arrhythmias 13
Furthermore, to tailor treatment strategy of postinfarction ventricular arrhythmias
to individual patients, extensive knowledge on electrophysiologic mechanisms
and anatomic localization of the arrhythmogenic substrate in individual patients
is required.
1.1 Mechanisms of cardiac arrhythmias
At present, several mechanisms that underlie cardiac arrhythmias are recognized.
The most important among these mechanisms are: triggered activity, enhanced
abnormal automaticity, anatomically defined reentry and functional (‘leading cir-
cle’) reentry. Postinfarction ventricular arrhythmias are considered to be caused
mainly by the latter two mechanisms.
1.1.1 Anatomic reentry
The first model of reentry in cardiac tissue was described by Mines in 1913 [27].
In an anatomically defined circuit he recognized that the duration of the refrac-
tory period and conduction velocity within the circuit determined whether or not
reentry could occur. This resulted in the definition of conditions that are obligatory
for the initiation of a circus movement tachycardia: (1) the existence of an arc of
unidirectional block, (2) conduction around this arc of block and (3) re-excitation
of tissue proximal to the site of conduction block [27, 28]. Several properties of
anatomic reentry can be inferred from the intrinsic properties of the reentry cir-
cuit. In anatomically delineated reentry circuits the localization and length of
the pathway are fixed and defined by the perimeter of the anatomic structure,
which forms the unexcitable center of the circuit. The conduction velocity of the
wave front and the length of the circuit determine the cycle length of the arrhyth-
mias. The wavelength of the cardiac impulse is defined as the distance traveled by
the depolarization wave in a time interval equal to the refractory period [29]. In
anatomic reentry, the length of the circuitous pathway can be significantly longer
than the wavelength of the impulse, leaving a segment of the reentrant circuit fully
or partially excitable. This is called an ‘excitable gap’. Because of such an excitable
gap, the revolution time of the impulse in the circuit is determined primarily by its
conduction velocity and will not be significantly influenced by moderate changes
in the refractory period. Furthermore, rightly timed impulses originating from
outside the circuit may enter it and either reset, entrain or terminate the rhythm.
1.1.2 Functional reentry
Anatomically bounded tracts or obstacles are not a prerequisite for the occurrence
of reentry in the heart. Garrey was the first to observe this as he wrote in an
article published in 1914: ‘natural rings are not essential for the maintenance of
circus contractions’ [30]. Studies conducted by Allessie et al. have demonstrated
the properties of reentry without an anatomical obstacle, e.g. the ‘leading circle’
concept [31–33]. In the absence of a fixed barrier, both localization and size of
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the reentry circuit may vary, causing the ‘leading circle’ to drift through the my-
ocardium. The central area of the circuit is kept refractory by centripetal wavelets
and serves as an obstacle. The length of a functional reentrant circuit is therefore
not fixed, but determined by the local electrophysiologic properties of the tissue,
e.g. conduction speed and refractory period. The wavelength of the circulating
impulse equals the dimensions of the circuit. This implies, that the depolarization
wave circulates in the smallest possible pathway in which the electromotive force
of the wave front is just strong enough to excite the tissue ahead, which is still
in its relative refractory period. In other words, the head of the circulating wave
front follows its own tail of refractoriness. The absence of an excitable gap implies
that changes in the refractory period will influence the revolution time of the cir-
cuit. Thus, shortening of the refractory period will enable the impulse to circulate
in a smaller circuit with a shorter revolution time thereby accelerating the circus
movement rhythm. On the other hand, prolongation of the refractory period will
result in a larger circular pathway and slowing of the rhythm or, if such a pathway
is not available, in blocking of reentry and termination of the tachycardia.
The prevalence of unidirectional (functional) block remains mandatory for reen-
try to occur. Factors which may lead to transient functional conduction block are:
1) anisotropy of conduction in myocardial tissue [34–36]; 2) differences in mem-
brane responsiveness of cardiac cells; 3) spatial dispersion in recovery from elec-
trical activation. From the study of Allessie et al. in isolated rabbit left atrium,
it emerged that a minimum difference of 11–16 ms in refractory period between
adjacent areas, induced by a premature beat, may be sufficient to cause local con-
duction block [32].
In the absence of an anatomic obstacle, the dimensions of the arc of functional
block is of great importance. This will determine, together with conduction speed
and refractory period, whether or not reentry of the functional type will occur.
1.2 Localization of the arrhythmogenic substrate
Wellens et al. demonstrated that the predominant mechanism in postinfarction
VT is indeed reentry and that VT can be reproducibly induced by using an ex-
trastimulus technique [37–39]. The arrhythmogenic substrate is often anatomi-
cally localized in the subendocardium [38, 40]. De Bakker et al. proved that the
extent of the slow conduction pathway can cover a substantial part of the left ven-
tricle perimeter, confirming that VT in the postinfarction heart usually is caused
by ‘macro-reentry’ [41–43].
When considering curative ablation of postinfarction ventricular tachycardia
(VT), i.e. definite interruption of the anatomic reentry circuit, by means of either
radiofrequency catheter ablation or antiarrhythmic surgery, several approaches
are available for identification of ablation target sites. The anatomical localization
of characteristic landmarks of the circuit can be derived from the electrophysiolog-
ical properties of the reentrant circuit as described above. In general, two types of
target sites can be selected: the VT exit site and the pathway of slow conduction.
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1.2.1 Electrocardiographic localization of the exit site of VT
The terminal part of the tract of slow conduction, which inserts into the non-
infarcted myocardium, is commonly called the exit site of VT. This VT exit site pos-
sesses distinguishable electrocardiographic features. Centrifugal spread of activa-
tion in non-infarcted myocardium that follows completion of conduction through
the tract of slow conduction, results in a QS complex in the local unipolar elec-
trogram. This implies that mapping of the left ventricular endocardium or epi-
cardium can be performed to locate areas where QS complexes in the unipolar
electrogram are found, displaying local activation that is early relative to the body
surface QRS complex [44]. This concept should, however, be treated with caution
since anisotropy of conduction due to the arrangement of fibers may also result
in electrograms with QS complexes at sites where the wave front merely passes
instead of originates [42]. At the body surface, intracardiac centrifugal spread of
activation from the exit site will result in QS complexes in unipolar ECG leads,
which are in close proximity to the VT exit site and observe a departing wave
front. This principle has been used to localize the site of origin of VT by means
of the 12-lead surface ECG [45, 46]. Both methods, endocardial catheter activation
sequence mapping and 12-lead surface electrocardiographic mapping, have their
own merits and drawbacks. For endocardial mapping, inducibility of VT, hemo-
dynamical tolerance of the arrhythmia and paucity of VT morphologies are a pre-
requisite. Localization of the VT exit site by means of the 12-lead ECG is mostly
hampered by the limited amount of spatial information that can be derived from
a restricted set of predominantly precordial surface ECG leads. To circumvent the
limitations associated with endocardial catheter activation sequence mapping and
12-lead ECG localization of VTs, body surface mapping (BSM) was introduced by
SippensGroenewegen et al [47, 48]. In summary, this technique consists of ob-
taining spatially dense electrocardiographic data at the body surface. First, body
surface QRS integral maps are constructed [49]. These dipolar QRS isointegral
maps are characteristic for specific endocardial sites of origin of activation and
subsequent spread of activation. By comparing these QRS isointegral maps to a
database containing mean paced QRS isointegral maps from known endocardial
sites, predictions about the presumed endocardial site of origin can be made on a
beat-to-beat basis.
1.2.2 Localization of areas of slow conduction
Localization of the isthmus of slow conduction during ventricular tachycardia.
Whereas localization of exit sites of VT is considered to be adequate for surgical
ablation of postinfarction VT, success rates of VT exit site directed radiofrequency
catheter ablation appear to be lower [50–52]. This is presumably due the relative
confined thermal lesion inflicted by radiofrequency catheter ablation in relation
to the often large endocardial exit site area. This finding has encouraged other
investigators to search for methods that allow for ablation of the tract of slow
conduction.
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Josephson et al. were the first to report that sites, where continuous electrical
activity can be recorded during the diastole of VT, represent tracts of preserved
conduction in the infarction scar [53]. De Bakker et al. later demonstrated that
conceptualizing the reentrant circuit as a structure consisting of relatively few,
anatomically bounded, tracts of slow conduction within the infarction scar is a his-
tological and electrophysiological simplification [54]. In fact, the chronic postin-
farction scar often consists of an intricate network of interconnecting, surviving
fibers, some of which appear to be a critical part of the reentrant circuit, whereas
others merely play a role as bystander [55]. Therefore, when aiming at interrup-
tion of the reentrant circuit, anatomical localization of tracts of slow conduction
does not suffice: also the functional significance of pathways of slow conduction
within the circuit will have to be clarified.
Functional characterization of tracts of slow conduction can be done by pace
mapping of the infarction scar during VT [56]. Stevenson et al. introduced a struc-
tured approach for determination of the significance of tracts of slow conduction
[55]. If concealed entrainment is obtained and specific stimulus-to-electrogram in-
terval criteria are met, it is not only possible to identify a surviving bundle within
the infarction scar, but it is also possible to identify whether that specific site is
critical to the reentrant circuit [57]. At these sites radiofrequency energy can then
be delivered. Still, for this method inducibility and sustenance of VT as well as
hemodynamical tolerance of the arrhythmia are a prerequisite.
Instead of ablation during VT, attempts can be made to reconstruct the entire
left ventricular area containing tracts of slow conduction during VT and subse-
quently perform the ablation during sinus rhythm. This can be done, if accurate
information on the 3D position of the ablation catheter in the left ventricle can be
combined with local activation times derived from that site. Several catheter po-
sition monitoring methodologies are currently available for this purpose [58, 59].
More recently, non-contact mapping techniques have been developed that give in-
formation on activation sequences in the heart on a beat-to-beat basis [60]. Some
authors have reported on this approach of reconstructing the isthmus of slow con-
duction during VT with the aid of these 3D endocardial mapping techniques and
subsequent creation of linear radiofrequency ablation lesions across this isthmus
during sinus rhythm [61].
Localization of the substrate during sinus rhythm
Ideally, the critical part of the arrhythmogenic substrate should be localized dur-
ing sinus rhythm. This would preclude the problems of multiple VT morphologies
and non-inducibility or non-sustenance of VT. Furthermore, it would save patients
from having to endure prolonged periods of VT during the ablation session [62].
Several methods to localize the area of functional or anatomical block during
sinus rhythm have been proposed. Localization of the tract of slow conduction
can be done by ventricular pacing of the postinfarction scar while measuring the
delay between stimulus and QRS complex or comparing the derived paced QRS
complexes with the VT QRS morphology [63–66]. This can be combined with the
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timing of diastolic potentials relative to the QRS complex during sinus rhythm,
but overall results appear to be disappointing [67]. More recently, elaborate tech-
niques to locate the isthmus of VT by adaptive template matching or difference
maps obtained by pacing in the setting of sinus rhythm at multiple sites have
been proposed, but their clinical value remains to be proven [68, 69].
1.3 Identifying patients at risk for sudden cardiac death
1.3.1 Non-invasive identification of patients with areas of slow
conduction
Berbari et al. were the first to describe the recording of arrhythmogenic signals at
the end of the QRS complex in the late 1970’s [70]. Later the concept of these late
potentials was elaborated by Simson [71]. Late potentials are considered the body
surface correlate of conduction in the intracardiac pathways of slow conduction
and therefore signify the patient’s predisposition for life threatening arrhythmias.
Over the years, a large body of evidence has been gathered that links the presence
of late potentials — in conjunction with other clinical variables — to an increased
risk of sudden cardiac death [16,72–77]. Sensitivity of late potentials for predicting
arrhythmic events appears to be limited [78].
1.3.2 Non-invasive identification of patients with disparity in
repolarization
Disparity in repolarization is an important etiologic factor in postinfarction ven-
tricular arrhythmias that have functional reentry as an underlying mechanism,
e.g. ventricular fibrillation [79]. Several techniques have been developed to non-
invasively identify patients subject to increased arrhythmia vulnerability because
of their increased dispersion in repolarization. Among these techniques are QT
dispersion, non-dipolar content of body surface mapped QRST integrals, and T-
wave alternans [80–91].
1.4 Aim of this thesis
Much knowledge concerning the mechanisms and nature of the postinfarction ar-
rhythmogenic substrate has been gathered in the past decades. The ever-expanding
therapeutic options require more insight in the selection of postinfarction patients
at risk for developing life-threatening arrhythmias as well as a better understand-
ing of which therapy should be selected for an individual patient. Ideally, methods
should be developed that 1) are non-invasive in nature 2) allow mapping during
sinus rhythm 3) allow ablation during sinus rhythm.
Aim of this thesis was to gain more knowledge on the genesis of postinfarction
arrhythmias by utilizing combined electrophysiologic and computational tech-
niques that allow visualization and functional characterization of the mechanisms
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underlying postinfarction ventricular arrhythmias. In chapter 2 the clinical value
of body surface mapping to guide antiarrhythmic surgery is investigated. In chap-
ter 3 the electrophysiological basis for failure of body surface mapping to identify
the correct site of origin of postinfarction VT was analyzed by means of simul-
taneous multi-lead endocardial and body surface mapping of VT. In chapter 4
new ways are explored that allow mapping of the postinfarction arrhythmogenic
substrate during sinus rhythm. In chapter 5 the use of signal averaged electro-
cardiography for detection of late potentials is extended to electrocardiographic
monitoring of the entire body surface area. The purpose was twofold: 1) to inves-
tigate whether the sensitivity of signal averaged electrocardiography for detection
of patients at risk can be increased and 2) to analyze the potential of spatially dis-
tributed late potentials at the body surface to anatomically delineate areas of slow
conduction within the left ventricle. In chapter 6 disparity in repolarization is
investigated. Invasively obtained, spatially dense endocardial electrophysiologic
repolarization measurements are compared with non-invasive ECG and body sur-
face map parameters that are believed to estimate disparity in repolarization. In
chapter 7 the physical principles that form the basis of the computational tech-
niques used for analysis of the postinfarction arrhythmogenic substrate in this
thesis are explained. Finally, in chapter 8 clinical implications of the currently
presented work are discussed and future directives for arrhythmia research are
suggested.
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2.1 Abstract
Objectives: To investigate the influence of body surface mapping on outcome of
ventricular antiarrhythmic surgery.
Methods: Preoperative mapping is advocated to optimize map-guided antiar-
rhythmic surgery of postinfarction ventricular tachycardia. We sequentially ana-
lyzed the results of catheter activation sequence mapping, body surface mapping
and intraoperative multielectrode mapping in 54 patients (Group A) and made
a comparison with 30 control patients (group B) in whom catheter activation se-
quence mapping was omitted. Endpoints were actuarial survival, freedom of ar-
rhythmia and comparability of the localization of sites of ventricular tachycardia
origin.
Results: A total of 128 morphologically different monomorphic sustained ven-
tricular tachycardias were mapped in group A. In group A, 87 ventricular tachy-
cardias were mapped preoperatively with body surface mapping and 30 ventricu-
lar tachycardias with catheter activation sequence mapping. In 19 of 24 ventricular
tachycardias (79%) that were localized with both mapping methods the ventricu-
lar tachycardia exit site was similar. In-hospital death was 1 of 85 (1.2 %). Actu-
arial freedom from ventricular arrhythmias at 4-year follow-up was 74.1±6.0% in
group A vs. 90.0±5.5% in group B (p=0.10). In group A 14 of 54 patients died
(29.6%), whereas 4 of 30 patients (13.3%) died in group B (p=0.09).
Conclusions: Arrhythmia freedom and survival is as good in patients mapped
with body surface mapping only as in patients mapped with body surface map-
ping and catheter activation sequence mapping.
2.2 Introduction
Ventricular arrhythmias occurring late after myocardial infarction constitute an
important etiologic factor in mortality from cardiac disease [1]. In contrast to
symptomatic treatment strategies such as implantable cardioverter/defibrillators
or antiarrhythmic drug therapy, percutaneous radiofrequency catheter ablation
and map-guided surgical ablation of the arrhythmogenic substrate are considered
to be curative approaches for treatment of these life-threatening postinfarction
ventricular arrhythmias [2–4]. Detailed delineation of the site of the arrhythmo-
genic substrate is an essential prerequisite for both surgical and radiofrequency
ablation [5].
Several authors have reported that extensive pre- and intraoperative mapping
may improve surgical outcome [6–9]. Preoperative mapping remains an impor-
tant method in surgical work-up since due to general anesthesia, ventriculotomy
or removal of mural thrombi ventricular tachycardia (VT) may not be inducible
during surgery. Historically, mapping efforts have been directed at detecting the
site of VT origin — i.e. the exit from the zone of slow conduction into the non-
infarcted myocardium — since this site offers the best discernible local electro-
graphic features [10, 11]. Several non-invasive techniques, like the 12-lead elec-
trocardiogram (ECG) and body surface mapping (BSM) and invasive techniques,
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such as percutaneous endocardial catheter activation sequence mapping (CASM)
and intraoperative endocardial and epicardial multielectrode mapping (IMEM),
are presently available for electrophysiologic delineation of the site of VT ori-
gin [11–13]. Josephson et al. have shown that there is an adequate correlation be-
tween preoperative mapping data acquired with CASM and intraoperative map-
ping results obtained with IMEM [14]. Therefore CASM is generally accepted as
the current method of choice for preoperative mapping of the site of origin of
postinfarction VT.
SippensGroenewegen et al. reported on the use of non-invasive BSM as a
means of detecting the site of origin of postinfarction VT [12]. Due to its non-
invasive nature and its capability of determining the site of origin on the basis of
one single heartbeat, BSM is not limited by the many disadvantages associated
with CASM. At present, detailed information about the feasibility, applicability,
and reproducibility of BSM, as well as the correlation in outcome between BSM
and the other aforementioned mapping techniques is lacking. Furthermore, the
issue whether BSM can replace CASM, which is often patient burdening and time
consuming, remains unresolved. Therefore, we performed a prospective sequen-
tial group analysis study to analyze surgical outcome, survival and therapeutic
efficacy data in a group of consecutive patients with postinfarction VT who un-
derwent map-guided surgery after mapping with BSM, CASM and IMEM. These
data were compared with another group patients undergoing postinfarction VT
surgery after application of only BSM and IMEM.
2.3 Methods
Study patients and preoperative examination
All patients admitted to our hospital for arrhythmia surgery between July 1990
and July 1995 with a history of coronary artery disease, documented recurrent
ventricular arrhythmias with or without aborted sudden cardiac death, as well as
inducible monomorphic VT during preoperative programmed electrical stimula-
tion, were included in the study. Patients were considered eligible for map-guided
arrhythmia surgery if at least 3 of 9 segments of the left ventricle showed a normal
contraction pattern according to a previously described angiographic wall motion
score [15]. Ventricular arrhythmia surgery was considered indicated if the patient
was refractory to antiarrhythmic drug treatment or as additional procedure in pa-
tients with postinfarction VT who underwent cardiovascular surgery for other rea-
sons. Preoperative analysis was performed according to a routine preoperative
protocol that included left and right sided heart catherization, coronary angio-
graphy, nuclear left ventricular ejection fraction determination, exercise stress test-
ing, Holter monitoring, two-dimensional and Doppler echocardiography and pro-
grammed electrical stimulation. Patients, who underwent antiarrhythmic surgery
between July 1990 and July 1993, constituted Group A and patients operated be-
tween July 1993 and July 1995 formed Group B. Group A intentionally underwent
BSM, CASM and IMEM, whereas Group B was mapped with BSM and IMEM
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only.
Preoperative electrophysiologic studies and body surface mapping
Conventional 12-lead ECG recordings and 64-lead BSM of spontaneously occur-
ring clinical VTs were obtained. A VT was considered sustained, if it lasted for
more than 30 seconds or if electrical cardioversion was required for termination
due to hemodynamical deterioration. A particular VT morphology was consid-
ered documented if at least standard ECG leads I, II, III and V1 were available.
All patients underwent an electrophysiologic study in the postabsorptive state at
least five half-lives after discontinuation of antiarrhythmic medications. Induc-
tion of VT was carried out using a routine stimulation protocol including delivery
of up to 3 extrastimuli with increasing prematurity following a train of 8 driven
beats with three different cycle lengths (600, 500 and 430 ms). Stimulation im-
pulses (width 2 ms, strength twice the diastolic threshold) were delivered by a 6
Fr quadripolar catheter positioned in the right ventricular apex or right ventric-
ular outflow tract. If necessary, isoproterenol infusion was used to facilitate VT
induction. Catheter mapping was performed by sequentially obtaining unipolar
and bipolar local electrograms from multiple endocardial sites of the left ventri-
cle with an exploring 7 Fr quadripolar catheter. A VT was defined mappable by
catheter if it proved to be sustained and if mapping data from at least 15 differ-
ent endocardial sites could be obtained. If a VT appeared to be non-mappable
by catheter, because of hemodynamical deterioration, attempts were made to in-
crease the VT cycle length with intravenous delivery of low dose procainamide.
If multiple VT morphologies were induced, mapping was executed for these sub-
sequent morphologies as well. The site of VT origin was defined as the mapping
site at which the earliest local endocardial activation, i.e. the steepest descend-
ing slope (dV/dtmin

in the unipolar signal of the exploring ventricular catheter,
was recorded with respect to the onset of the QRS complex on the simultaneously
recorded surface ECG [10].
Body surface mapping data were recorded using a 64-channel ECG recording
system and a radiotransparent carbon unipolar electrode grid that does not inter-
fere with fluoroscopic imaging during catherization (figure 2.1). The electrodes
were positioned in 14 flexible vertical straps and applied on the anterior and pos-
terior thoracic surface as described elsewhere [16]. Analogue to digital conversion
occurred at a sampling frequency of 1 kHz, and 14-bits resolution. Wilson’s central
terminal was used as the reference [17, 18]. The amplifier system had a bandpass
characteristic using a frequency range of 0.16 – 120 Hz (3 dB frequencies). Data
were transmitted using a fiberoptic transmission unit and stored in a 486 PC mi-
crocomputer. For on-line data processing and analysis a second computer system
was available (Commodore Amiga 2000, Commodore ltd.) which was connected
to the data acquisition personal computer by a parallel connection.
To correct for any contribution of baseline drift to the QRS integral, baseline
correction was performed. Two markers were placed in isoelectrical intervals be-
fore and after the QRS complex under study. If the cycle length of VT was short,
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Figure 2.1: Orientation of the body surface mapping electrode array relative to the heart.
Open dots represent electrodes also utilized in standard 12-lead electrocardiography. Solid
dots represent the additional electrodes in the array.
baseline markers were placed at the putative onset of the QRS complex of the next
and preceding complex of the QRS complex under study. Linear interpolation
was performed between the baseline markers and each sample of the QRS com-
plex was adjusted proportionally according to the newly derived baseline. After
baseline adjustment, the QRS integral area was calculated. For each ECG tracing
the QRS integral was obtained by integrating the area within an interval between
onset and offset of the QRS complex. The onset and offset of the QRS complex are
considered to be isoelectrical and therefore selection of onset and offset was such,
that instantaneous voltages of less than 0.05 V in all ECG tracings were reached.
Body surface isointegral maps were calculated from the individual QRS inte-
grals by spatial interpolation (figure 2.2) and were quantitatively correlated with
two previously developed databases comprising mean paced QRS integral maps
produced at 18 to 22 different specific endocardial segments. These twp databases
included inferior myocardial infarction and anterior myocardial infarction to cor-
rect for geometrical deformations of the left ventricle due to earlier infarctions [19].
The computational derived VT origin was based on the location of the segment
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Figure 2.2: Calculation of the site of origin with body surface mapping. The left upper
map displays the body surface QRS integral map with corresponding ECG lead V1 of a
ventricular tachycardia (VT) in a patient with anterior myocardial infarction. Three QRS
integral maps from midseptal pacing segments of the anterior myocardial infarction pacing
database (7, 8 and 9) are displayed in the bottom part. The locations of the endocardial
segments at which the mean paced QRS integral patterns were previously generated as
well as the Josephson localization scheme are represented in the left ventricular diagram.
Best match in zero line configuration and mutual distance and orientation of the positive
and negative extreme is obtained in database map 8, thereby indicating a midseptal site of
origin of the VT under study.
corresponding to the best matching QRS integral map from the database. Quanti-
tative map comparison was checked by visual analysis of the VT QRS integral and
individual mean paced QRS integral maps from the database and adapted when
necessary if agreement was reached between 2 observers.
Intraoperative electrophysiologic study and surgical techniques
The same cardiovascular surgeon performed all operative procedures. Surgery
took place in the drug free state whenever possible. All patients were anaes-
thetized using nitrous oxide, narcotics and muscle relaxants. Normothermic car-
diopulmonary bypass was initiated with the perfusion temperature maintained at
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37  C. Two needle electrodes were attached to the left and right shoulder to serve
as far field reference electrodes for the unipolar balloon electrodes. Epicardial elec-
trodes were placed on the right ventricular outflow tract and the right atrium. The
left ventricular aneurysm or scar was incised and an inflatable balloon containing
64 unipolar electrodes was placed in the left ventricular cavity. Depending on the
anterior or inferior location of the left ventricular aneurysm a choice was made be-
tween 2 differently shaped endocardial balloons [20]. Standard surface ECG leads
I, II and III and V1 as precordial lead were simultaneously recorded during the
operation. Recordings of sinus rhythm before and during surgery were compared
to check for any possible electrical heart axis rotation caused by the opening of the
thorax, the ventriculotomy and the positioning of the balloon. Programmed elec-
trical stimulation using the right ventricular electrode and an induction protocol
of up to 4 extrastimuli was carried out, if necessary with additional infusion of iso-
proterenol. After induction of every new sustained monomorphic VT endocardial
maps were obtained using a computerized mapping system [20]. The site of origin
was defined as the site at which the earliest local presystolic activation — charac-
terized by the steepest descending slope (dV/dtmin

in the unipolar signal — was
recorded with reference to the onset of the simultaneously recorded QRS complex
on the surface ECG. Pre- and intraoperative VT morphologies were considered to
be the same if surface ECG leads I, II, and III during sinus rhythm and during VT
were identical. Information on the site of origin as obtained with BSM, IMEM and
CASM was handed to the surgeon and presented in a schematic diagram of the
left ventricular endocardium that was based on the Josephson 12-site left ventric-
ular mapping scheme [10]. The surgical procedure consisted of subendocardial
resection, endocardial cryoablation or a combination of these procedures [21]. Af-
ter completion of the surgical arrhythmia ablation, the ventriculotomy was closed
and if additional surgical procedures, such as ventricular aneurysm remodeling,
valve replacement or myocardial revascularization, were mandatory, the patient
was cooled, the aorta was cross-clamped, cold crystalloid cardioplegia was ad-
ministered and the surgical procedure was completed by standard techniques.
Postoperative electrophysiologic study
In all patients, a postoperative electrophysiologic study using temporary epicar-
dial right ventricular wires and a stimulation protocol up to 3 extrastimuli in accor-
dance to the preoperatively applied methodology was performed 7 to 10 days af-
ter surgery. A sustained monomorphic VT induced using one extrastimulus, was
considered clinically significant and in these cases antiarrhythmic drug therapy
guided by sequential electrophysiologic drug testing was instituted. Induction of
sustained monomorphic VT using two or more extrastimuli was not considered
to be a surgical failure per se, but antiarrhythmic drug treatment was adminis-
tered until follow-up programmed electrical stimulation in the drug free state was
undertaken after 6 months to evaluate the indication for prolonged antiarrhyth-
mic drug therapy. Induction of polymorphic VT or ventricular fibrillation was not
considered a surgical failure and antiarrhythmic drugs were not given routinely.
36 Chapter 2. BSM and clinical outcome of surgery
Comparison of sites of origin
For each mapping method, sites of origin were assessed as described above. Ven-
tricular tachycardias were considered morphologically identical if the ECG mor-
phology — as determined from the ECG leads I, II and III and other ECG leads if
available — were identical during sinus rhythm and during VT for each mapping
procedure. If no match with any known VT morphology could be found then the
VT morphology was classified as a new morphology.
Since each mapping technique used a different classification system to indicate
a specific endocardial area of VT origin, all sites of origin were translated into the
12 “Josephson locations” for catheter mapping as a common denominator. Each
Josephson location comprises an endocardial area of approximately 4 cm2 [14].
Sites of VT origin identified by different mapping techniques were considered
identical if they originated from the same or the bordering half of the adjacent
Josephson location. Although translating mapping data to a Josephson location
meant a loss of spatial resolution concerning the specific delineation of the site
of VT origin as derived from BSM and IMEM mapping data, Josephson locations
were considered to contain sufficient information for targeted guidance of surgical
ablation.
Long-term follow-up
Long-term follow-up was obtained in all patients. Data concerning recurrence
of VT and mortality were collected from out-patient clinic visits, letters from re-
ferring cardiologists or direct telephonic contacts with patients, relatives or local
physicians. Surgical failure was classified as spontaneous recurrence of VT, in-
ducible VT during programmed electrical stimulation requiring antiarrhythmic
drug therapy or (aborted) sudden death.
Statistical analysis
All data were stored in a computerized patient record database. Data analysis was
performed on a personal computer using the ‘The SAS System for Windows 6.08
statistical software’ (SAS Institute, Inc). Continuous data are presented as mean
values ± SD unless stated otherwise. Subgroup comparisons were made using
 -square or Fisher’s exact test, whenever appropriate. Analysis of therapeutic
failure and survival was performed by the Kaplan-Meier method and compared
in both groups by the log-rank test. Proportional hazard analysis was performed





Fifty-seven consecutive patients who underwent ventricular arrhythmia surgery
for recurrent VT between July 1990 and July 1993 were included in group A. One
patient underwent emergency surgery without intraoperative mapping attempts
and one patient turned out to be non-inducible during preoperative and intraop-
erative programmed electrical stimulation. In 1 patient mapping attempts were
deliberately omitted because of the extent of the associated coronary artery dis-
ease. Therefore these 3 patients were excluded from the study. Group B consisted
of 30 patients who were operated on between July 1993 and July 1995. Baseline
clinical characteristics for both groups were comparable (Table 2.1). All patients
underwent arrhythmia surgery more than 3 weeks after their most recent myocar-
dial infarction to allow for adequate healing of the myocardial scar.
Comparison of sites of origin
Group A. In total, 160 distinct sustained monomorphic VT morphologies were
recorded in 54 patients. Successful mapping with at least 1 mapping method was
performed in 128 (80 %) of these 160 VTs. No mapping data were available in 32
documented VT morphologies (24 patients) because these VT morphologies were
documented outside the electrophysiology laboratory, e.g. in referring hospitals
without BSM facilities, or because the VT terminated before a mapping attempt
was completed. The distribution of the mapping procedures is shown in figure
2.3. In only 12 VT morphologies (12 patients), localization data from all three
mapping methods could be obtained. In 24 VT morphologies (22 patients) map-
ping data was acquired with BSM and CASM, in 16 VTs (16 patients) IMEM and
CASM was performed and in 36 VTs (20 patients) the site of origin was derived
using IMEM and BSM. In 10 patients, no intraoperative VT mapping could be
performed due to non-inducibility of sustained monomorphic VT.
Results on concordance in mapping findings are shown in Table 2.2. For 19 of
24 VTs documented with BSM and CASM (79 %) a similar exit was found, whereas
21 of 36 VTs (58 %) localized with IMEM and BSM showed comparable exits. Map-
ping data obtained exclusively from IMEM and CASM were available from 16 VTs
of which 9 VTs (56 %) were considered to have the same site of origin. If all 3 map-
ping methods could be applied 7 of 12 VTs (58 %) were found to have the same exit
in all mapping procedures. Although BSM and CASM tended to correlate better
than IMEM and BSM (difference 21 %, 95% CI -2 to 44 %) or CASM and IMEM
(difference 23 %, 95% CI -6 to 52 %), no statistical significance was reached.
Group B. In 30 patients 58 VT morphologies were documented. Successful
mapping with BSM, IMEM or both was achieved in 41 (70.7 %) of these 58 VTs.
No successful mapping could be performed in 17 VTs (12 patients). Distribution of
the mapping procedures is shown in figure 2.3. Comparable exit sites were found
in 3 (50 %) of 6 VTs mapped with both IMEM and BSM, which is not significantly
different from Group A.
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Group A Group B
(N=54) (N=54)
Age (years) 64.1 ± 7.8 63.7 ± 8.8
Sex
Male 47 (87 % ) 27 (90 % )
Female 7 (13 % ) 3 (10 % )
No. of VT morphologies per patient  2.3 (1 – 7) 1.6 (1 – 7)
No. of AAD trials prior to surgery  1.2 (1 – 5) 1.0 (1 – 5)
Baseline PES
No. of VT morphologies  1.9 (1 – 5) 1.2 (1 – 7)
VT cycle length (ms) 314.2 ± 60.7 313.4 ± 54.5
Scintigraphic LVEF (% ) 28.3 ± 11.5 36.0 ± 12.6
WMS (max. 9 of 9 segments)  3.6 (3-6) 3.3 (3-7)
Extent of coronary artery disease
1 vessel 18 (33 % ) 9 (30 % )
2 vessel 17 (32 % ) 9 (30 % )
3 vessel 19 (35 % ) 12 (40 % )
Location of myocardial infarction
Anterior 31 (57 % ) 16 (53 % )
Inferior 21 (39 % ) 14 (47 % )
Anterior and Inferior 2 (4 % ) 0 (0 % )
Concomitant surgery
CABG 32 (59 % ) 5 (9 % )
MVR/MVP 23 (77 % ) 3 (10 % )
Cardiopulmonary bypass (min) 119.5 ± 39.9 133.7 ± 53.5
Intraoperative mapping (min) 22.4 ± 6.8 24.0 ± 6.8
Aortic cross clamping time (min) 56.8 ± 24.9 60.4 ± 33.1
Table 2.1: Baseline characteristics (AAD = antiarrhythmic drugs; CABG = coronary
artery bypass grafting; LVEF = left ventricular ejection fraction; MVR/MVP = mitral
valve replacement or valvuloplasty; PES = programmed electrical stimulation; WMS =
wall motion score; VT = ventricular tachycardia.  = Data shown as median (range)).
Analysis of survival and freedom of arrhythmic events
Group A. One of 85 patients (1.2 %) died in-hospital due to a flucloxacillin resistant
staphylococcal sepsis. The follow-up for the entire group A was 4.0 years. Actu-
arial survival at 4-year follow-up as estimated by the Kaplan-Meier product-limit
method was 70.4 ± 6.2 % (mean ± standard error) (Figure 2.4). In total, 14 of 54
(25.9%) patients died. Causes of death are summarized in table 2.3. Spontaneous
recurrence of VT was documented in 9 patients after 0.2 to 33.2 months follow-


























Figure 2.3: Distribution of successful mapping attempts indicated by procedure, for a to-
tal of 160 ventricular tachycardia morphologies induced in group A and Group B. Group
A includes patients who intentionally underwent body surface mapping, catheter activa-
tion sequence mapping and intraoperative multielectrode mapping to guide arrhythmia
surgery, while Group B includes patients who intentionally underwent body surface map-
ping and intraoperative multielectrode mapping. (CASM = catheter activation sequence
mapping, BSM = body surface mapping, IMEM = intraoperative multielectrode map-
ping).
Group B
Mapping Methods Number Similar Number Similar
of VTs findings of VTs findings
BSM vs. CASM 24 (18.8 % ) 79 % N/A N/A
BSM vs. IMEM 36 (28.1 % ) 58 % 6 (14.6 % ) 50 %
IMEM vs. CASM 16 (12.5 % ) 56 % N/A N/A
IMEM vs. CASM vs. BSM 12 (9.4 % ) 58 % N/A N/A
Table 2.2: Concordance of mapping results using Body Surface Mapping (BSM=Body
Surface Mapping; CASM=Catheter Activation Mapping; IMEM=Intraoperative Multi-
Electrode Mapping; VT=Ventricular Tachycardia)
Group A (N=54) Group B (N=30)
Congestive heart failure 6 0
Sudden death 5 1
Non-cardiac mortality 3 2
Table 2.3: All cause mortality.












































Figure 2.4: Proportional survival from all causes of death during 4-year follow-up after
map-guided postinfarction ventricular tachycardia surgery. Group A includes patients
who intentionally underwent body surface mapping, catheter activation sequence mapping
and intraoperative multielectrode mapping to guide arrhythmia surgery, while Group B
includes patients who intentionally underwent body surface mapping and intraoperative
multielectrode mapping.
arrhythmia at 4-year follow-up was 74.1 ± 6.0 % (Fig. 4)
Group B. There were no in-hospital deaths. During follow-up of 48 to 72 months
3 patients died (Table 2.3). In 4 of 30 (13.3%) patients inducibility of VT during
postoperative programmed electrical stimulation using 3 extrastimuli persisted
and programmed electrical stimulation guided antiarrhythmic drug treatment was
instituted and were scheduled to undergo programmed electrical stimulation af-
ter 6 months. One of these 4 patients had a spontaneous recurrence 2 weeks later
and therefore this patient was considered a surgical failure. Cumulative survival
at 4-year follow-up as estimated by the Kaplan-Meier product-limit method was
86.6 ± 6.2 % (Figure 2.4). Cumulative survival in group B did not differ signif-
icantly from group A (P = 0.09). In total, spontaneous recurrence of VT or per-
sisting inducibility of VT requiring antiarrhythmic drugs was documented in 5
patients. Cumulative freedom of any recurrence of ventricular arrhythmia at 4-
years of follow-up was 90.0 ± 5.5 % (Figure 2.5). Again, postoperative recurrence

















































Figure 2.5: Proportional freedom of recurrences of fatal or non-fatal ventricular arrhyth-
mias or (aborted) sudden death during 4-year follow-up after map-guided postinfarction
ventricular tachycardia surgery. Group A include patients who intentionally underwent
body surface mapping, catheter activation sequence mapping and intraoperative multielec-
trode mapping to guide arrhythmia surgery, while Group B includes patients who inten-
tionally underwent body surface mapping and intraoperative multielectrode mapping.
Proportional hazard analysis
To identify factors predisposing for recurrence of fatal or non-fatal ventricular ar-
rhythmias or death, a proportional hazard analysis according to the Cox regres-
sion model was performed. Clinically relevant variables at baseline such as age,
gender, pre- and intraoperative mapping strategy, concomitant myocardial revas-
cularization, the period in which the operation occurred, number of preoperative
VT morphologies, average VT cycle length, preoperative angiographic wall mo-
tion score and extent of coronary artery disease were included in a forward selec-
tion model. The P value for entry into the model was set at 0.10. Two models were
constructed. In model A, the recurrence of ventricular arrhythmias was analyzed.
None of the aforementioned clinical variables appeared to contribute to the model,
with the entry level of significance set at 0.10. In model B the occurrence of death
from all causes and recurrence of fatal or non-fatal ventricular arrhythmias was
reviewed. The resulting model B (Table 2.4) consisted of a single variable, namely
the period in which the patient underwent surgery, as the only significantly con-
tributing variable (P=0.04).
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Relative Risk P-value
(95% CI)
Operated between 01.07.90 and 01.07.93 2.4 (1.0 - 6.0) 0.04
Age 0.36
Concomitant coronary revascularization 0.36
Average VT cycle length 0.39
Catheter activation sequence mapping 0.43
Intraoperative mapping 0.47
Number of VT morphologies 0.82
Female gender 0.85
Body surface mapping 0.91
Table 2.4: Proportional hazard analysis of occurrence of death from all causes or re-
currence of fatal or non-fatal ventricular arrhythmias using the Cox regression model
(VT=ventricular tachycardia)
2.5 Discussion
Although there has been a decline in the number of centers performing surgi-
cal ablations for postinfarction ventricular arrhythmias, antiarrhythmic surgery
can still be considered an efficacious treatment of postinfarction VT in patients
requiring open heart surgery for additional indications such as myocardial revas-
cularization or aneurysmectomy. At present, 15 patients on average undergo an-
tiarrhythmic surgery each year in our hospital ( 1998: 12 patients; 1999: 17 pa-
tients; 2000: 18 patients ). Preoperative mapping remains mandatory since during
surgery it may be impossible to localize the sites of origin of VT due to nonin-
ducibility.
The site of origin of postinfarction VT is electrocardiographically well defined
in terms of earliest presystolic local endocardial activation and its detection can
reliably be done by invasive measures such as CASM and IMEM. From our study,
BSM and CASM appeared to correlate well (79 %). Comparability between CASM
and IMEM on the one hand and BSM and IMEM on the other tended to be less, al-
though the lack of data on the precordial ECG morphology during surgery seems
to hamper correct identification of VT morphologies.
Major advantages of BSM are its convenience of use, its low cost and the pos-
sibility of mapping otherwise unmappable VTs, such as spontaneously occurring
VTs, hemodynamically unstable tachycardias and non-sustained VTs. These ad-
vantages clearly increase the preoperative yield of BSM as compared to CASM. In
group A 87 of 128 VTs (67.9 %) were localized with BSM whereas only 30 of 128
VTs (23.4 %) could be localized with CASM (P  0.0001).
The influence of mapping data on technical decisions of the surgeon during
the operative procedure is difficult to measure. The surgeon’s view on the arrhyth-
mogenic substrate is undoubtedly influenced by the electrophysiological data ac-
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quired with the pre- and intraoperative mapping procedures as well as by local
anatomical data as obtained by direct visual inspection of the endocardial scar.
Therefore, the question whether BSM can replace CASM as preoperative mapping
procedure for arrhythmia surgery of postinfarction VT can best be answered in
terms of clinical outcome. As compared to results reported by other authors, over-
all satisfying follow-up data were achieved [22]. Using the Kaplan-Meier estimate
of event freedom, no significant difference could be found in survival analysis
from all causes of mortality or freedom of recurrence of ventricular arrhythmias
in patients intentionally mapped with CASM, BSM and IMEM as compared to
patients in whom CASM was abandoned.
A proportional hazard analysis using a Cox regression model analysis was
performed to investigate whether specific clinical variables predisposed for surgi-
cal failure. The preoperative mapping strategy appeared to have no independent
influence on surgical outcome. Only the period, in which the patient underwent
arrhythmia surgery, turned out to be an independent risk factor (relative risk = 2.4,
95%, confidence interval 1.0 – 6.0) for occurrence of major clinical events, not influ-
enced by the pre- and intraoperative mapping strategy or other clinical variables.
This information suggests that the indication for ventricular arrhythmia surgery
may have changed over the years. It is our belief, that the advent of implantable
cardioverter/defibrillator therapy allows for more stringent patient selection and
that improved therapeutic strategies of patients with congestive heart failure, such
as ACE inhibition and Ð -blockade, offer better postoperative management of these
patients who often have a moderate to severe left ventricular dysfunction [23, 24].
We were not able to demonstrate any influence of the performance of CASM on
the occurrence of fatal or non-fatal clinical events (Table 2.4). From this and other
studies BSM appears to be a valid tool for delineating site of origin of postinfarc-
tion VT for map-guided surgical ablation [12, 19, 25]. Therefore, we conclude that
catheter mapping, which is time consuming, potentially hazardous and patient
burdening, can be safely omitted in the preoperative management of patients un-
dergoing ventricular arrhythmia surgery and substituted by BSM.
Limitations
In order to compare mapping data obtained with BSM, CASM and IMEM, data
on the site of origin had to be translated to Josephson locations as a common
denominator. Although BSM and particularly IMEM are capable of providing
high-resolution delineation of the endocardial site of origin, this resolution was
decreased in the translation process. However, the objective of the mapping pro-
cedures was to provide the surgeon with data for surgical ablation of the arrhyth-
mogenic substrate. The above-mentioned translation was considered to contain
sufficient information for these purposes.
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2.6 Conclusions
Ventricular arrhythmia surgery remains an efficacious treatment of late ventric-
ular arrhythmias following myocardial infarction in selected patients. Detailed
pre- and intraoperative mapping allows for selective elimination of the arrhyth-
mogenic substrate. BSM appears to be an easy-to-use alternative method for local-
izing the site of origin of postinfarction VT and allows analysis of otherwise un-
mappable arrhythmias such as spontaneous VTs and hemodynamically not well-
tolerated ventricular arrhythmias. As compared to the currently applied method
for mapping of VTs in the electrophysiology laboratory BSM seems to offer com-
parable results in localizing the site of origin of postinfarction VTs. CASM can be
safely omitted as a preoperative mapping method, since therapeutic efficacy and
postoperative mortality are not influenced. Detailed VT exit site mapping for all
spontaneous and induced VT morphologies increases the extent of the identified
arrhythmogenic region. BSM can be expected to play an important role in these
methodologies by determining the exit sites of the re-entry circuit and thereby
delineating the area where crucial components can be found.
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3.1 Abstract
Background. Body surface mapping (BSM) can be used to identify the site of ear-
liest endocardial activation of ventricular tachycardias (VTs). The multielectrode
QRS morphology during VT is, however, determined not only by the site of earli-
est ventricular activation but also by the subsequent spread of electrical activation
through the ventricles. This study investigated the relationship between the site
of earliest endocardial activation, endocardial spread of activation and the mor-
phology of the multielectrode surface map in patients with remote myocardial
infarction.
Methods and Results. In 14 patients with VT late (8.2 ± 5.2 yrs) after my-
ocardial infarction BSM and simultaneous left ventricular 64-site basket endocar-
dial mapping was performed during a total of 17 monomorphic VTs. In addition,
multisite pacing by sequential use of the 64 basket electrodes was performed in 9
patients. BSM and basket mapping revealed the same endocardial breakthrough
sites in of 8 of 17 VTs (47 %) and 189 of 322 pacing sites (59 %); adjacent sites
were found in 2 of 17 VTs (12 %) and 36 of 322 pacing sites (11 %). Large zones
of conduction block explained the mismatch in localization in 2 of 17 VTs (12 %)
and 52 of 322 pacing sites (16 %). Regional differences in endocardial electrogram
amplitudes were found as a cause for dissimilarity in 3 of 17 VTs (18 %) and 73
of 322 pacing sites (23 %). Multiple endocardial breakthrough sites were found
1 of 17 VTs (6 %) and 8 of 322 pacing sites (2 %). Finally, an epicardial exit site
was suggested in 3 of 17 VTs (18 %) as an explanation for mismatch since no early
endocardial activity could be recorded.
Conclusion. Zones of conduction block, regional differences in signal am-
plitude and multiple endocardial breakthrough sites are frequent causes for mis-
match between BSM and basket catheter activation mapping.
3.2 Introduction
Body surface mapping (BSM) can be used as a non-invasive tool to determine
the site of earliest endocardial activation of postinfarction ventricular tachycardia
(VT). For this purpose, integral maps of the total QRS complex acquired with mul-
tiple body surface leads are compared with a reference database of QRS integral
maps previously obtained during endocardial pace mapping [1].
It is well known that the mechanism underlying postinfarction VT late after
myocardial infarction can be attributed to reentry and that the arrhythmogenic
substrate is often situated in the subendocardium [2–4]. The endocardial exit site,
i.e. the site where surviving strands of myocardial fibers are connected to the
non-infarcted myocardium, can be considered as an electrophysiologically well-
defined anatomical landmark of the arrhythmogenic substrate. This landmark
can be used as a starting point to identify other parts of the reentrant circuit, such
as the central common pathway, which is often used as a direct target for radiofre-
quency or surgical ablation [5].
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Because of its greater spatial resolution BSM has been shown to be superior to
the conventional 12-lead electrocardiogram (ECG) for assessment of the VT exit
site [6,7]. However, the potential at every point on the body surface is determined
by summation of the electric activity in the entire heart. This implies that not only
the site of earliest endocardial and epicardial activation, but also the global spread
of activation will contribute to the genesis of the QRS complex on the surface ECG.
In the structurally normal left ventricle, BSM is capable of providing a high spatial
VT localization resolution [5]. In patients with prior myocardial infarction, the
spread of activation during VT may be profoundly affected due to structural and
functional changes, which may cause a spatial mismatch between the endocardial
and epicardial breakthrough site [8,9]. This may partly explain why BSM is able to
assess the exact endocardial exit site of postinfarction VT in only 60–70 % of cases
while it offers an approximation of the origin in an additional 25 % of cases [1].
To date, there have been no clinical studies reported in which the total body
surface QRS morphology was simultaneously compared with endocardial spread
of left ventricular activation. It was the purpose of this study to identify mecha-
nisms that may cause BSM to fail in assessing the correct site of earliest endocar-
dial activation in patients with prior myocardial infarction. To reach this goal, we
simultaneously recorded 62 body surface potentials and 64 endocardial unipolar
left ventricular electrograms using a basket catheter in patients with VT remote
after myocardial infarction. The endocardial breakthrough site and the BSM de-
termined site of origin were compared during VT and endocardial pacing. These
data were then evaluated with respect to the patterns of left ventricular activation.
3.3 Methods
3.3.1 Patient selection
All patients admitted to our hospital between November 1997 and February 1999
for antiarrhythmic surgery or radiofrequency catheter ablation of infarct related
VT were considered for inclusion in this study. Specific eligibility criteria included:
(1) documented recurrent ventricular arrhythmias with or without aborted sud-
den cardiac death; (2) inducible sustained monomorphic VT during programmed
electrical stimulation. Transthoracic echocardiography was applied to assess the
dimensions of the left ventricle and to exclude the presence of a mural left ven-
tricular thrombus or significant aortic valve disease since these conditions can
interfere with safe deployment of the basket catheter. All antiarrhythmic drugs
were discontinued for at least 5 drug elimination halve times before the study.
The research protocol was approved by the Ethical Committee of the St Antonius
Hospital. Prior written informed consent was obtained.
3.3.2 Electrophysiologic study
Induction of VT was carried out using a routine stimulation protocol including
delivery of up to 3 extrastimuli following a drive train of 8 stimuli (2 ms pulse
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width at twice the diastolic threshold current) with three different cycle lengths
(600, 500 and 430 ms). A 6 Fr quadripolar catheter was positioned in the right
ventricular apex or right ventricular outflow tract for this purpose.
If VT proved to be inducible, a 64-electrode unipolar basket catheter (Constel-
lation CatheterTM, Boston Scientific, Inc.) was percutaneously inserted after termi-
nation of VT. In a subset of 9 patients pace mapping during sinus rhythm with the
basket catheter was performed before renewed induction of VT was attempted.
The threshold was determined separately for each electrode of the basket catheter
and, if capture could be obtained, pacing just above the current threshold with a
drive cycle of 500 ms was performed.
3.3.3 Data acquisition and mapping
Data from the endocardial basket catheter and BSM electrodes were recorded si-
multaneously on a battery-powered 128-channel digital acquisition device [10,11].
Analogue to digital conversion occurred at a sampling frequency of 2 kHz, 16-bits
resolution and a bitstep of 2 Ñ V/bit. Wilson’s central terminal was used as refer-
ence for the unipolar surface ECGs. The amplifier system had a bandpass char-
acteristic using a frequency range of 0.16 – 400 Hz (3 dB frequencies). Data were
transmitted using a fiberoptic transmission unit and stored in a Pentium based
PC.
3.3.4 Body surface mapping
Body surface ECGs were recorded using a radiotransparent carbon unipolar elec-
trode grid that does not interfere with fluoroscopic imaging during catheteriza-
tion. The 62 electrodes were positioned in 14 flexible vertical straps that were
applied on the anterior and posterior thoracic surface as described elsewhere [12].
A mean of 2.0 ± 1.8 leads per map were rejected because of unsatisfactory sig-
nal quality and were replaced by a value computed from neighboring electrodes.
Our methods of processing and analysis have been described previously [13]. In
short, after performing a baseline correction to exclude any possible contribution
of baseline drift or interelectrode offset difference, the beginning and end of the
QRS complex were set at the time instant at which one of the extreme amplitudes
reached Ò 0.2 mV and at the J point, respectively. A QRS integral map was com-
puted for each VT and for every paced ventricular complex. Each VT and paced
QRS integral map pattern was correlated with an anterior or inferior myocardial
infarction database comprising mean paced QRS integral maps produced previ-
ously at 18 and 22 different specific endocardial segments, respectively (Figure
3.1 and 3.2) [14]. Pattern matching of QRS integral maps was performed both
visually and mathematically using correlation coefficients [14, 16]. Visual analy-
sis involved comparison of the position and orientation of the extremes and the
morphology of the zero line.
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Figure 3.1: This figure represents the database of mean paced QRS integral maps pre-
viously acquired in patients with prior anterior (AMI) myocardial infarction. Encircled
numbers depict the location of pacing segments in a schematic overview of the endocardial
surface of the left ventricle (LV) as defined in the previously developed AMI (18 segments)
database. Mean paced QRS integral database maps are displayed and matched to the endo-
cardial segment by the encircled number. Endocardial segments as defined by Josephson et
al. are indicated by the regular numbers (12 segments) [15]. Reproduced with permission
of the American Heart Association.
3.3.5 Multielectrode endocardial mapping
Catheter placement
The basket catheter consists of 8 self-expanding nitinol splines mounted on a 110
cm long 8 Fr catheter shaft. Each spline has 8 symmetrically arranged electrodes.
Selection of catheter size was based on the dimensions of the left ventricle as deter-
mined by 2D transthoracic echocardiography. In our series a basket catheter with
a diameter of either 75 mm or 94 mm was chosen resulting in a vertical interelec-
trode spacing of 7 or 9 mm, respectively. Horizontal interelectrode distance varied
with the positioning and deployment of the catheter. An 11 Fr introducer was in-
serted in the right femoral artery using the standard Judkins technique to advance
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Figure 3.2: The database representing mean paced QRS integral maps previously acquired
in patients with prior inferior (IMI) myocardial infarction is shown. Encircled numbers
depict the location of pacing segments in a schematic overview of the endocardial surface of
the left ventricle (LV) as defined in the previously developed IMI (22 segments) database.
Mean paced QRS integral database maps are displayed and matched to the endocardial
segment by the encircled number. Endocardial segments as defined by Josephson et al. are
indicated by the regular numbers (12 segments) [15]. Reproduced with permission of the
American Heart Association.
a 7 Fr pigtail catheter into the left ventricle. Then, a long 10 Fr guiding sheath
was placed in the left ventricle across the aortic valve over the pigtail catheter and
the collapsed basket catheter was advanced through the guiding sheath in the left
ventricle after removal of the pigtail catheter. The guiding sheath was then pulled
back allowing deployment of the basket catheter in the left ventricle. The activated
clotting time was kept longer than 300 seconds by full heparinization to avoid
thromboembolic complications. A 6 Fr quadripolar catheter was inserted percu-
taneously through the right femoral vein and positioned in the intra-abdominal
part of the inferior caval vein to serve as a far field recording and pacing reference


























Figure 3.3: Panel A shows right (RAO) and left (LAO) anterior oblique fluoroscopic
projections of the deployed basket catheter in the left ventricle. Markers for the A- and
B-spline are highlighted by small white arrows. The stimulation catheter (RV cath) is
positioned in the right ventricle and marked with a dashed white arrow. The proximal
part of the basket catheter (shaft) is located in the aorta and marked with a dashed white
arrow. Recording electrodes are depicted with a dot of unique color for each spline. Panel
B features the reconstruction of the 3D shape and positioning of the basket catheter in the
left ventricle as viewed in the RAO and LAO projections. Letters A to H identify the 8
individual splines. Electrodes along splines are numbered 1 to 8 from apex to base of the
heart.
Fluoroscopic localization of the basket catheter
Since basket catheter positioning varies from patient to patient, the exact posi-
tion of the individual basket electrodes was determined using biplane 45  right
(RAO) and left 45  anterior oblique (LAO) digital cine fluoroscopy (Philips Med-
ical Systems Integris). After selecting the same end-diastolic frames from both
fluoroscopic projections, splines A and B, which carry one and two additional ra-
diopaque markers, respectively, were identified (Figure 3.3A). After labeling elec-
trodes of these two splines, the other splines could be identified by comparing
their relative position with the known position of the first two splines. Each in-
dividual electrode and the central apical spline connector were then marked and
given 2D coordinates in the RAO and LAO projections. A panel of three expe-
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rienced interventional electrophysiologists verified correct identification of each
electrode. Finally, by combining the data from the RAO and LAO projections, 3D
coordinates for each electrode were calculated thereby allowing a realistic anatom-
ical rendering of the position and shape of the basket catheter in the left ventricle
for each individual patient (Figure 3.3B). The coloring of the basket in panel B
does not have an electrophysiological meaning, but is merely used to enhance 3D
visualization. To be able to compare basket catheter activation mapping and pace
mapping data with electrocardiographic localization results, the location of each
basket catheter electrode was mapped to an endocardial segment in one of the two
databases of paced QRS integral maps.
Endocardial data processing
A software package was developed for on-line data processing based on MatLab
5.1 (The MathWorks, Inc.) [17]. The surface Laplacian has been proposed to opti-
mize the detection of small deflections in the endocardial unipolar electrograms.
These small sharp deflections are believed to result from local events as opposed
to larger, more flaccid, deflections which are presumed to be caused by remote
events [18–20]. The Laplacian suppresses remote deflections, but still has the char-
acteristics of the unipolar electrogram. In contrast to bipolar electrograms, the
Laplacian is direction independent. However, the surface Laplacian has only been
validated for spatially dense electrode grids (interelectrode distances of 1 mm or
less), and no data on its value for electrode systems with interelectrode systems of
5–10 mm are available at present. Therefore, in our study a co-axial electrogram
was used. This co-axial electrogram was constructed by subtracting the mean
electrogram from the 8 surrounding electrodes weighted for distance, from the
unipolar signal recorded at the central electrode. This procedure is numerically
equivalent to the surface Laplacian but differs from it by a factor that is deter-
mined by the electrode distances. Therefore, activation time parameters, such as
zero line crossing, moment of dVdtminand onset and offset of the electrogram are
equal to those derived from a surface Laplacian. An example of activation se-
quences reconstructed with the aid of co-axial electrograms is shown in figure 3.4.
3.3.6 Definitions of parameters and related terminology
A VT was considered to be monomorphic and sustained if it lasted for at least 30
seconds without significant changes in the QRS morphology as monitored in the
12-lead ECG. The local endocardial activation time was determined by the steep-
est deflection (dV/dtmin

in the local electrogram. An endocardial breakthrough
was defined as an endocardial site where an activation wave front emerged and
from where it spread radially. The endocardial VT exit site was defined as the
site where the earliest endocardial breakthrough occurred relative to the onset of
the QRS complex on the simultaneously recorded surface ECG [15]. An epicardial












Figure 3.4: An example of activation sequences reconstructed during VT. Standard pre-
cordial lead V3 and 8 endocardial electrograms (A1 to A8), obtained using co-axial elec-
trogram reconstruction, are shown. The dotted line indicates the body surface QRS onset.
The diastolic activation pattern is indicated by the large black arrow pointing downwards.
Small black arrows indicate the presence of diastolic potentials. Diastolic activation leads
to electrode A7, which precedes the QRS complex and is considered the exit site of VT.
¿From there, systolic activation (large upward pointing black arrow) can be traced back to
the start of the diastolic wave front in electrode A1, completing the reentry circuit.
10 ms after the onset of the body surface QRS complex. If activation times of sig-
nals recorded at contiguous sites (7–9 mm apart) differed by 50 ms, conduction
block was considered present [21].
3.3.7 Statistical analysis
All data were stored in a computerized patient record database. Data analysis
was performed on a personal computer using the “The SAS System for Windows
6.12” statistical software package (SAS Institute, Inc). Data are presented as mean
values ± SD unless stated otherwise. Statistical significance was defined as a P
value  0.05.





















Figure 3.5: Endocardial activation mapping and BSM during ventricular tachycardia
(VT) in patient 6 (Table 2) who suffered from a previous anterior infarction. Panel A
depicts the activation sequence of the left ventricle in right (RAO) and left (LAO) anterior
oblique projections. Activation times in the isochrone maps are relative to the onset of the
body surface QRS complex and range from 2 ms (red) to 268 ms (blue). The VT exit site
is located midseptal at electrode A3 (origin of black arrows). Panel B depicts the VT QRS
integral map, which is compatible with the mean paced QRS integral map belonging to
segment AMI9 (correlation coefficient of 0.92) located in the midseptal wall, compatible
with Josephson location 3.
3.4 Results
3.4.1 Patient characteristics
Seventeen consecutive patients with documented infarct-related sustained ven-
tricular arrhythmias were eligible for the study. In 2 of 17 patients (12 %), no
adequate deployment of the basket catheter could be obtained, while in 1 of 17
patients (6 %), only non-sustained VTs could be induced. These three patients
were excluded from further analysis. The characteristics of the remaining 14 pa-



















































Figure 3.6: Endocardial activation mapping and BSM during ventricular tachycardia
(VT) in patient 2 (Table 2) who suffered from a previous posterolateral infarction. Panel A
depicts the activation sequence of the left ventricle in right (RAO) and left (LAO) anterior
oblique projections. Activation times in the isochrone maps are relative to the onset of
the body surface QRS complex and range from -9 ms (red) to 127 ms (blue). The VT
exit site is located basal and posterolateral at electrode A7 (origin of white arrows). A
line of block extending from the basal posterolateral area to the apical posterolateral area
(along spline B) can be noted (white dotted line). This line of block forces the activation
front to propagate towards the anterolateral wall. In panel B the RAO basket projection
has been rotated computationally in horizontal and vertical direction to provide a non-
standard rear projection in order to demonstrate the area of interest, i.e. the line of block
along the B-spline. Panel C depicts the VT QRS integral map, which is compatible with
the mean paced QRS integral map belonging to segment IMI7 (correlation coefficient of
0.91) located at a remote segment in the basal anterior wall compatible with electrode 1 on
spline G (Josephson location 12).
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No. of VT morphologies per patient∗ 1.3 ( 1– 4 )
VT cycle length (ms) 318 ± 65
Scintigraphic LVEF (% ) 27.8 ± 9.5
Echocardiographic dimensions
LV end diastolic length (mm) 90.5 ± 9.6
LV end diastolic width (mm) 55.2 ± 6.8
WMS (max. 9 of 9 normal segments)∗ 3.2 (3 – 5)




Time since infarction (years) 8.2 ± 5.2
Site of myocardial infarction
Anterior 9
Inferior 5
Table 3.1: Baseline characteristics (N=14). (CAD = coronary artery disease; LV = left
ventricle; LVEF = left ventricular ejection fraction; WMS = wall motion score; VT =
ventricular tachycardia. ∗ = median (range))
3.4.2 Correlation of VT localization using body surface mapping
and basket catheter activation mapping
A total of 17 sustained monomorphic VTs were localized using BSM and basket
catheter activation mapping (Table 3.2).
In 8 of 17 VTs (47 %), the endocardial exit site was located in the endocardial
segment predicted by BSM, whereas in 2 other VTs (12 %), the endocardial exit site
was situated in a neighboring segment. Seven of 17 VTs (41 %), originated from
a segment remote from the segment identified by BSM. Therefore, in 10 of 17 VTs
(59 %), BSM appeared to correctly localize or regionalize the actual endocardial
VT exit site. An example of a matching VT site of origin is shown in figure 3.5.
3.4.3 Body surface mapping during endocardial pace mapping
For a median of 30 of 64 electrodes (range 17 – 54) pacing capture could be ob-
tained. This required a mean pacing current strength of 7.9± 6.4 mA. The mean in-
terval between the pacing stimulus and the onset of the body surface QRS complex
was 36 ± 20.4 ms. There was no significant difference in the mean stimulus-to-
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VT VT mor- Axis Cycle Segment Site of Distance
phology Length of earliest of earliest between




1 VT1 LBBB Superior 340 IMI2 {1} IMI2 {1} Same
2 VT1 RBBB Inferior 430 IMI7 {12} IMI19 {10} Remote
3
VT1 RBBB Superior 200 IMI9 {3} IMI20 {7} Remote
VT2 RBBB Inferior 250 IMI6 {11 6 12} IMI6 -12} Same
4 VT1 RBBB Superior 420 AMI17 {9-11} AMI1 {1-7} Remote
5 VT1 RBBB Horizontal 380 AMI17 {9-11} AMI3 {11} Adjacent
6 VT1 LBBB Superior 330 AMI9 {3} AMI9 {3} Same
7 VT1 RBBB Superior 320 AMI8 {2-3} AMI7+AMI13 Adjacent
{3}+{5-7}
8 VT1 RBBB Inferior 230 AMI18 {10} AMI18 {10} Same
9 VT1 RBBB Inferior 240 AMI18 {10} AMI7 {3} Remote
10 VT1 LBBB Superior 260 AMI9 {3} AMI15 {9-10} Remote
11 VT1 RBBB Superior 440 IMI16 {5} IMI3 {11} Remote
12 VT2 RBBB Superior 320 AMI17 {9} AMI17 {9} Same
VT3 LBBB Superior 320 AMI9 {3} AMI1 {1} Remote
13 VT1 LBBB Superior 320 IMI9 {3-4} IMI9 {3-4} Same
VT2 RBBB Superior 320 IMI13 {4} IMI13 {4} Same
14 VT1 LBBB Superior 300 AMI9 {3} AMI9 {3} Same
Table 3.2: Comparison of VT site of origin determined using body surface mapping
and basket activation mapping. (AMI=Anterior myocardial infarction database seg-
ment; BSM=Body surface mapping; IMI=Inferior myocardial infarction database seg-
ment; JL=Josephson Location; LBBB=Left bundle branch block morphology; RBBB=Right
bundle branch block morphology; VT=Ventricular tachycardia)
QRS interval between matching and non-matching pace mappings (p=0.8). This
implied that localization mismatch was not due to breakthroughs that were re-
mote from the pacing site as can be seen when stimulation occurs within the zone
of slow conduction. A total of 322 paced QRS maps (median 30, range 17 – 54 per
patient) were obtained. The mathematical correlation between each paced QRS
integral map and the best matching mean paced QRS integral map from the ref-
erence database was 0.87 ± 0.07 (range 0.48 – 0.98). For 189 of the 322 paced QRS
integral maps (59 %), the fluoroscopic position of the pacing electrode was located
in the same endocardial segment as the best matching mean paced QRS integral
map from the database. An adjacent segment of the database was found in 36










































Figure 3.7: Endocardial activation mapping and BSM during ventricular tachycardia
(VT) in patient 7 (Table 2) who suffered from a previous anterior infarction. Panel A
depicts the activation sequence of the left ventricle in right (RAO) and left (LAO) anterior
oblique projections. Activation times in the isochrone maps are relative to the onset of the
body surface QRS complex and range from -2 ms (red) to 310 ms (blue). The VT exit site
is located anteroseptal and midposterior at electrode A7 and electrode F5 (origin of black
arrows). In panel B the basket projection has been rotated computationally to provide a
non-standard inferior view. Clearly, two distinct exit sites are visible. Panel C depicts
the VT QRS integral map, which is compatible with the mean paced QRS integral map
belonging to segment AMI8 (correlation coefficient of 0.89) located at an adjacent segment
in the inferoseptal region, compatible with electrode 4 on spline H (Josephson location 3-5).
of 322 pacing sites (11 %). The database segment was located remote from the
endocardial pacing site in 97 of 322 paced QRS integral maps (30 %)
3.4.4 Electrophysiologic mechanisms responsible for mapping
mismatches
Endocardial activation patterns and electrogram distributions acquired during
VT and pacing with the basket catheter, were reviewed in detail to explain mis-
matches between sites of earliest endocardial activation identified with BSM and
basket mapping. Three major mechanisms could be identified: extensive lines of









































































Figure 3.8: Endocardial pace mapping data obtained in patient 2 with previous posterolat-
eral myocardial infarction. The infarction scar is located basal posterolateral near splines
A and B. Stimulation is performed at electrode C2, located midinferior (Josephson location
5). Panel A depicts the activation sequence of the left ventricle in right (RAO) and left
(LAO) anterior oblique projections, ranging from -14 ms at electrode C2 (red) to 109 ms
(dark blue). The solid black arrow indicates the site of stimulation. Panel B shows the
paced QRS integral map that compares best (correlation coefficient of 0.84) with the mean
paced QRS integral map of database segment IMI14 which is located basal inferoseptal
(Josephson location 4-6). Panel C demonstrates RAO and LAO projections of the dis-
tribution of endocardial signal amplitude, ranging from 0.42 V (dark blue) to 8.8 V (red).
The dashed black arrow indicates the position of database segment IMI14, which is situated
adjacent to the stimulation site in an area where the signal amplitude is larger.
docardial signal amplitude.
Conduction block
Substantial lines of conduction block were found in 2 of 17 VTs (12 %) that were
both obtained in patients with inferior myocardial infarction preventing centrifu-
gal spread of ventricular activation. In 52 of 322 paced activation sequences (16 %)
lines of block prevented radial spread from the area of initial activation. This re-
sulted in a mismatch between the segment of earliest activation determined with
BSM and the actual location of the pacing electrode on the basket catheter. At 36 of
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52 pacing sites (69 %) that were not correctly localized with BSM, the best match-
ing database segment was situated remote from the pacing electrode, whereas in
16 of these 52 incorrectly identified pacing sites (31 %), the pacing location was lo-
calized to an adjacent database segment. An example of BSM mismatch as a result
of conduction block is shown in figure 3.6.
Multiple endocardial breakthroughs
In 1 of 17 VTs (6 %) that was obtained in a patient with previous anterior myocar-
dial infarction (Patient 7 in Table 2), two endocardial breakthroughs were found:
one in the midanteroseptal area and the other near the posterior papillary mus-
cle. Localization using the BSM database indicated a midinferoseptal segment of
origin, which is located in between the two actual endocardial breakthrough sites.
An example is shown in figure 3.7.
During pace mapping, multiple breakthrough sites (i.e. two distinct sites with
radial spread of activation) were found in 8 of 322 maps (2 %). In these cases the
site of stimulation appeared to be at a remote location remote with respect to the
database segment identified with BSM.
Differences in signal amplitude
In 3 of 17 VTs (18 %) where the BSM database localized the site of origin to an
adjacent endocardial segment, the electrogram amplitude at the endocardial seg-
ment of origin predicted by BSM was much larger than that measured at the true
endocardial exit. At 73 of 322 pacing sites (23 %), differences in signal amplitude
resulted in a mismatch between the two methods. The obtained database seg-
ment was remote in 52 of 73 incorrectly localized pacing sites (71 %). At 21 of 73
pacing sites (29 %), an adjacent database segment was predicted. An example of
BSM mismatch caused by differences in magnitude of the endocardial potential,
is shown in figure 3.8.
Epicardial breakthrough
In 3 of 17 VTs (18 %), no clear reason for mismatch could be found by examining
the endocardial spread of activation. Two of these three VTs were documented
in patients with previous anterior myocardial infarction, one VT was found in a
patient with a prior inferior myocardial infarction. In these VTs, no early endocar-
dial activity (i.e. within 10 ms after the onset of the body surface QRS) was noted.
These findings were considered to be suggestive for an epicardial or intramural
exit.
3.5 Discussion
The present study shows that BSM indicated the correct left ventricular segment
of initial endocardial activation in 50 – 60% of VT episodes and endocardial pac-
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ing sequences, whereas in an additional 10 – 20 % regional approximation was
achieved. These localization results are comparable to previously reported retro-
spective data obtained in a similar patient cohort [1].
The earliest site of endocardial activation, the subsequent spread of ventric-
ular activation and the site of epicardial breakthrough all contribute to the QRS
morphology on the body surface ECG. In order to predict the earliest site of en-
docardial activation, one of the assumptions made in electrocardiography is that
the activation front during VT spreads out centrifugal and travels predominantly
in a perpendicular fashion from the presumed endocardial breakthrough site to
the epicardial surface. However, in postinfarction VT the anatomical substrate is
often extensively altered. Therefore, the spread of activation may deviate from its
anticipated centrifugal pattern. This can give rise to alternative activation spread
patterns after myocardial infarction [9]. It has also been shown that minor shifts
in the endocardial exit site can lead to major differences in body surface ECG mor-
phology if transmural spread of activation is not directly from endocardium to epi-
cardium [22–25]. Although this problem is partially circumvented by using BSM
databases that are specific for previous anterior or inferior myocardial infarction,
it is conceivable that due to the complex anatomical nature of the postinfarction
arrhythmogenic substrate, activation patterns may differ between individual pa-
tients. This may lead to incorrect BSM prediction of the presumed endocardial
segment of origin of postinfarction VT. In our study, several patterns of activation
were identified that can explain disparity in mapping outcome.
3.5.1 Electrophysiologic mechanisms causing disparity between
body surface mapping and endocardial mapping
Non-homogeneous spread of endocardial activation due to large zones of conduc-
tion block caused dissimilarity in mapping findings in 2 of 17 VTs (12 %) and 52
of 322 paced activation sequences (16 %). Zones of conduction block prevented
radial spread of activation from the site of endocardial breakthrough. This was
also observed in a canine infarct model where the extent of the line block was one
of the causes of different scalar ECG morphologies during sustained VT [26]. Oss-
wald et al. have shown in a similar experimental model that minor changes in the
site of endocardial breakthrough can lead to different activation spread patterns
and subsequent body surface ECG morphology [25].
Two separate endocardial breakthrough sites were found in only a minority
of cases during pacing and VT. Multiple breakthrough sites in the postinfarction
heart, especially after anterior myocardial infarction, have been reported previ-
ously both during sinus rhythm [9] and VT [27]. Since database guided BSM of
postinfarction VT is developed to localize a single segment of earliest activation,
simultaneous occurrence of two or more distant breakthrough sites will by defini-
tion produce an incorrect localization result using the BSM approach. In our study,
the segment of VT origin was, however, spatially localized by BSM between the
two actual endocardial breakthrough sites.
In 15–20% of VT episodes or pacing sequences, the breakthrough site was situ-
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ated in the infarct border generating small signal amplitudes, whereas signal am-
plitudes were larger in other non-infarcted endocardial areas. Since high-voltage
areas will generate more electromotive force on the surface ECG, they may in fact
partially suppress the low-voltage information resulting from the true endocardial
site of VT origin. Mathematical correlation between measured VT QRS integral
maps and reference database mean paced QRS integral maps is currently obtained
by computing the normalized inner product of the vectorized measured map and
all vectorized reference database maps and selecting the highest correlation coef-
ficient [13]. This makes the computational result more susceptible to the number,
location and magnitudes of the positive and negative extremes on the map. If the
magnitude of the positive and negative extremes on the map differ considerably,
the best mathematical match between the VT or paced QRS integral map and the
reference database mean paced QRS integral map will be based primarily on the
position of the larger extreme.
Although the reentrant circuit in postinfarction VT is believed to be located
predominantly in the subendocardial layer, other mapping studies that combined
endocardial and epicardial mapping have demonstrated that approximately 15 %
of VTs have a partially subepicardial circuit and an earlier epicardial breakthrough
of the activation wave front [28]. We did not find clear early endocardial activity
within 10 milliseconds of the onset of the body surface QRS complex in 18 % of
VTs. In these cases an earlier epicardial or intramural exit site was believed to
be present although this could not be confirmed due to lack of epicardial activa-
tion data. The absence of early endocardial activation may also have been caused
by insufficient endocardial basket coverage of the endocardial exit site. However,
the incidence of our findings is similar to the incidence of early epicardial break-
through of postinfarction VT reported in the literature [28].
3.5.2 Methodological considerations in QRS isointegral mapping
Apart from electrophysiologic considerations, methodological issues connected
with reference database oriented QRS isointegral mapping should be taken into
account as well. Correct identification of the baseline and onset QRS are crucial
for accurate computation of QRS areas intended for QRS integral map localiza-
tion of sites of VT origin. Two major problems concerning baseline correction
and identification of the onset of the QRS complex are: superposition of the on-
set of the QRS complex on the T-wave of the preceding QRS-complex and non-
simultaneous departure of the QRS complex in different leads. We think that two
separate cases should be contemplated. The first case is when the VT under study
does not have an extremely short cycle length. Then, usually an isoelectric inter-
val between T-wave and QRS onset can be identified which can be utilized for
baseline correction. The onset and offset QRS are subsequently chosen from an
instantaneous isopotential map as the instant when the first electrode has reached
a value of more than 0.2 mV (onset) and the instant when each lead has dropped
below 0.2 mV (offset), respectively. In this case non-simultaneous departure of the
QRS complex will not be of great influence since the integral of the QRS complex
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is used: the contribution of the integral of a prolonged isoelectric interval before
onset QRS in an individual lead with late QRS departure to the entire QRS integral
will be approximately zero. It is possible that in leads with earliest QRS complex
departure a small post J-point part of the ST-T segment is integrated, but since
voltages in the early ST-T segment are usually low, the integral of these early ST-T
segment parts over a small time interval will be neglectable as compared to the
magnitude of the QRS integral.
The second case is when the VT under study has a short cycle length and there
is no clear isoelectric interval between the T-wave end and onset QRS. VTs of this
particular rapid rate usually will be sinusoid in shape with QRS complex and T-
wave morphology that are approximately similar but opposite in sign. Baseline
correction points are subsequently chosen at best clinical judgment. The possi-
bility remains that — due to confluence of QRS complex and T-wave and non-
simultaneous QRS complex departure — unequal parts of the T-wave are inte-
grated with the QRS complex in different leads. However, in these leads with
late QRS departure also unequal parts of the terminal QRS complex will not be
included in the QRS integral. This will amount to approximately the same abso-
lute value as the additional area of the T-wave end that was erroneously added in
these leads since the T-wave has approximately the same shape as the QRS com-
plex. We think that these errors of measurements will approximately annihilate
each other, since QRS complex and T-wave are of opposite sign. This will still
allow QRS integral map localization by reference database comparison.
3.5.3 Limitations of the study
The basket catheter used in this study is introduced in the left ventricle in a col-
lapsed state. Before it is capable of providing high resolution mapping of endocar-
dial activation it has to be fully deployed in the left ventricle. To reliably locate the
exit site of VT adequate endocardial basket catheter coverage of the exit site area
is mandatory. Since complete catheter deployment of the catheter is not always
feasible endocardial VT breakthrough sites located in uncovered endocardial re-
gions may have not been recorded. To prevent this, two patients with imperfect
catheter deployment were omitted from further analysis. Additionally, localiza-
tion differences were studied during basket pacing. When endocardial pacing is
performed and capture is obtained, the exact site of earliest endocardial activation
is the fluoroscopic location of the basket catheter electrode. Therefore endocardial
basket coverage is less an issue during endocardial pacing.
No simultaneous epicardial mapping was performed and therefore VTs with
an epicardial exit site may have been wrongly classified as VTs where the BSM
localization and endocardial exit site did not match. In 3 of 17 VTs, in our series
no early endocardial breakthrough could be detected and therefore an epicardial
exit was believed to be present.
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3.5.4 Clinical application of body surface mapping.
BSM has been used previously for guiding ventricular arrhythmia surgery. In our
study, BSM has proven to identify or approximate the segment containing the VT
exit site in 70–80 % of cases. Because the surgeon can ablate the reentrant circuit
more substantially than the more circumscribed thermal lesion, produced during
radiofrequency ablation, the resolution that BSM offers appears to be sufficient
[29].
In a recent study BSM has proven to be of great clinical utility in guiding ra-
diofrequency ablation of idiopathic VT [5]. The mapping results in their study are
very well comparable to the localization results in our study. Reference database
guided BSM was compared by Peeters et al. with endocardial pace mapping in
the same patient. The same endocardial segment was found in 53 % of VTs and
47 % of VTs were mapped to an adjacent endocardial segment. It should be noted
that the patients involved in this study did not have any structural heart disease.
Therefore it can be expected that activation spread patterns were not influenced
by altered anatomy of the left or right ventricle. Furthermore, when using pace
mapping in combination with BSM and comparing the paced maps with the QRS
integral map of VT induced in the same patient, as was done in the study of Peeters
et al. [5], each patient is used as his own reference. Because all map comparisons
are done in the same patient — i.e. the same electrophysiologic substrate — dis-
crepancies due to differences in torso, heart geometry and individual activation
spread patterns are no longer relevant.
Reference database guided BSM is a non-invasive tool that can greatly facil-
itate mapping of postinfarction VT including hemodynamic unstable and non-
sustained VTs. In the normal left ventricle BSM offers a high spatial mapping
resolution that is appropriate to directly guide radiofrequency ablation. How-
ever, changes in activation spread patterns in the structurally altered postinfarc-
tion heart cause BSM to provide inaccurate results in 20–30% of the localized VTs.
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4.1 Abstract
Introduction. The exit site and central common pathway of slow conduction
are preferred sites to guide radiofrequency ablation of postinfarction ventricular
tachycardia (VT). Both require inducibility of VT. In addition, their low ampli-
tude hampers direct recording of potentials generated by activation in pathways
of slow conduction. We hypothesized that pacemapping during sinus rhythm is
able to detect the VT exit site and potentials generated by activation in pathways
of slow activation.
Methods and Results: In 13 patients suffering from VT late after anterior (10
pts) or inferior (3 pts) myocardial infarction stimulation was performed in scarred
endocardium at 23.5 (13–36) sites per patient during arrhythmia surgery. Multi-
electrode recordings (64 sites) during stimulation at fixed cycle length of 500 ms
were obtained. Endocardial breakthrough sites distant ( Ò 2 cm) from the pacing
site were found at 4.3 (3–19) pacing sites per patient. Low amplitude discrete po-
tentials could be detected between the pacing site and the breakthrough site in 2.3
(0–13) of 4.3 stimulation sequences. In these patients 19 VTs were induced and the
exit site determined. In 6 patients the distant pacing breakthrough site was identi-
cal to the VT exit site, whereas in 7 patients no similar exit sites were found. Low
amplitude discrete potentials during VT were found at median 2.0 (0–14) sites per
patient.
Conclusion: Pacemapping of the postinfarction endocardial scar during sinus
revealed 46% of the endocardial exit sites of VT and the same number of low am-
plitude discrete potentials observed during VT.
4.2 Introduction
The mechanism underlying postinfarction ventricular tachycardia (VT) is reentry
and the arrhythmogenic substrate is often anatomically localized in the subendo-
cardium [1–3]. Surviving myocardial fibers, encased in a fibrous sheath, provide
tracts of slow conduction that are essential for the emergence and perpetuation of
VT [4]. Direct electrographic detection of these tracts of slow conduction is diffi-
cult due to short cycle length of VT and the limited size of these tracts resulting in
relatively small electrographic deflections as compared to remote signals from sur-
rounding viable myocardium [5]. Furthermore, the existence of presystolic poten-
tials during VT does not necessarily imply a functional role of the corresponding
tract in maintaining VT. Stevenson et al. reported on the contribution of concealed
entrainment during VT in functionally localizing these tracts [6]. Concealed en-
trainment, however, can only be applied as localization method in patients with
inducible VTs.
We hypothesized that pace mapping of the arrhythmogenic substrate during
sinus rhythm may help to identify the VT exit site and surviving tracts of my-
ocardium and clarify their anatomic relation to the site of origin of VT [7, 8]. We
carried out multi site pace mapping and multi-electrode registration during sinus
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rhythm to identify zones of slow conduction in the subendocardial scar that may
be crucial pathways of the postinfarction VT substrate.
4.3 Methods
4.3.1 Study patients and preoperative examination
Patients admitted to our hospital for ventricular arrhythmia surgery between April
1995 and May 1998 with a history of coronary artery disease and documented re-
current ventricular arrhythmias with or without aborted sudden cardiac death
were eligible for the study. Patients were considered eligible for map-guided ar-
rhythmia surgery if at least 3 of 9 segments of the angiographically visualized left
ventricle showed a normal contraction pattern according to a ventriculographic
wall motion score [9]. Electrophysiologic recordings during pacing required less
than 10 minutes of mapping time. Patients were informed about the arrhythmia
mapping and surgical procedure according to our hospital policy. Informed con-
sent was obtained from all patients.
4.3.2 Intraoperative electrophysiologic study and surgical
techniques
Antiarrhythmic drugs were withdrawn for at least 5 half times before surgery in
all patients. All patients were anaesthetized using nitrous oxide, narcotics and
muscle relaxants. Normothermic cardiopulmonary bypass was initiated with the
perfusion temperature maintained at 37  C. A needle electrode impaled in non-
excitable tissue served as far field reference electrodes for the unipolar balloon
electrodes. Epicardial bipolar pacing electrodes were placed on the right ven-
tricular outflow tract and the right atrium. A unipolar pacing far field reference
electrode was positioned in the subcutis of the border of the sternotomy wound,
which was considered remote electrically unexcitable tissue. The left ventricu-
lar aneurysm or scar was incised and a small opening was created to be able
to insert a custom made inflatable balloon in collapsed state into left ventricu-
lar cavity (Figure 4.1). The balloon, which contained 64 unipolar terminals at an
interelectrode distance of 1 to 1.5 cm, was then inflated to provide electrode endo-
cardium contact. Depending on the anterior or inferior location of the left ventric-
ular aneurysm or scar a choice was made between 2 differently shaped endocar-
dial balloons [10]. Standard surface ECG leads I, II and III were simultaneously
recorded during the mapping procedure.
Recordings of sinus rhythm were used to determine the extent of the postin-
farction endocardial scar. An electrode was considered to be situated in scarred
tissue if the derived endocardial unipolar signal was “fragmented” (Figure 4.2)
and the putative moment of local activation displayed a dV/dtmin of less than
20% of the maximal negative dV/dtmin found in the endocardial recording area in
the same patient [4].






Figure 4.1: The introduction of the balloon electrode designed for anterior myocardial
infarction patients in the left ventricle is depicted. The apical aneurysm is opened just
enough to allow insertion of the deflated balloon. Then, the ventriculotomy is partially
closed and the balloon inflated to insure optimal electrode-endocardium contact.
Prior to induction of VT unipolar pacing was performed on each balloon elec-
trode, identified as situated in scarred endocardial tissue. Pacing was done with
a fixed drive cycle of 500 ms, a pulse width of 2 ms and stimulus strength of just
above the diastolic threshold. A standard external stimulation unit (Nihon Koh-
den VM186) was used for this purpose. Multi-electrode recordings were made
for each pacing sequence with adequate capture using a computerized mapping
system [10]. The mapping system consisted of a 256-channel analog-to-digital con-
version amplifier with entrance characteristics of 2 Ñ V/bit and 16-bit width.
Local main activation was defined as the steepest descending slope (dV/dtmin

in the unipolar electrogram (Figure 4.2). A breakthrough was defined as an endo-
cardial site where an activation wave front emerged and from where it spread ra-
dially. The endocardial VT exit site was defined as the endocardial breakthrough
that occurred earliest with respect to the onset of the QRS complex on the simul-
taneously recorded surface ECG [11]. The “breakthrough site” of pacing was de-
fined as the site located near the infarction scar border where electrical activity
entered viable myocardium.
To induce VT, programmed electrical stimulation with up to 4 extrastimuli was
















Figure 4.2: Electrographic definitions. Local endocardial electrograms are shown which
are considered: (1) normal. The black arrow indicates the moment of local activation;
(2) fragmented as in scarred endocardium; (3) contain low amplitude discrete potentials
(LADPs) (black arrows); (4) represent the exit site of VT. Note the Purkinje signal preced-
ing the main electrographic deflection (black arrow). The vertical lines indicate the onset
of the QRS complex on the surface ECG.
made and endocardial activation maps determined. The endocardial site of origin
was defined as that site at which the earliest local activation — characterized by
the steepest descending slope (dV/dtmin

in the unipolar signal — was recorded
with reference to the onset of the simultaneously recorded QRS complex on the
body surface ECG. The surgical ablation procedure consisted of subendocardial
resection, endocardial cryoablation or a combination of these procedures [12]. Sur-
gical resection or cryoablation was performed as selectively and limited as possi-
ble. Selection of areas suitable for resection or cryoablation was guided by visual
inspection of the endocardium by the surgeon and the endocardial maps obtained
by mapping of the induced VTs.
After completion of the surgical arrhythmia ablation, the ventriculotomy was
closed. If additional surgical procedures, such as ventricular aneurysm remod-
elling, valve replacement or myocardial revascularization, were mandatory, the
patient was cooled, the aorta cross-clamped, cold crystalloid cardioplegia admin-
istered and the surgical procedure completed by standard techniques.
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4.3.3 Signal processing
The electrographic deflections of interest often have low amplitude and may be
masked by large remote deflections or stimulus artifacts during pacing. To en-
hance delectability of tiny electrograms the following signal processing techniques
were applied.
Due to the exponential post pacing RC current decay, unipolar pacing tended
to distort the initial 30 ms of post pacing interval of the electrograms recorded in
neighboring electrodes. In order to improve the detection of early activations, an
exponential decaying signal was subtracted from each channel starting from the
end of the pacing spike. Fitting of the exponential decaying signal was performed
by a least square fit of amplitude, time constant and offset to the interval 30 ms af-
ter the manually indicated end of pacing artifact. The exponential was subtracted
in an interval of 50 ms if the timeconstant was in the expected range.
To further optimize the detection of small electrographic deflections indicating
local events as opposed to large remote deflections a Laplacian transformation
was used [13, 14]. The Laplacian is the second spatial derivative of the unipolar
electrogram and a measure for the transmembrane current at the recording site.
It therefore suppresses remote deflections, but still has the characteristics of the
unipolar electrogram. Thus, in contrast to bipolar electrograms, the Laplacian is
direction independent. In our study the Laplacian is determined by subtracting
the mean of the signals of the 8 surrounding electrodes, weighed for interelectrode
distance, from the signal recorded at the central recording electrode.
Finally, to improve signal to noise ratio and to emphasize the high frequency
local deflections without a phase shift a Blackman filter with band pass character-
istics of 40-200Hz was used.
4.3.4 Analysis of mapping data
All mapping data were reviewed in detail in a data committee consisting of 3
experienced electrophysiologists. Concomitant review of the original recording
and filtered or otherwise processed signals was performed.
Breakthrough sites were considered distant relative to the pacing electrode if
the breakthrough characteristics were found in other electrode recordings than
those directly adjacent to the pacing electrode. In these cases, conduction was
considered to follow strands of preserved myocardial fibers connecting the pac-
ing site to non-infarcted myocardium. All other pacing electrodes were labeled as
having non-distant breakthrough sites. Since electrode interspacing was 1.0 to 1.5
cm, distant breakthrough sites were more than 2 cm apart from the pacing elec-
trode. Attempts were made to reconstruct the path of conduction from the pacing
electrode to the breakthrough site by closely examining the interposed electrodes
for low amplitude discrete potentials (LADPs).
The following definitions of LADPs were used. In sinus rhythm a LADP was
defined as a small electrographic deflection, consistently present in all recorded
QRS complexes, which was located after the offset of the body surface QRS com-
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plex. During pacing and VT a LADP was defined as a small consistent electro-
graphic deflection preceding activation recorded at the endocardial breakthrough
or exit site respectively (Figure 4.2 ).
4.3.5 Statistical analysis
All data were stored in a computerized patient record database. Data analysis was
performed on a personal computer using the “The SAS System for Windows 6.12
statistical software (SAS Institute, Inc)”. Continuous data are presented as mean
values ± SD unless stated otherwise. Subgroup comparisons were made using
Chi-square or Fisher’s exact test, whenever appropriate. Statistical significance
was defined as a P value  0.05.
4.4 Results
4.4.1 Study population
Thirteen patients who underwent arrhythmia surgery for recurrent postinfarction
VT between April 1995 and May 1998 were included in the study. Baseline clini-
cal characteristics are displayed in Table 4.1. All patients underwent arrhythmia
surgery more than 6 months after their most recent myocardial infarction to allow
for adequate healing of the myocardial scar. Most patients had multiple sustained
VT morphologies during preoperative electrophysiologic testing (median 2.4 VT
morphologies, range 1 – 5).
4.4.2 Clinical results
There was no in-hospital mortality. All patients underwent postoperative elec-
trophysiologic testing 7 days after surgery. Two patients were inducible with an
induction sequence including 2 extrastimuli. These patients were treated with so-
talol and remained arrhythmia free during 2-year follow-up. In one patient one
VT morphology remained inducible with a single extrastimulus, but the VT cycle
length had increased from 240 ms to 420 ms. This patient underwent successful
radiofrequency catheter ablation for this VT. Finally, one patient that was non-
inducible during postoperative electrophysiologic testing died suddenly 3 months
later. An arrhythmic death was presumed in this case.
4.4.3 VT Morphologies
In total, 29 VT morphologies were induced during preoperative electrophysiologic
testing. Fifteen of these 29 preoperative VT morphologies (52 %) were re-induced
during ventricular antiarrhythmic surgery in these patients. Four of the 19 in-
traoperatively induced VT morphologies (21 %) were never documented before
surgery. In 1 of 13 patients (8 %) no VTs could be induced during surgery. Only in
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Age (years) 59.5 ± 8.2
Sex
Male 11 (85 %)
Female 2 (15 % )
No. of VT morphologies per patient∗ 2.4 (1 – 5)
VT cycle length (ms) 295 ± 56
Scintigraphic LVEF (% ) 30.1 ± 11.1
WMS (max. 9 of 9 normal segments)* 3.6 (3-6)
Extent of CAD ( Ò 70 % stenosis)
0 vessel 2 (15 % )
1 vessel 3 (24 % )
2 vessel 2 (15 % )
3 vessel 6 (46 % )
Time since infarction (years) 12.5 ± 7.8
Site of myocardial infarction
Anterior 10 (77 % )
Inferior 3 (23 % )
Concomitant surgery
CABG 7 (54 % )
MVR/MVP 1 ( 8 % )
Surgical procedure
Cardiopulmonary bypass (min) 98.1 ± 36.8
Intraoperative mapping (min) 21.5 ± 3.1
Aortic cross clamping time (min) 42.5 ± 22.8
Table 4.1: Baseline and surgical intervention characteristics (N=13). (CABG = coronary
artery bypass grafting; CAD = coronary artery disease; LVEF = left ventricular ejection
fraction; MVR/MVP = mitral valve replacement or valvuloplasty; WMS = wall motion
score; VT = ventricular tachycardia. * = Median (range). )
2 of 13 patients (15 %) all VT morphologies that were documented during preop-
erative electrophysiologic testing were re-induced intraoperatively.
4.4.4 Endocardial electrograms
Data on the endocardial electrograms are summarized in Table 4.2. The percent-
age of endocardium that was scarred was 36.7% (a median of 23.5 of 64 electrode
terminals per patient). A significant correlation was found between the number
of terminals situated in scarred endocardium and the mean dV/dtmin in sinus
rhythm in all 64 electrodes (r=0.59, p=0.03). A schematic overview of the signal
analysis flow sheet is presented in Figure 4.3.
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Extent of endocardial scar (electrodes)* 23.5 (36.7 % ) [13–36]
Adequate pacing capture (% ) 59.0 ± 23.2
Non-distant breakthroughs per patient (electrodes)* 9.0 (14.1 % ) [3–22]
Distant breakthroughs per patient (electrodes)∗ 4.3 (6.7 % ) [3–19]
Distant breakthroughs per patient with bridging 2.3 (3.6 % ) [0–13]
LADPs (electrodes)*







































Figure 4.3: Schematic overview of signal analysis. All electrograms are inspected for
fragmentation to identify whether they are located in scar tissue (1). Electrode terminals
situated in scarred endocardium are paced if capture can be obtained (2). If capture can be
obtained activation maps are reviewed for distant breakthroughs and anatomical paths of
conduction (3).
4.4.5 Pacing in scar tissue and VT exit site
Adequate pacing capture could be obtained in 59.0 % of selected electrodes per
patient using stimulus strengths up to 9.9 V at pulse width of 2.0 ms. Non distant
breakthrough sites were found in median 9.0 (3-22) of these successful pacing at-
tempts per patient, whereas distant breakthrough sites were found in median 4.3
(0-13) stimulation sequences per patient. In median 2.0 stimulation attempts per
patient a distant breakthrough was found. Delay between the moment of stim-
ulation and the emergence of electrical activity at the breakthrough site was sig-
nificantly longer when the breakthrough was distant than in those stimulation
attempts where the breakthrough was non-distant (44.8 ± 4.8 ms vs. 17.9 ± 2.1
ms, P=0.02).
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Type of recording Number of electrode terminals displaying
low amplitude discrete potentials
Sinus rhythm 0.7 ± 1.3 (range 0–4) of 64 terminals
Ventricular tachycardia 2.0 ± 3.4 (range 0–14) of 64 terminals
Distant breakthrough 2.4 ± 3.7 (range 0–20) of 64 terminals
Non distant breakthrough 0.8 ± 1.5 (range 0–7) of 64 terminals
Table 4.3: Low amplitude discrete potential characteristics.
In 13 patients 19 intraoperative sustained monomorphic VTs with distinct VT
morphology (median 1.1, range 1–3) were induced whereas in these patients in
54 distinct stimulation sites (median 2.3, range .0-13) a distant breakthrough was
found during pacing. Thirty-seven of these 54 pacing sites with distant break-
throughs proved to be anatomically distinct (median per patient 2.3, range 0-6).
The exit site of 7 of the 19 induced VTs (37 %) was identical with a distant break-
through site during pacing. In 7 patients 1 VT exit site was identical to one of the
distant breakthrough sites, whereas in 6 patients no intraoperative VT with similar
pacing breakthrough site was found.
4.4.6 Isolated low amplitude discrete potentials
The distribution of the presence of LADPs is summarized in Table 4.3. More
LADPs were identified during VT than during sinus rhythm. A distinction was
made between LADPs recorded during VT in the border zone of the infarct (i.e. an
electrode terminal located in scarred tissue bordering normal tissue) and LAPDs
recorded in the inner scar. From a total of 75 recorded LADPs during VT, 34
LADPs were found in the infarct border, whereas 41 LADPs were found in the
central scar.
When pacing was performed during sinus rhythm approximately the same
number of electrode terminals was found displaying LADPs as during VT if a so-
called distant breakthrough was present. However, in pacing interventions that
showed a non-distant breakthrough the presence of isolated LADPs was equiv-
alent to that during sinus rhythm. Significantly more LADPs were found when
a distant breakthrough was present as compared to non-distant breakthroughs
(p=0.0001). If LADPs could be identified in VT then in 70 % of cases (sites) LADPs
were seen during pacing at these same anatomical sites. Only in 24 % of cases
LADPs were seen during sinus rhythm at sites where LADPs had been noticed
during VT.
4.4.7 Pathways during infarct pacing and VT
Isolated LADPs recorded during infarct pacing were found at more than 1 site in























Figure 4.4: Fractionated electrograms during sinus rhythm. Panel A. Schematic repre-
sentation of the endocardial surface of the left ventricle. The outlined grayed septal and
anterolateral area depicts the endocardial scar. Panel B. Electrographic tracings (A-G)
obtained during sinus rhythm from electrode terminals located along the putative diastolic
path of VT as indicated in Figure 4.5. The dotted line indicates the offset of the body sur-
face QRS complex in lead II. Clear fragmentation is present in electrodes B, C, D, F and
G. Only at site G a low amplitude deflection occurs after the offset of the surface QRS
complex (arrow).
able to reconstruct the tract from pacing site to breakthrough site and to correlate
it with recordings during VT. An example is illustrated in the figures 4.4 to 4.8. A
same schematic drawing of the left ventricular endocardium with the location of
scar tissue indicated is shown in panel A. The myocardial wall is incised along the
left anterior descending artery and then folded outwards. The endocardial scar
(gray area) is located in the septal and anterolateral region with extension into the
posterior area. Numbers indicate recording sites. The characters A to G point to
sites where electrograms with the same character were recorded. Short arrows in
electrograms point to local activation times. Long arrows show the sequence of
activation where applicable.
In figure 4.4 tracings are shown during sinus rhythm. Electrograms are frac-
tionated, indicating that the recording sites are located in scar tissue. In figure 4.5
seven electrograms obtained during VT are shown. The sequence of activation






















Figure 4.5: Activation during ventricular tachycardia. Panel A as in figure 4.4.The
arrow indicates the putative pathway of the reentrant circuit of the VT within the infarcted
zone. Panel B shows electrographic tracings obtained during ventricular tachycardia.
Small black arrows indicate local activation times. Diastolic pathways (long arrows) are
demonstrated which run from the apicoseptal area through the anterior wall to a mid-
anterolateral (E) and an anterolateral-basal breakthrough (K) as visualized by the arrow in
panel A. I, II, III = standard extremity ECG leads.
delineates a diastolic pathway (arrows in figure 4.5A), leading through the scar to
2 breakthrough sites in the mid-anterolateral (site E) and anterolateral-basal (site
K) region respectively.
Pacing at electrode 42 (site J in figure 4.6), located adjacent to the diastolic path-
way resulted in LADPs at sites where diastolic potentials were recorded during
VT. Figure 4.7 shows the electrograms of figure 4.6 after subtraction of the expo-
nential decay of the stimulus artifact and application of the Laplacian technique.
Conduction delays between the sites D and A in the tract were similar during VT
and stimulation (45 ms respectively 42 ms).
Conduction to the mid anterolateral VT breakthrough site (site E) occurred via
an alternative tract, evidenced by the fact that site E was activated prior to site
C. Activation proceeded towards the site where activation entered the diastolic
pathway during VT (site G) via the same pathway, but in retrograde direction.
Activation along this section of the pathway blocked near the entrance site (site G).
























Figure 4.6: Activation during stimulation at site J. Panel A as in figure 4.4. The ar-
row indicates the putative pathway of the reentrant circuit of the VT within the infarcted
zone. Panel B depicts local endocardial electrograms obtained during unipolar pacing at
electrode terminal J in sinus rhythm at pacing cycle length 500 ms. Note that the break-
through into the viable myocardium at site E is the same as during VT (4.5, Panel A).
Black arrows mark low amplitude discrete potentials (LADPs). Propagation from D to A
and towards F is via the same route as during VT (long arrows in Panel A). Activation
is conducted from J to E via an alternative tract (short arrow in Panel A). Retrograde
conduction to F appears to block between F and G (no breakthrough at G).
stimulation.
In the same heart, pacing from site A (the exit site of the VT in the anterolateral-
basal area) resulted in a distant exit (site E in figure 4.8). Activation proceeded via
the same diastolic pathway as during VT and stimulation at site J, but in opposite
direction. Arrows in panel B point to activation times. Their sequence indicate
spread of activation from B to E. Activation delay between site B and E was 68
ms, which is similar to the activation delay between these 2 sites during VT (72
ms). To justify the selected activation times, the same signal processing procedures
as indicated in the methods were applied. Panel C shows the electrograms after
subtraction of the exponential decay.



















Figure 4.7: Signal processing of electrograms shown in figure 4.6. Electrograms are dis-
played after subtraction of the exponential pacing decay and application of the Laplacian
procedure. Arrows mark the moment of local activation in the signals. Note that in tracing
D the local deflection was masked in the raw signal by the stimulus artifact
4.5 Discussion
4.5.1 Main results
In our study, pacing with adequate capture was possible in 59 % of “scarred”
electrode terminals although large stimulation amplitudes (9.9 V) were required
in a number of pacing sequences. In approximately one third of electrodes dis-
playing features of scarring the pacing breakthrough was found in the adjacent
electrode. In these cases propagation of electrical activity was considered to be
the result of capture of nearby non-infarcted myocardium. In 10 % of paced elec-
trode terminals breakthrough site electrograms were found with variable delay
in non-adjacent electrodes. In these cases conduction along a strand of surviv-
ing myocardial tissue, anatomically separated by fibrous tissue from surrounding
myocardium, was postulated to take place. Therefore, these pacing sites were con-
sidered to be potentially located in the reentrant circuit. The exit site of 37 % of the
VTs was identical with a distant breakthrough site during pacing.
The extent to which LADPs can be recorded during sinus rhythm appears to be
limited. In our series less than 1 LADP on average was found per 64 electrode ter-
minals. This number increases to 2.4 LADPs, which is the same number of LADPs
found during VT, when pacing at a cycle length shorter than the sinus rhythm cy-
cle length is applied. Signal processing techniques as described are necessary for






















Figure 4.8: Panel A as in figure 4.5. The arrow indicates the putative pathway of the
reentrant circuit of the VT within the infarcted zone. Panel B depicts local endocardial
electrograms at sites obtained during unipolar pacing at electrode terminal A in sinus
rhythm at pacing cycle length 500 ms. The wave front propagates towards E via part of the
diastolic pathway during VT (Figure 4.5). Panel C shows electrograms after subtraction
of the exponential decay. Arrows mark the moment of local activation
4.5.2 Signal processing
Unipolar electrograms were chosen in this study, because information on the tim-
ing of local activation is more precise [15]. Furthermore, the detection of a passing
wave front is not dependent on the direction of this wave front. In our study in-
terelectrode distance ranged from 1 to 1.5 cm. This spatial resolution may have
implications for the number of LADPs found. It is conceivable that more LADPs
can be found when mapping is performed with a mapping electrode with smaller
interelectrode distance. Major disadvantage of the use of unipolar electrogram is
that the LADPs are relative small compared to the remote deflections of the cavity
potential. Using the Laplacian technique circumvents this disadvantage.
To increase the visibility of LADPs at recording sites near the stimulus expo-
nential curve subtraction had to be used. Laplacian spatial filtering and exponen-
tial subtraction were the two signal processing techniques that highly improved
detection of LADPs. The value of bi-directional Blackman filtering was less signif-
icant.
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4.5.3 Pacing threshold
Stimulation was performed with just above pacing threshold. However, in a sub-
stantial number of cases fairly large stimulation currents were needed. This might
be due to abnormal current flow in infarcted myocardium and the large distance
from the site of stimulation to excitable non-infarcted myocardium. It cannot be
ruled out that these stimulation currents may have caused capture of remote ex-
citable tissue erroneously resulting in distant breakthroughs. It should be noted
that distant breakthroughs were by definition at least two interelectrode distances
( Ò 2 cm) from the pacing site and therefore it is unlikely that pseudo-distant break-
throughs by remote capture occurred in a large number of cases.
Secondly, pacing scarred tissue with sufficient stimulation strength to achieve
capture often resulted in disfiguration of the initial unipolar electrogram follow-
ing the pacing spike. To permit analysis of LADPs in the initial 30 ms following
the pacing spike subtraction of an exponentially fitted curve from this segment
of the electrogram was in fact obligatory. Since this malformation of the electro-
gram by pacing causes merely an RC exponential decay curve by the capacitive
and resistance properties of the electrode-tissue interface, we believe that this sig-
nal processing did not introduce new artifacts or obscure true deflections in the
original electrogram.
4.5.4 Related studies
Bogun et al. demonstrated that arcs of block that are anatomically determined
and present during sinus rhythm bound the area of slow conduction [8]. The
authors stated that sites displaying isolated diastolic potentials in VT that cannot
be dissociated during concealed entrainment appear to represent effective sites for
radiofrequency ablation. In addition, they showed that these LADPs also could be
identified during pacing in sinus rhythm at these sites. However, in their study
the presence of LADPs during sinus rhythm was investigated in patients, who
exhibited isolated diastolic potentials during VT. This study was performed in
incessant and hemodynamically stable VTs and only sites of interest that were
already identified during VT were explored for the presence of LADPs during
sinus rhythm. Therefore it cannot be concluded from the study of Bogun that in
non-selected patients these sites can be identified without prior knowledge of their
appearance during VT.
In our study, fractionated electrograms were identified in 23.5 of 64 electrodes
(36.7 %). This is highly comparable to the spatial amount of electrocardiographical
scarring in postinfarction sinus rhythm mapping that has been reported in other
studies [16, 17]. Kienzle et al. reported that in 4 of 13 patients 5 % of mapped sites
displayed isolated potentials during sinus rhythm [16]. This appears to correlate
with the number of LADPs found during sinus rhythm in our study
4.5. Discussion 89
4.5.5 Clinical significance of VT exit sites and LADPs
Ablation of infarct related VT can be carried out at the VT exit site as well as in
the central common pathway. The latter is usually preferable because it affects
the most vulnerable site with the smallest dimensions of the circuit. The exit site
may be wide requiring more extensive ablation. The advantage of VT exit abla-
tion is however the fact that this site can always be determined whereas signals
generated by the common pathway are often too small to be detected.
We showed that VT exit sites can be determined by our pacing technique in
37 % of VTs. Several factors can be hold responsible for this rather poor yield. In
the first place, the direction of conduction over the diastolic pathway may differ
during VT and pacing. Therefore VT scar-entry sites may have been presented as
endocardial breakthroughs during endocardial pacing. Since endocardial break-
through was defined as the endocardial site which displays earliest radial endo-
cardial spread of activation, the site where the diastolic pathway connects to the
non-infarcted myocardium that is anatomically closest to the pacing site, will be
presented as breakthrough, regardless whether it is the entry or exit site of the
VT circuit. Secondly, it should be noted, that a pacing cycle length of 500 ms was
used, which often is considerably longer than the VT cycle length. This differ-
ence in cycle length might affect the presence of unidirectional functional block
within the circuit thereby again presenting VT entry sites as endocardial pacing
breakthroughs. Thirdly, a 64-electrode balloon was used. It is conceivable, that
the ability of pace mapping to detect pathways of slow conduction is dependent
on the electrode resolution of the balloon and the size of the slow conduction
pathway. Narrow tracts of fibers leading to VT exit sites may have been missed
due to too low spatial electrode resolution. Better results may be achieved with a
256-electrode balloon. Fourthly, the yield of intraoperative VT induction is com-
paratively low. In order to position the endocardial balloon, the left ventricular
postinfarction aneurysm was incised. Therefore, the postinfarction VT reentrant
circuit may have been interrupted before measurements were made. Only 52 %
of preoperative VT morphologies were re-induced during surgery. This may ex-
plain why more endocardial breakthrough sites were found during pacing than
intraoperative VT exit sites. The latter may be an advantage over traditional acti-
vation sequence mapping since information on the arrhythmogenic substrate that
otherwise might have been unobtainable can now be retrieved.
Stevenson et al. reported on the use of pacing interventions during VT for
determining the functional significance of the various constituting parts of the
reentry circuit [6]. Analysis of the post pacing interval following concealed en-
trainment can identify sites suitable for radiofrequency catheter ablation of a lim-
ited but crucial part of the arrhythmogenic substrate. However, localization of the
common slow conducting pathway with concealed entrainment can only be per-
formed if VT is inducible. Furthermore, it appears that not all sites fulfilling post
pacing interval criteria that are compatible with a location in the central common
pathway are in fact located along a crucial pathway [18, 19].
Finding the central common pathway of postinfarction VT in sinus rhythm
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would substantially improve clinical applicability of radiofrequency ablation of
postinfarction VT. Sinus rhythm mapping has, however, a number of drawbacks.
We showed that, the number of LADPs recorded during sinus rhythm is smaller
than during pacing. Furthermore, during sinus rhythm the direction of the wave
front causing the LADP is not known since the onset of this wave front is not
known. This precludes reconstruction of the path of propagation. In contrast,
when ventricular pacing is performed the relation of the LADP with the direction
of propagation of the activation front is known since the onset — i.e. the pacing
electrode — and the destination — i.e. the endocardial breakthrough — of the
wave front are known. This allows for reconstruction of a path between the pacing
site and the endocardial breakthrough.
This study shows that pathways of conduction in the infarction scar can be
found by using endocardial pacing. Whether the currently presented mapping
technique is helpful in ablating the central common pathway of postinfarction
VT can as yet not be concluded from these data. Firstly, it is not certain that all
sites that display LADPs and that are located between pacing electrode and en-
docardial breakthrough are along the same path. It is possible that these sites are
situated on interconnecting and branching paths. Secondly, the role these recon-
structed connections fulfill in perpetuation of VT remains unclear. As outlined
before, our pacemapping method only anatomically localizes surviving strands of
myocardium in the endocardial scar. Whether these tracts are crucial parts of the
reentrant circuit or merely play a role as bystander pathways cannot be derived
from these data.
Currently, most of the data analysis was performed offline. The functional role
of surviving strands in perpetuating VT could therefore not be proven by selective
interruption of these strands and its effect on inducibility of VT. Online data anal-
ysis and selective interruption of these tracts, which results in non-inducibility
of VT, will be necessary to identify the exact functional nature of the surviving
strand. Online analysis of the data is feasible since all the algorithms required for
signal processing have been developed. Also, newly developed mapping devices
such as electromagnetic mapping and non-contact mapping may be very helpful
in extending this mapping technique to the electrophysiology laboratory [20, 21].
4.6 Conclusion
Pacemapping and multi-electrode recording increases information on the course
of conduction through the postinfarction scar. The extent to which LADPs are
found is significantly greater than during sinus rhythm and comparable to VT.
This localization method is less dependent on inducibility of VT or paucity of
coexisting VT morphologies. At present, this mapping technique cannot be con-
sidered a replacement for activation sequence mapping for ablation of VT but it
does provide information on arrhythmogenic regions in the postinfarction heart.
To judge whether interruption of the pathways found results in curative termina-
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5.1 Abstract
Objective: Signal averaged electrocardiography (SAECG) is used as a non-invasive
tool to predict arrhythmic events in various subsets of patients. At present, in-
formation on the location of arrhythmogenic regions in the heart cannot be ob-
tained from standard SAECG using 3 orthogonal leads. Objectives were (1) to in-
vestigate the sensitivity and specificity of signal averaged body surface mapping
(SABSM) in detecting late potentials as compared to SAECG and (2) to localize
non-invasively the arrhythmogenic regions in postinfarction ventricular tachycar-
dia (VT) by SABSM.
Methods: Simultaneous 3-minute recordings with a 62-electrode body surface
mapping (BSM) device to obtain SABSM and SAECG and a 64-electrode endocar-
dial basket catheter were obtained during sinus rhythm as well as during VT in 16
patients (12 male) with remote (8.7± 5.1 years) myocardial (10 anterior, 6 inferior)
infarction. In 12 patients without structural heart disease SABSM and SAECG
were performed without endocardial mapping. QRS complexes obtained with
BSM were signal averaged and a 25 Hz high-pass bi-directional filter was applied.
Body surface integral maps of the 50 ms following the J-point (LPMAP) were con-
structed. Basket recordings were reviewed for late potentials. Electrodes display-
ing late potentials were marked on the 3D reconstruction of the basket catheter.
Results: None of the patients without structural heart disease showed activity
in the LPMAP or had a positive SAECG. All postinfarction VT patients did show
activity in the LPMAP, whereas in 13 of 16 patients the 3-lead SAECG was nega-
tive. In total 6.2± 5.7 (range 1–18) endocardial late potentials during sinus rhythm
were found in the VT patients. Visual inspection showed anatomic correlation of
0.6± 0.12 between the basket site of diastolic potentials and activity in the LPMAP
electrode.
Conclusion: SABSM has an increased sensitivity and specificity in detecting
late potentials as compared to SAECG. Furthermore, SABSM is capable of delin-
eation of these areas that are indispensable for the genesis of postinfarction VT.
Whether SABSM may be useful in non-invasively confining areas that serve as
target for VT ablation procedures remains to be established in a prospective study.
5.2 Introduction
High resolution signal averaged electrocardiograms (SAECG) have shown low-
level, high-frequency potentials immediately after the QRS complex in patients
suffering from coronary artery disease related ventricular tachycardia (VT) dur-
ing sinus rhythm [1]. At present, SAECG is used to identify subjects prone to
sustained VT, but detection of late potentials (LPs) has been of limited use [2–4].
Only 17% to 29% of postinfarction patients with LPs on the SAECG will experi-
ence sustained VT or ventricular fibrillation within 1 year [5]. Several authors re-
ported that extending the number of surface electrodes and performing frequency
domain analysis, may enhance the diagnostic value of signal averaging [6, 7].
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The mechanism underlying postinfarction VT can be attributed to reentry and
the arrhythmogenic substrate is often situated in the subendocardium [8–10]. Sur-
viving myocardial fibers, encased in a fibrous sheath, provide tracts of slow con-
duction that are essential for the emergence and perpetuation of postinfarction
VT [11]. It has been suggested that late ventricular potentials on the SAECG arise
from activation in these tracts of slow conduction [12, 13]. Therefore, late poten-
tials are believed to reflect the presence of areas of delayed conduction, which are
part of the reentrant circuit [14, 15]. Direct detection of these tracts of slow con-
duction of postinfarction VT by catheter mapping is often time consuming due to
the extent of scarred endocardium. Non-invasive delineation or narrowing down
of the regions where tracts of slow conduction can be found during sinus rhythm
may greatly facilitate radiofrequency ablation of postinfarction VT.
At present, no spatial information on the anatomical sites of origin of LPs can
be derived from the SAECG. A spatially high resolution body surface mapping
electrode system, in addition to the low noise level obtained by signal averaging,
may enhance non-invasive detection of the endocardial areas that generate LPs
during sinus rhythm and may provide information on their anatomical location
[13, 16, 17].
Therefore, we postulated that 1) the sensitivity for detection of LPs increases by
signal averaged body surface mapping (SABSM) as compared to SAECG without
loss of specificity and 2) SABSM is capable of anatomic delineation of endocardial
areas with delayed conduction. To validate this hypothesis, 62-channel SABSM
and 3-lead SAECG was performed in addition to simultaneous multisite endocar-
dial mapping by means of a 64-electrode basket catheter in patients with postin-
farction VT, whereas for comparison SABSMs and 3-lead SAECGs were obtained
in 12 healthy controls.
5.3 Methods
5.3.1 Patient selection
The research protocol, which was approved by the Ethical Committee of our in-
stitution, was performed on two groups of patients who had given prior written
informed consent. The control group consisted of 12 healthy controls (7 females, 5
males), mean age 42.1 ± 16.6 years (range 16 – 63 years), who had normal electro-
cardiograms, normal echocardiograms, no history of cardiovascular disease and
who were not receiving medication. The patient group comprised 16 patients re-
ferred to our hospital between November 1997 and February 1999 for antiarrhyth-
mic surgery or radiofrequency catheter ablation of infarct related VT. Specific eli-
gibility criteria included both: (1) documented recurrent ventricular arrhythmias
with or without aborted sudden cardiac death; (2) inducible sustained monomor-
phic VT during programmed electrical stimulation. The investigation conforms
with the principles outlined in the Declaration of Helsinki. Characteristics of the
patient group are presented in Table 5.1. In both groups SAECG and SABSM was
performed, but only in the patient group a basket catheter was percutaneously
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No. of VT morphologies per patient∗ 1.3 ( 1 – 4 )
VT cycle length (ms) 318 ± 65
Scintigraphic LVEF (%) 26.0 ± 9.3
Echocardiographic dimensions
LV end diastolic length (mm) 91.8 ± 9.7
LV end diastolic width (mm) 56.4 ± 7.9




Time since infarction (years) 8.7 ± 5.1
Site of myocardial infarction
Anterior 10
Inferior 6
Table 5.1: Patient characteristics (N=16). (CAD = coronary artery disease; LV = left ven-
tricle; LVEF = left ventricular ejection fraction; VT = ventricular tachycardia. ∗ = median
(range))
inserted in the left ventricle. Transthoracic echocardiography was applied before
the procedure to assess the dimensions of the left ventricle and to exclude the
presence of a mural left ventricular thrombus or significant aortic valve disease
since these conditions interfere with safe deployment of the basket catheter. All
antiarrhythmic drugs were discontinued in the patient group for at least 5 drug
elimination halve times before the study. Two postinfarction patients were previ-
ously treated with amiodarone but in these patients amiodarone was discontinued
5 and 6 weeks before the study, respectively.
5.3.2 Electrophysiologic study
Induction of VT was carried out using a routine stimulation protocol including
delivery of up to 3 extrastimuli following a drive train of 8 stimuli (2 ms pulse
width at twice the diastolic threshold current) with three different cycle lengths
(600, 500 and 430 ms). A 6 Fr quadripolar catheter was positioned in the right
ventricular apex or right ventricular outflow tract for this purpose. If VT proved
to be inducible, a 64-electrode unipolar basket catheter (Constellation CatheterTM,
Boston Scientific, Inc.) was percutaneously inserted after termination of VT. Then
renewed induction of VT was attempted.
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5.3.3 Data acquisition and mapping
Data from the endocardial basket catheter and BSM electrodes were recorded si-
multaneously using a 128-channel digital acquisition device (Biosemi Inc.) [18,19].
Analogue to digital conversion occurred at a sampling frequency of 2 kHz, 16-bits
resolution and a bitstep of 2 Ñ V/bit. Wilson’s central terminal was used as refer-
ence for the BSM electrograms. The amplifier system had a bandpass characteristic
using a frequency range of 0.16 – 400 Hz (3 dB frequencies). Data were transmitted
using a fiberoptic transmission unit and stored in a Pentium based PC. Continuous
3-minute 128-channel recordings of sinus rhythm were obtained.
5.3.4 Signal averaged body surface mapping
Recording and signal averaging
Body surface ECGs were recorded using a radiotransparent carbon unipolar elec-
trode grid that does not interfere with fluoroscopic imaging during catheteriza-
tion. The 62 electrodes were positioned in 14 flexible vertical straps that were
applied on the anterior and posterior thoracic surface as described elsewhere [20].
A mean of 2.0 ± 1.8 leads per map were rejected because of unsatisfactory signal
quality and were replaced by a value computed from neighboring electrodes.
To calculate signal-averaged electrograms, a template QRS complex was se-
lected. The beginning and end of the template QRS complex were set at the time
at which one of the extreme amplitudes reached Ò 0.2 mV and at the J point, re-
spectively. Then, an interval for signal averaging was selected comprising the
template QRS complex and its subsequent T-wave. The QRS template was used
to scan the entire lead recording for QRS complexes that fitted the QRS template
with a correlation coefficient of more than 0.80. The selected intervals were time
aligned and baseline correction was performed for all QRS complexes. Mean and
standard deviation for the entire selected interval were computed for every time
instant of the time aligned interval. To allow exclusion of non-sinus rhythm beats
and intervals that contained artifacts, even if the artifacts were outside the QRS
template, only selected intervals in which no sample exceeded the mean of the
time aligned interval plus three times its standard deviation were used for signal
averaging. The noise level in each interval was estimated in the filtered signal in
a 100 ms interval near the end of the T-wave. This noise estimate was used to
compute an averaged signal that was weighted for noise instead of a coherently
averaged signal. This insured the reconstruction of a signal averaged QRS com-
plex that contained minimal noise.
Three orthogonal X, Y, and Z leads were reconstructed from a selection of 3
electrode pairs from the 62 body surface electrodes that matched the positions of
the XYZ leads best. The SAECG was obtained from these X, Y, and Z leads. De-
tection of LPs in the SAECG and the 62 body surface electrodes was performed
as described earlier [5]. In short, a bi-directional Butterworth 25 Hz high pass fil-
ter was applied from beyond the end of the QRS complex and before the onset of
the QRS complex towards the middle of the QRS complex. Finally, the root mean
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squared filtered signal was computed. Parameters indicative for the presence or
absence of LPs were defined according to the Simson criteria [1]. To summarize
these criteria: end of the total filtered QRS complex was considered the time where
- when searching in reverse direction from T-wave towards the filtered QRS com-
plex - the signal amplitude became larger than the mean noise level and three
times its standard deviation for more than 5 ms. Total QRS duration (QRSD) is
the duration from onset to end of the filtered QRS complex [1]. The LAS40 was
defined as the number of milliseconds preceding the end of the filtered QRS com-
plex where the signal amplitude was smaller than 40 Ñ V. The RMS40 was defined
as the root mean square value of the voltage in the last 40 ms before the QRS offset
of the filtered QRS complex.
Calculation of late potential maps
Body surface integral maps of LPs (LPMAP) were obtained by calculating the inte-
gral of the root mean squared filtered complex in the 50 ms segment following the
end of the QRS complex (J-point) as determined in the unfiltered QRS complex for
each of the 62 body surface electrodes. To correct for the influence of the distance
of the body surface electrode to the heart, each integral value in the LPMAP was
divided by the normalized integral value of the root mean squared filtered total
QRS complex in that lead. The LPMAP was considered positive for LPs if its value
exceeded the 50 ms integral of noise for that channel three times.
5.3.5 Multielectrode endocardial mapping
Catheter placement
The basket catheter consists of 8 self-expanding nitinol splines mounted on a 110
cm long 8 Fr catheter shaft. Each spline has 8 symmetrically arranged electrodes.
Selection of catheter size was based on the dimensions of the left ventricle as deter-
mined by 2D transthoracic echocardiography. In our series a basket catheter with
a diameter of either 75 mm or 94 mm was chosen implying a vertical interelectrode
spacing of 7 mm or 9 mm, respectively. Horizontal electrode distance varied with
the positioning and deployment of the catheter. An 11 Fr introducer was used
to insert a long 10 Fr guiding sheath in the left ventricle across the aortic valve.
The collapsed basket catheter was advanced through the guiding sheath and de-
ployed in the left ventricle after pulling back the guiding sheath. The activated
clotting time was kept longer than 300 seconds by full heparinization to avoid
thromboembolic complications. A 6 Fr quadripolar catheter was inserted percu-
taneously through the right femoral vein and positioned in the intra-abdominal
part of the inferior caval vein to serve as a far field recording and pacing reference
electrode for the unipolar basket catheter electrodes.
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Fluoroscopic localization of the basket catheter
Since basket catheter positioning varied from patient to patient, the exact position
of the individual basket electrodes was determined using biplane right (RAO) and
left anterior oblique (LAO) digital cine fluoroscopy (Philips Medical Systems Inte-
gris). After selecting the same end-diastolic frames from both fluoroscopic projec-
tions, two recognizable splines, which carry one and two additional radiopaque
markers, respectively, were identified. After labeling the electrodes of these two
splines, other splines could be identified by comparing their relative position with
the known position of the first two splines. Each individual electrode and the
central apical spline connector were then marked and given 2D coordinates in the
RAO and LAO projection. Finally, by combining the data from the RAO and LAO
projections, 3D coordinates for each electrode were calculated, thereby allowing a
realistic anatomical rendering of the position and shape of the basket catheter in
the left ventricle for each individual patient (figure 3.3).
Endocardial data processing
A software package was developed for on-line data processing based on Matlab
5.1 (The MathWorks, Inc. [21]. A surface Laplacian was used to detect small elec-
trographic deflections in infarcted regions which may be masked by large remote
components in the unipolar electrogram [22–24]. The Laplacian is the second spa-
tial derivative of the unipolar electrogram and a measure for the transmembrane
current at the recording site. It suppresses remote deflections, but still has the
characteristics of the unipolar electrogram. In contrast to bipolar electrograms, the
Laplacian is direction independent. In our study, the Laplacian was determined by
subtracting the mean of the signals of the 8 surrounding electrodes, weighed for
interelectrode distance, from the unipolar signal recorded at the central recording
electrode.
5.3.6 Spatial correlation between endocardial recordings and
SABSM
To correlate endocardial findings spatially with areas displaying late potentials on
the body surface a transfer matrix was calculated. The physical principles are ex-
plained in Appendix A. In summary, for each patient the position of the basket
catheter electrodes relative to the thoracic surface was derived computationally
by placing the basket electrode virtually in the left ventricle of cross-sectional im-
ages of a human thorax as can be found on the internet1. Subsequently, a virtual
line was drawn from each electrode in the body surface electrode array to the
center of the basket catheter and for each basket electrode the distance perpendic-
ular to this line was calculated. This resulted in a distance matrix containing the
weighted contribution of each basket electrode to the electrical events recorded at
each body surface site. Multiplying the endocardial map containing information
1http://www.nlm.nih.gov/research/visible/visible human.html [25]
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Patient group Control group P-value
(N=16) (N=12)
Number of complexes 231.7 ± 122.0 112.5 ± 49.9 P=0.0020
QRSD (ms) 131.8 ± 22.1 81.5 ± 14.0 P  0.0001
RMS40 ( Ñ V) 28.2 ± 21.7 143.0 ± 72.4 P  0.0001
LAS40 (ms) 34.2 ± 19.2 10.4 ± 5.6 P=0.0003
Noise ( Ñ V) 1.9 ± 1.4 4.0 ± 1.9 P=0.0021
Positive Simson criteria 1.3 ± 1.2 0 ± 0 P=0.0002
Table 5.2: Standard 3-lead signal averaged ECG parameters.
on the presence of diastolic potentials by the distance matrix then generated the-
oretical LPMAPs. The correlation coefficient between these theoretical LPMAPs
and the actually recorded LPMAPs was calculated and used as a measure of spa-
tial fit between LPMAPs and endocardial diastolic potentials.
5.3.7 Definitions of parameters and related terminology
Electrogram activity, either on the body surface or endocardium, exceeding the
surface QRS offset of the unfiltered QRS complex during sinus rhythm was called
a late potential. Endocardial diastolic potentials representing intracardiac post-
QRS activity during VT were defined as endocardial electrogram deflections ex-
tending beyond the surface QRS offset of the unfiltered QRS complex. Body sur-
face LPs were defined in the LPMAP as sites where the root mean square value
of the filtered QRS complex exceeded the noise level and twice its standard devi-
ation in the 50 ms interval following the J-point as determined in the unfiltered
averaged QRS complex.
5.3.8 Statistical analysis
All data were stored in a computerized patient record database. Data analysis
was performed on a personal computer using the “The SAS System for Windows
v8” statistical software package (SAS Institute, Inc). Data are presented as mean
values ± SD unless stated otherwise. Subgroup comparisons were made using
Chi-square, Student T-test or Fisher’s exact test, whenever appropriate. Statistical
significance was defined as a P value  0.05.
5.4 Results
5.4.1 Standard 3-lead SAECG
The standard parameters QRSD, LAS40, and RMS40 obtained with 3-lead SAECG
are shown for patient and control group in 5.2. In the patient group, QRSD was
significantly longer (131.8± 22.1 ms vs. 81.5± 14.0 ms, p  0.0001) as well as LAS40
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Patient group Control group
(N=16) (N=12)
0 criteria 5 12
1 criterion 3 0
2 criteria 5 0
3 criteria 3 0
Table 5.3: Number of patients with positive Simson SAECG criteria.
Patient group Control group P-value
(N=16) (N=12)
Number of complexes 220.7 ± 118.9 113.0 ± 50.8 P = 0.0049
QRSD (ms) 132.9 ± 31.4 90.7 ± 23.0 P = 0.1947
RMS40 ( Ñ V) 14.3 ±12.3 88.0 ± 81.9 P  0.0001
LAS40 (ms) 58.8 ± 25.9 25.0 ± 15.0 P = 0.0002
Noise ( Ñ V) 0.8 ± 0.7 1.4 ± 1.2 P = 0.3171
No. of leads with 3 LP criteria 20.1 ± 22.4 0.75 ± 1.7 P  0.0001
Table 5.4: Signal averaged body surface mapping. (LP = Late potential according to
Simson [1])
(34.2 ± 19.2 ms vs. 10.4 ± 5.6 ms, p=0.0003). RMS40 was significantly smaller as
compared to the control group (28.2 ± 21.7 Ñ V vs. 143 ± 72.4 Ñ V, p  0.0001). Table
5.3 shows that in the patient group, 3 of 16 (18.8 %) patients had body surface LPs
as defined by fulfillment of all 3 SAECG criteria [1]. None of the healthy control
subjects had positive SAECG criteria. This implies that in this group the sensitivity
of SAECG was 0.19 whereas the specificity was 1.00.
5.4.2 Signal averaged body surface mapping
In table 5.4 standard parameters QRSD, LAS40, and RMS40 derived from SABSM
are shown. If Simson criteria were applied to define the presence of late potentials
in a given SABSM surface lead, the following results were obtained: In 4 of 16
postinfarction patients (25 %) none of the 62 body surface leads were positive for
all 3 Simson criteria, in 4 of 16 patients (25 %) less than 4 SABSM leads contained
LPs. Eight patients were found to have 3 positive criteria for LPs in more than 4
SABSM leads (range 14 to 55 of 62 leads). In the control group, 8 of 12 subjects
(66.6 %) had no SABSM leads positive for LPs, 3 of 12 (25 %) control subjects had 1
positive SABSM lead and 1 of 12 subject (8.3 %) had 6 SABSM leads positive for LP.
This means that, defining SABSM as indicative of late potentials by the presence
of at least 1 lead satisfying all 3 Simson criteria, will result in a sensitivity of 0.75,
whereas the specificity of SABSM will be 0.66. Therefore, the likelihood ratio of a
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Patient group Control group P-value
(N=16) (N=12)
Uncorrected LPMAP ( Ñ Vms) 115.6 ± 120.2 67.8 ± 66.0 P  0.0001
Corrected LPMAP( Ñ Vms) 577 ± 1077.1 248.8 ± 263.1 P  0.0001
Total QRS integral value ( Ñ Vms) 388.3 ± 239.8 383.0 ± 231.1 P = 0.2855
Number of subjects with positive
LPMAP
14 (87.5 %) 1 (8.3 %)
Table 5.5: LPMAP data
positive test equals 2.27, whereas the likelihood ratio of a negative test equals 0.38
In Table 5.5, the LPMAP calculation results are shown. In the patient group the
integral values of the 50 ms post J-point segment contained significantly more en-
ergy. In the patient group, 14 of 16 patients (87.5 %) were positive on the LPMAP,
whereas 1 of 12 controls (8.3 %) was positive in the LPMAP. Therefore, this method
results in a sensitivity of 0.88 and a specificity of 0.92. The likelihood ratio of a pos-
itive test equals 11.0, whereas the likelihood ratio of a negative test equals 0.13.
5.4.3 Endocardial mapping
Late endocardial activity during sinus rhythm was found in 13 of 16 (81 %) sub-
jects in the patient group during sinus rhythm. In these patients, a median of 6.3
of 64 leads (range 2 to 18) contained late potentials. During VT, 7 of 16 patients
(43.8 %) were found to have diastolic potentials. These diastolic potentials were




Late potentials Absent - 52 (32.9 %) 52
(Sinus rhythm) Present 81 (51.3%) 25 (15.8%) 106
81 77 158 (100 %)
Table 5.6: Endocardial basket catheter leads containing diastolic potentials.
Table 5.6 displays the distribution of late and diastolic potentials during sinus
rhythm and VT. In total, diastolic and late potentials during either VT or sinus
rhythm or both were found on 158 basket catheter leads in 16 patients. Late po-
tentials during sinus rhythm and diastolic potentials during VT were found at the
same endocardial site in 25 of 158 leads (15.8 %). Diastolic potentials only present
during VT or late potentials only discernable during sinus rhythm were found in
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Figure 5.1: In Panel A the 3-lead signal averaged ECG of a patient with previous infero-
posterior myocardial infarction is shown. All three parameters (QRSD, RMS40, LAS40 )
indicate the presence of late potentials. Panel B displays the late potential map (LPMAP),
i.e. the integral value of the 50 ms segment, following the unfiltered J-point, of the filtered
QRS complex. Dark areas mark the presence of delayed activity following the J-point. The
3D reconstruction of the basket catheter are shown in Panel C. Dark areas signify areas
where diastolic potentials are present. The 4 images of the basket catheter are displayed be-
neath the LPMAP such that the basket catheter is oriented towards the aspect of the thorax
that is facing that particular side of the basket.
5.4.4 Correlation between SABSM and sites of endocardial
diastolic potentials
For the patient group, 3D anatomical activation maps of the left ventricle during
sinus rhythm were reconstructed. This enabled comparison of the sites containing
diastolic potentials and LPMAPs. In 13 of 16 patients (81 %), visual comparison
of the LPMAPs and the endocardial maps suggested a correlation between the
endocardial sites containing late potentials and evidence for LPs in the LPMAP.
An example is shown in figure 5.1.
In 2 patients no clear late potentials were found during sinus rhythm and
therefore no valid comparison could be made. In one patient with a previous
apical myocardial infarction, diastolic potentials were clearly found in the apical
region of the endocardium, whereas activity in the LPMAP was located high pos-
terior on the thorax.
In order to quantify the similarity between endocardial findings and body sur-
face LPs, LPMAPS were reconstructed from the endocardial maps utilizing the
surface electrode/basket electrode distance matrix. An example is shown in fig-
ure 5.2.
A correlation coefficient of 0.6 ± 0.12 between actually recorded and virtually
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A B
Figure 5.2: Panel A displays the folded open anterior and posterior aspect of the recorded
late potential map (LPMAP) of a patient with previous anterolateral myocardial infarction.
Dark regions represent the presence of late potentials. A clear area of late potentials in this
patient can be noted on the left upper and upper midsternal aspect of the thorax. Panel B
shows the results of the theoretically reconstructed SABSM by multiplying the endocardial
map with a transfer matrix. Late potentials can be noted in the same area as Panel A
(r=0.75)
reconstructed maps was found.
5.5 Discussion
SAECG is a non-invasive tool for detection of patients at risk for sudden cardiac
death. Until now, the clinical predictive value for the individual patient is low.
Although specificity of SAECG appears to be sufficient, sensitivity is disappoint-
ing. Furthermore, only a small proportion of patients with positive SAECGs will
develop life threatening ventricular arrhythmias in the subsequent years [5]. This
study shows that SABSM with multiple thoracic leads increases the spatial electro-
graphic resolution for detection of LPs. Sensitivity is well improved (75 %) at the
expense of a slight lowering of the specificity (66 %). Sensitivity and specificity
of SABSM can be further improved by looking at the energy content corrected
for distance in the 50 ms interval following the J-point. Sensitivity is then 88 %,
whereas specificity is 92 %. SABSM also allows identification of endocardial ar-
eas where late potentials can be found during sinus rhythm in 81 % of patients. In
this study, it was also shown that, in a substantial number of VTs, endocardial sites
that show diastolic potentials during VT do not display endocardial late potentials
during sinus rhythm at these sites.
5.5.1 Limitations of SAECG
In this study, 0 of 12 (0%) healthy control subjects had evidence of LPs on the
SAECG. In 13 of 16 (18.8 %) postinfarction patients, who all had documented spon-
taneous and inducible sustained monomorphic VT, no LPs were present. Several
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Figure 5.3: Example of a false negative SAECG in a patient with previous anterior/apical
myocardial infarction. In Panel A, the standard SAECG reconstructed from the orthogo-
nal XYZ leads is shown. None of the 3 SAECG parameters (QRSD, LAS40 and RMS40)
can be considered positive for late potentials. The late potential map (LPMAP) is depicted
in Panel B. Dark areas indicate more activity in the segment — following the unfiltered
J-point — of the filtered QRS complex. Most activity is located in the vicinity of the apex
(left precordial) and the high-midanterior thorax. White dots mark the positions of the
XYZ lead electrodes. All XYZ-electrodes are located in areas with little post-QRS activity
thereby explaining the absence of late potential criteria in the SAECG. 3D reconstructions
of the basket catheter are shown in Panel C. Dark areas signify areas where diastolic po-
tentials are present. The 4 images of the basket catheter are displayed beneath the LPMAP
such that the basket catheter is oriented towards the aspect of the thorax that is facing that
particular side of the basket.
on the body surface is inhomogeneously distributed as has been clearly demon-
strated in this study. Therefore the detection of LPs by SAECG is dependent of the
location of the electrodes of the 3-lead XYZ in thoracic areas with LPs. An example
of a false negative SAECG is shown in figure 5.3.
Secondly, SAECG is only capable of detecting post QRS activity during sinus
rhythm. This implies, that parts of the VT reentry circuit that display diastolic po-
tentials during VT may be hidden in the QRS complex during sinus rhythm due
to the different activation sequence of the left ventricle in different rhythms. In
this study, it has been shown that 52 of 77 diastolic potentials (67 %) that can be
recorded during VT are not present during sinus rhythm. Thirdly, false negativity
of the SAECG may be due to the ‘bi-directional’ Butterworth filtering technique
that is currently used. This filtering technique tends to give a time shift of high en-
ergy content of the filtered signal towards the middle of the QRS complex, thereby
making LPs disappear within the main filtered QRS deflection.
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5.5.2 Related studies
Fauge`re et al. showed increased sensitivity of SABSM using a 63-electrode array in
21 patients with postinfarction VT [17]. In this study isopotential mapping instead
of isointegral mapping was performed. However, filtering of the QRS complex
may result in time shifts and polarity reversal thereby distorting the instantaneous
isopotential map [13]. Such a distortion does not occur when using isointegral
maps.
Nakai et al. performed SABSM in 8 patients with previous myocardial infarc-
tion using a unipolar 45-electrode array [26]. They concluded that the distribu-
tion of delayed activity on the isointegral SABSM correlated well with the site of
previous myocardial infarction. Freedman et al. investigated in an animal left lat-
eral and right ventricular infarction model the correlation between SABSM and
prolonged epicardial ventricular electrograms [16]. In this study most LPs were
found on the SABSM leads that were located anterior, supporting our hypothesis
that electrode-heart distance correction is necessary to improve accuracy of local-
ization of endocardial areas of delayed potentials. Sasaki et al. performed SABSM
in 50 postinfarction patients using a unipolar 16-electrode array that was reposi-
tioned three times to obtain a 48-lead SABSM [27]. Afterwards patients underwent
left ventricular single catheter activation sequence mapping during sinus rhythm.
They found that constructing isointegral maps that displayed activity of less than
28 Ñ V in the last 20 ms of the QRS complex yielded a sensitivity of 91% and a speci-
ficity of 69% in predicting vulnerability to ventricular arrhythmias. These data are
well comparable with our results.
Lacroix et al. investigated the use of 63-lead SAECG and subsequent epicar-
dial and endocardial mapping in 16 patients. They found post-QRS activity in
83 % of patients without intraventricular conduction delay in 5 % of endocardial
recording sites [13]. They also observed that 55 Hz-filtered isopotential maps of
the thoracic and intracardiac signals showed a close spatial correlation between
location, amplitude and orientation of the extremes. These data are very well in
line with our results.
Finally, several authors have claimed that sensitivity and specificity of SABSM
can be improved by frequency domain analysis. This technique has the advantage
that identification of areas with high frequency content is not restricted by the lim-
itation of conventional time domain SABSM analysis, namely that only post-QRS
activity can be detected. Hosoya et al. performed this technique with an 87-lead
unipolar electrode array in 50 patients with prior anterior myocardial infarction
and suggested that activity in the 40-80 Hz frequency range predicted ventricu-
lar arrhythmias [28]. Kavesh et al. performed SABSM with a 192-lead electrode
array in 43 postinfarction patients and found that patients displaying activity in
the 1-7 Hz isoharmonic map were vulnerable to ventricular arrhythmias. Interest-
ingly, again most isoharmonic 1-7 Hz activity was found in the electrodes nearest
to the heart [7]. This suggests that some form of electrode-heart distance correc-
tion as performed in this study is also mandatory in frequency domain analysis of
SABSM.
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5.5.3 Parameterization and feature extraction from SABSM
When using the standard SAECG parameters LAS40, RMS40 and QRSD for inter-
pretation of SABSM great care should be taken. All three parameters are heavily
dependent on determination of the QRS offset, which in turn is determined by the
signal-to-noise ratio. When using SABSM — in contrast to using an orthogonal
bipolar XYZ lead system — the signal amplitude in the unipolar electrode is de-
termined by the square of the distance of the electrode to the heart while the noise
is mainly determined by local electrode conditions. Signal-to-noise ratio will tend
to be lower in more remote electrodes and the QRS offset will be located more
towards the middle of the filtered QRS complex. This will cause the QRSD and
LAS40 to be shorter and the RMS40 to be larger.
Sasaki et al. decided in their study not to consider QRSD or LAS40, but merely
to evaluate the averaged RMS of the last 20 ms before the offset of the filtered QRS
complex [29]. This diminishes the influence of signal-to-noise ratio and electrode-
heart distance, but does not eliminate it. Therefore, in the currently presented
study a different parameter was selected, namely the integral of the root mean
squared value of the 50 ms segment following the J-point of the unfiltered QRS
complex. This may have lead to an underestimation of the energy content of this
specific integral due to shift of high energy content towards the QRS complex
caused by ‘bi-directional’ filtering, thereby masking true LPs within the QRS com-
plex. However, any SAECG parameter derived after ‘bi-directional’ filtering will
be hampered by this phenomenon. Second modification was a computation to
correct for the distance of the electrode to the heart. This technique allows for
better comparison between leads that are closely adjacent to the heart — such as
the precordial leads — and leads more distant to the heart. This may have lead
to an overestimation of the energy content contributed by noise in the more dis-
tant leads such as the leads on the posterior thoracic surface. However, since the
noise level was low in this study, it is unlikely that this has major influence on the
results.
5.5.4 Correlation between LPMAPs and SABSM
In order to compare endocardial maps quantitatively with body surface electro-
cardiographic data a transfer matrix was calculated. This resulted in a correlation
of 0.6 ± 0.12 between recorded LPMAPs and computationally derived LPMAPs.
Several assumptions were made when constructing the model. The currently de-
scribed model does not account for individual differences in thorax geometry or
torso volume conductor inhomogeneities. However, since these torso inhomo-
geneities appear to have minimal effect on the 12-lead ECG in the forward recon-
struction of the surface ECG from epicardial potentials, this appears to be justi-
fied [30,31]. Furthermore, it should be noted that the reconstructed maps represent
the binary presence of endocardial LPs. LPMAPs represent the body surface mea-
surement of the amplitude magnitude of endocardial LPs and therefore display a
more gradual representation of the endocardial presence of LPs. This may lower
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the correlation coefficient between reconstructed maps and LPMAPs as well.
5.5.5 Clinical significance
SABSM allows the delineation of areas with delayed endocardial activation with
higher sensitivity than standard SAECG while the specificity is comparable. Fur-
thermore, non-invasive anatomical information can be obtained, identifying areas
where endocardial diastolic potentials can be found in 80 % of cases. This may be
helpful in limiting the endocardial area to be mapped for diastolic potentials and
sites of entrainment during radiofrequency catheter ablation or surgical ablation
of VT. However, one should realize that a difference exists between endocardial
sites displaying late potentials during sinus rhythm and sites that are involved in
the reentry circuit during VT [32]. On the other hand, since in a number of cases
radiofrequency ablation of postinfarction VT can be exceedingly difficult due to
non-inducibility or hemodynamical intolerance, new techniques to ablate the VT
substrate during sinus rhythm are under investigation [33, 34]. In analogy of ab-
lation of ‘channels’ of conduction — as is currently done with intra-atrial reentry
tachycardia [35] — areas of delayed conduction within the infarction scar may be
identified with SABSM, thereby facilitating the detection of channels of conduc-
tion.
5.5.6 Limitations of the study
When detecting delayed activity following the QRS complex in an electrode sys-
tem other than the classic XYZ 3-lead orthogonal system, the distance of the par-
ticular surface electrode to the heart will affect the magnitude of the LPs. This will
lead to overestimation of the energy content of late potential integral maps in the
precordial leads as opposed to more remote electrodes. Since the magnitude of
the entire electrogram will be dependent on electrode distance to the heart, inte-
gral values of the LPMAP were expressed relative to the value of the QRS inte-
gral. Of course, QRS complex and deflections in the LPMAP can result from wave
fronts travelling in different directions, i.e. normal activation from endocardium
to epicardium yielding a QRS complex and delayed activity in slow conduction
pathways within the myocardial infarction scar, respectively. Since only unipolar
electrodes were used, the magnitude of QRS integral and LPMAP were considered
independent of the direction of the underlying wave front propagation.
To define which body surface electrode corresponded with a specific endo-
cardial region a theoretical SABSM was computed with the aid of a projection of
the basket catheter relative the thoracic surface. To be able to do this detailed
anatomical information of the patient’s build is mandatory, which requires mag-
netic resonance imaging (MRI) data. It is possible that better results would have
been obtained if a magnetic resonance image of the thorax of each patient had
been available. Since however changes in built of the thorax appear to have lim-
ited effect on the body surface electrograms a standardized cross-sectional thorax
image was used [30, 31]. Better results might have been achieved when correla-
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tions were made between endocardial sites and body surface leads by means of a
mathematical inverse solution model.
Another limitation is that no basket catheter data are available for the healthy
control subjects. None of the normal subjects, however, displayed positive SAECG
or SABSM criteria and therefore it is not presumable that basket mapping would
have provided new insights.
5.6 Conclusion
SABSM is a non-invasive tool to detect delayed endocardial activity on the body
surface. SABSM has greater sensitivity than SAECG and comparable specificity.
Furthermore SABSM is able to indicate the anatomical sites where endocardial late
potentials originate during sinus rhythm in 81 % of cases.
5.7 Appendix
To estimate the weighted contribution of each basket electrode to the presence of
late potentials on the SABSM a transfer matrix was calculated. This technique
was based on the physical principle that each body surface electrogram is deter-
mined by the electrical dipole traveling through the heart and the space angle un-
der which this dipole is observed. To estimate which basket electrodes (i.e. which
part of the endocardial surface) are within the space angle of a specific body sur-
face electrode, for each patient and for each of the 62 body surface electrodes a
virtual line connecting both body surface electrode and center of the basket (i.e.
center of the left ventricle) was computed (Figure 5.4). Then for each of the 64 bas-
ket electrodes the inverse of the distance perpendicular to this line was computed.
This resulted in a 62 times 64 (BSM electrodes times basket electrodes) distance
matrix containing weighing factors of the contribution of each basket electrode to
each body surface electrode. Multiplying the 64 times 1 vector representing the
endocardial activity by the distance matrix yields a 62 times 1 vector representing
the SABSM.


































Figure 5.4: Panel A. Reconstruction of the anatomical relation of the body surface elec-
trodes and endocardial basket electrodes. The raster represents the thoracic cage. Solid
black dots represent electrodes in the body surface electrode array. Smaller solid black dots
in the center of the figure represent the basket electrodes. Panel B demonstrates how the
distance between the basket electrodes and the intersecting line are calculated. Distances
carry a positive value if basket electrodes are located on the same side of the basket center
as the surface electrode, whereas distances are negative if the basket electrodes are locate on
the opposite site of the basket center as the surface electrode.
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6.1 Abstract
Objectives: Despite the fact that data on direct comparison of QT dispersion
(QTd) with invasively obtained repolarization characteristics in the human ven-
tricle are scarce, QTd has been widely adopted as a measure of dispersion in re-
polarization. Objective of this study was to compare non-invasive and invasive
measures of repolarization.
Methods: Simultaneous recordings with a 62-electrode body surface mapping
(BSM) device and a 64-electrode endocardial basket catheter were obtained during
sinus rhythm in 13 patients with remote myocardial infarction and documented
spontaneous sustained ventricular tachycardia (VT). In 23 patients with remote
myocardial infarction without VT and 19 healthy controls BSMs were obtained.
Activation recovery intervals (ARIs) were calculated from the endocardial record-
ings. QTd, mean QT interval, T-wave peak to T-wave end (TE) were calculated
for the 12-lead ECG. These same ECG indices as well as QRST integral maps were
calculated for the BSM array. Activation recovery time gradients (ARTGs) were
computed as a measure of local dispersion in repolarization for both BSM and
basket catheter.
Results: Although 12-lead QTd correlated with endocardial ARTG standard
deviation (r=0.39), BSM QTd correlated better (r=0.52). TE in V5 correlated strongly
(r=0.87) with endocardial ARTG range and non-dipolar content on QRST integral
maps were inversely related with the mean ARI (r=0.64). Finally, the range of body
surface ARTGs correlated well with the range of endocardial ARTGs (r=0.63).
Conclusion: Although information on intracardiac repolarization properties
can be derived from the 12-lead ECG QTd to some extent, its use appears limited.
Extending the surface ECG lead set to cover the entire thorax offers better detec-
tion of endocardial repolarization properties. Non-dipolar content of BSM QRST
integral maps and TE in V5, as well as surface ARTG range correlated strongly
with variance in ARIs and endocardial ARTGs, indicating their predictive poten-
tial for detection of dispersion in repolarization.
6.2 Introduction
Evidence of T-wave end inequality among surface ECG leads traces back to the
earliest days of electrocardiography [1]. Later, “disparity in repolarization times
across the ventricles of the heart” was identified as an index of arrhythmia suscep-
tibility [2]. Several investigational techniques were developed to quantify repolar-
ization dispersion. Among these techniques are body surface mapping (BSM) and
direct endocardial or epicardial recordings [3–8]. More recently, authors have tried
to infer dispersion in repolarization from the 12-lead ECG [9–12]. Some controver-
sies remain, especially concerning the value of QT dispersion (QTd) in identifying
postinfarction patients at risk for sudden death. Zabel et al. failed to prove the pre-
dictive value of QTd for mortality in a large follow-up study [13]. Similar observa-
tions were made by the Diamond-CHF investigators, who failed to demonstrate
any predictive value of QT dispersion in patients with severe heart failure [14].
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At present, the only study that was done to compare electrocardiographic esti-
mates with repolarization parameters obtained in the intact human ventricle was
reported by Zabel et al [15]. In their study, monophasic action potential data ob-
tained at a limited number of endocardial and epicardial sites were subsequently
compared with 12-lead ECG variables to asses disparity in ventricular repolariza-
tion. They showed that dispersion in repolarization can be detected by the 12-lead
ECG.
In the currently presented study, we were able to collect endocardial electro-
grams at 64 sites simultaneously with 62-channel body surface mapping (BSM)
recording on a beat-to-beat basis in the intact normothermic human ventricle.
For this purpose, several 12-lead ECG repolarization estimates, such as QTd and
BSM QRST integral non-dipolar content were compared to endocardial activation-
recovery-interval (ARI) related parameters. Finally, we developed the activation
recovery time gradient (ARTG) as a new, electrode array independent, parame-
ter to express local differences in repolarization duration between recording elec-
trodes.
Aim of this study was 1) to investigate the relation between QTd and endocar-
dial repolarization parameters; 2) to investigate the value of body surface QRST
integral maps and T-wave peak to T-wave end intervals derived from precordial
leads in quantifying nonuniform electrical recovery from excitation and 3) to eval-
uate activation recovery time gradients as a new parameter that may better ex-
press spatial dispersion in repolarization.
6.3 Methods
6.3.1 Patient selection
The research protocol, which was approved by the Ethical Committee of our in-
stitution, was performed on two groups of patients that had given prior written
informed consent. The patient group (VT Group) comprised 13 patients referred
to our hospital between November 1997 and February 1999 for antiarrhythmic
surgery or radiofrequency catheter ablation of infarct related VT. Specific eligi-
bility criteria included: (1) documented recurrent ventricular arrhythmias with
or without aborted sudden cardiac death and (2) inducible sustained monomor-
phic VT during programmed electrical stimulation. The second group (non-VT
Group) consisted of 23 patients with remote myocardial infarction in whom never
any documentation of sustained or non-sustained ventricular arrhythmias was
obtained, who did not have symptoms of unexplained syncope and for whom
no suspicion of sustained ventricular arrhythmias existed at that point in time.
These patients were not receiving antiarrhythmic medication. The control group
(Control Group) consisted of 19 healthy controls, who had normal electrocardio-
grams, no history of cardiovascular disease and who were not receiving medica-
tion. Characteristics of all three groups are presented in Table 6.1. In all three
groups BSM was performed, but only in the VT Group a basket catheter was per-
cutaneously inserted in the left ventricle. In those patients, transthoracic echocar-




Age (years) 67.7 ± 9.7 57.4 ± 8.9 40.7 ± 14.8
Gender
Male 9 21 5
Female 4 4 14
LVEF 23.7 ± 9.0 41 ± 23.6 N/A
Extent of CAD
(no. of vessels Ò 70% stenosis) 1.9 ± 0.9 1.9 ± 1.0 N/A
Site of infarction
Anterior 10 11 N/A
Inferior 3 14 N/A
Time since infarction (years) 7.4 ± 5.2 2.6 ± 3.3 N/A
VT cycle length (ms) 318 ± 70 N/A N/A
No. of VT morphologies per patient 1.8 ± 0.9 N/A N/A
Table 6.1: Baseline characteristics. (CAD = coronary artery disease; LVEF = left ventric-
ular ejection fraction; VT = ventricular tachycardia; N/A = Not available)
diography was applied before the procedure to assess the dimensions of the left
ventricle and to exclude the presence of a mural left ventricular thrombus or sig-
nificant aortic valve disease since these conditions can interfere with safe deploy-
ment of the basket catheter. All antiarrhythmic drugs were discontinued in the
patient group for at least 5 drug elimination halve times before the study. Two
patients in the VT Group were previously treated with amiodarone but in these
patients amiodarone was discontinued 5 and 6 weeks before the study, respec-
tively.
6.3.2 Data acquisition and mapping
Data from the endocardial basket catheter and BSM electrodes were recorded si-
multaneously with a 128-channel digital acquisition device (Biosemi Inc.). Ana-
logue to digital conversion occurred at a sampling frequency of 2 kHz, 16-bits res-
olution and a bitstep of 2 Ñ V/bit. Wilson’s central terminal was used as reference
for the BSM electrograms. The amplifier system had a bandpass characteristic us-
ing a frequency range of 0.16 – 400 Hz (3 dB frequencies). Data were transmitted
using a fiberoptic transmission unit and stored in a Pentium based PC.
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6.3.3 Surface electrocardiographic estimation of repolarization
dispersion
Body surface ECGs were recorded using a radiotransparent carbon unipolar elec-
trode grid that does not interfere with fluoroscopic imaging during catheteriza-
tion. The 62 electrodes were positioned in 14 flexible vertical straps that were ap-
plied on the anterior and posterior thoracic surface as described elsewhere [16].
Continuous 24-second recordings of sinus rhythm were obtained. A mean of
2.0 ± 1.8 leads per recording were rejected because of unsatisfactory signal qual-
ity and were replaced by a value computed from neighboring electrodes. Offset
differences, linear baseline drifting, or both were corrected with a computer algo-
rithm.
Selection of QRS complexes for analysis
Before analysis of the signals a 150 Hz low pass 4th order Butterworth filter was
applied to remove noise and facilitate detection of the onset and offset of the QT
interval. Then, a template QRS complex was selected in precordial lead V2. The
onset and offset of the template QRS complex were set at the time when the ab-
solute value of the instantaneous voltage exceeded 0.02 mV and at the J point,
respectively. Subsequently, an interval was selected comprising the template QRS
complex and its subsequent T-wave. The QRS template was used to scan the en-
tire lead recording for QRS complexes that fitted the QRS template with a correla-
tion coefficient of more than 0.80. The selected complexes were time aligned and
baseline correction was performed. Mean and standard deviation for the entire se-
lected interval were computed for every instant of the time-aligned interval. Only
intervals in which no sample exceeded the mean of the time aligned interval plus
three times its standard deviation, were ultimately selected for analysis. This per-
mitted exclusion of non-sinus rhythm beats and intervals that contained artifacts,
even if the artifacts were outside the QRS template.
QT interval and T-Peak to T-End measurement
QT intervals were determined for each complex in each lead individually. There-
fore, for each selected QRST interval in each of the 62 individual surface elec-
trodes, the onset of the QRST complex was defined as the instant when the ab-
solute value of the voltage exceeded 0.02 mV. Since the amplitude of the QRST
complex is dependent on the distance of the recording electrode to the heart, an
electrode specific criterion for determination of the offset of the T-wave was in-
troduced. First, the top of the T-wave was determined by selecting the largest
absolute voltage value between the manually indicated J-point and a marker set
in the isoelectric baseline well after the offset of the T-wave. If the instantaneous
value of the T-wave peak exceeded 0.1 mV, then the threshold for determination
of the T-wave offset was set at 0.02 mV, else the T-wave offset threshold was set
at 0.2 times the absolute value of the T-wave peak. The T-wave offset was consid-
ered the instant in time following the T-wave peak when the absolute value of the
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Figure 6.1: Panel A displays calculation of QT interval and peak T-wave to end T-wave
interval in surface electrogram lead V2. In Panel B the activation recovery interval (ARI)
is indicated.
voltage dropped below the T-wave offset threshold. All computationally assigned
markers were checked by visual inspection and corrected if necessary. The QT
interval was defined as the time interval between individually determined QRS
onset and T-wave offset for each electrode. TE interval was defined as the time
interval between T-wave peak and T-wave offset (Figure 6.1).
Body surface mapping
Mean total QRST integral maps were calculated as described previously [17–19].
In short, isopotential maps were generated at a 0.5-millisecond interval during the
QRST complex. It should be noted, that for computation of QRST integrals, onset
and offset of the QRST interval were, in contrast to QT interval determination, set
at the same instant for all surface electrodes. The onset of the QRS complex was
defined as the instant in time when the earliest activation exceeded 0.02 mV in
any of the surface leads; offset of the T wave was set at the point in time when
the absolute value of the voltage dropped below 0.02 mV in all leads or reached
its minimum for all electrodes. U waves were not included in the QRST interval.
Subsequently, an integral map of the complete QRST interval was constructed and
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a quantitative analysis was carried out to estimate the nondipolar content of the
QRST integral map. A previously developed software package for on-line data
processing based on Matlab 5.1 (The MathWorks, Inc.) was used for this pur-
pose [20]. Eigenvectors previously calculated from a set of 26 healthy controls
were utilized for calculation of non-dipolar content of QRST integral maps [19].
In short, the 62-lead BSM vectors of these controls were extrapolated to an evenly
distributed 16 x 12 array. Then singular value decomposition was performed. The
192 eigenvectors were calculated from the derived 192 x 26 array. The first 12
eigenvectors (figure 6.2) of the entire set of 192 eigenvectors were subsequently
derived, and the QRST integral map of each patient was expressed in terms of
these 12 eigenvectors as described by Lux et al [21]. These authors demonstrated
that by using the first 12 eigenvectors of the complete data set, each individual
map could be reconstructed without a significant loss of information. In addition,
they showed that the first 3 eigenvectors of the eigenvector set reveal dipolar pat-
terns, whereas eigenvectors 4 through 12 show non-dipolar patterns. Therefore,
the non-dipolar content of each map was defined as the contribution of eigenvec-
tors 4 through 12 relative to the contribution of eigenvectors 1 through 12 [22].
6.3.4 Multielectrode endocardial mapping
Catheter placement
For the purpose of endocardial mapping, a 64-electrode unipolar basket catheter
(Constellation CatheterTM, Boston Scientific, Inc.) was percutaneously inserted.
This basket catheter consists of 8 self-expanding nitinol splines mounted on a
110 cm long 8 Fr catheter shaft. Each spline has 8 symmetrically arranged elec-
trodes. Selection of catheter size (75 mm or 94 mm in diameter) was based on the
dimensions of the left ventricle as determined by 2D transthoracic echocardiogra-
phy. This implied that interelectrode spacing along the spline was 7 mm or 9 mm,
respectively. Distance between splines varied with the positioning and deploy-
ment of the catheter. An 11 Fr introducer was used to insert a long 10 Fr guiding
sheath in the left ventricle across the aortic valve. The collapsed basket catheter
was advanced through the guiding sheath and deployed in the left ventricle after
pulling back of the guiding sheath. The activated clotting time was kept longer
than 300 seconds by full heparinization to avoid thromboembolic complications.
A 6 Fr quadripolar catheter was inserted percutaneously and positioned in the
intra-abdominal part of the inferior caval vein to serve as a far field recording and
pacing reference electrode for the unipolar basket catheter electrodes.
Fluoroscopic localization of the basket catheter
Since basket catheter positioning varied from patient to patient, the exact position
of the individual basket electrodes was determined using biplane right (RAO) and
left anterior oblique (LAO) digital cine fluoroscopy (Philips Medical Systems In-
tegris). After selecting the same end-diastolic frames from both fluoroscopic pro-
jections, splines A and B, which carry one and two additional radiopaque mark-
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Figure 6.2: Display of first 12 eigenvectors of the complete QRST integral data set. Each
eigenvector is represented in the body surface map format. Eigenvectors are sorted by
singular value in descending order. The top row contains the first three eigenvectors, which
are considered to demonstrate dipolar patterns; row 2 through 4 displays eigenvectors 4
through 12, which show non-dipolar patterns.
ers, respectively, were identified. After labeling electrodes of these two splines,
the other splines could be identified by comparing their relative position with the
known position of the first two splines. Each individual electrode and the cen-
tral apical spline connector were then marked and given 2D coordinates in both
RAO and LAO projection. Finally, by combining the data from the RAO and LAO
projections 3D coordinates for each electrode were calculated thereby allowing a
realistic anatomical rendering of the position and shape of the basket catheter in
the left ventricle for each individual patient (figure 3.3).
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Calculation of Activation-Recovery Intervals
A surface Laplacian was used to optimize the detection of local electrical events
in the endocardial unipolar electrogram [23–25]. The Laplacian is the second spa-
tial derivative of the unipolar electrogram and a measure for the transmembrane
current at the recording site. It suppresses remote deflections, but still has the
characteristics of the unipolar electrogram. In contrast to bipolar electrograms, the
Laplacian is direction independent. In our study the Laplacian was determined by
subtracting the mean of the signals of the 8 surrounding electrodes, weighed for
interelectrode distance, from the unipolar signal recorded at the central recording
electrode. ARIs were calculated as described by Gepstein et al [26]. In short, the
ARI was defined as the interval between the instant showing the steepest descent
in the unipolar electrogram during depolarization (dV/dtmin

and the steepest as-
cent in the Laplacian following the J-point on the surface ECG (Figure 6.1).
6.3.5 Estimates of spatial differences in repolarization duration.
Since electrodes in the BSM array and basket catheter electrodes are unevenly dis-
tributed, a new measure for interelectrode differences in QT interval or ARIs had
to be developed. These estimates of spatial differences in repolarization were cal-
culated as follows. For each patient the position of the basket catheter electrodes
relative to the thoracic surface was derived computationally. For this purpose,
cross-sectional images of a human thorax, as can be found on the internet1 were
utilized [27]. First, the 3D reconstructed basket catheter was virtually placed in
the left ventricle, making the center of the left ventricle and the center of the bas-
ket catheter coincide. The BSM electrodes were then virtually positioned on the
3D human torso model. Subsequently, virtual lines were drawn from each elec-
trode in the BSM electrode array and from each basket electrode to the center of
the basket catheter (i.e. the center of the heart). Then for each electrode pair, the
angle between the lines through these electrodes and the center of the heart was
calculated. This resulted in a 62 x 62 angle matrix for the BSM array and a 64 x
64 angle matrix for the basket catheter, respectively. Dividing the QT difference,
or the difference in ARI, between each electrode pair by the angle between these
electrodes yielded spatial activation recovery time gradients (ARTGs, dimension
ms/degree) for all surface electrodes as well as all basket electrodes (figure 6.3).
Since main interest in this study was focused on increased dispersion in repolar-
ization, for each electrode the largest ARTG with some other electrode was chosen.
This ARTG is expected to be indicative of local repolarization duration differences
independent of the used electrode system.
6.3.6 Definition of repolarization parameters.
All repolarization parameters were averaged per lead for a mean 21.1± 11.1 com-
plexes before interelectrode comparisons were made. QT dispersion (QTd) was
1http://www.nlm.nih.gov/research/visible/visible human.html





Figure 6.3: Demonstration of our methods to calculate the angles between electrode pairs.
In this case the specific transthoracic plain comprising precordial leads V4 and V5 is cho-
sen as an example. Angle  denotes the angle between the lines through both electrodes and
the center (C) of the left ventricle. The same procedure was repeated for every conceivable
electrode pair in both the surface electrode set and basket catheter electrode set.
defined as the difference between the longest (QTmax

and the shortest QT inter-
val (QTmin

measured in all leads at the body surface. QT standard deviation
(STDQT) was defined as the temporal variation in QT interval as measured per
ECG lead. Mean QT was calculated as the averaged QT interval in all leads. TE
V2 and TE V5 are the averaged TE interval in standard precordial lead V2 and
V5 , respectively. Mean ARI was calculated as the averaged ARI in all basket
catheter leads. STDARI was defined as the ARI standard deviation over all basket
catheter electrodes, thereby being a measure for spatial variance in repolarization.
ARI range was defined as the difference between the longest and the shortest ARI
measured in all basket catheter leads. ARTG measures were calculated separately
for body surface electrodes and basket catheter electrodes using QT interval and
ARI, respectively. Mean ARTG was calculated as the averaged ARTG in all leads.
STDARTG was defined as the ARTG standard deviation over all electrodes. ARTG
range was calculated as the difference between the largest and the smallest ARTG.
Maximal ARTG was considered the largest ARTG found in all electrodes.
6.3.7 Statistical analysis
All data were stored in a computerized patient record database. Data analysis was
performed on a personal computer using the “The SAS System for Windows v8”
statistical software package (SAS Institute, Inc). Data are presented as mean val-
ues ± SD unless stated otherwise. Group comparisons were made using Student
T-test. Statistical significance was defined as a P value  0.05. For continuous vari-
ables the Pearson’s correlation coefficients were computed. Variables showing a
correlation coefficient Ò 0.7 were selected for entry in a linear regression model for
estimation of the independent predictive value of that variable.
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VT non-VT Control P-Values
Group Group Group
(N=13) (N=25) (N=19)
QT duration (ms) 400 ± 82 407 ± 41 357 ± 29 1 P=0.73
2 P  0.0001
3 P=0.04
QTd (ms) 61 ± 21 63 ± 22 52 ± 22 1 P=0.74
2 P=0.11
3 P=0.27
STDQT (ms) 3.8 ± 2.3 5.1 ± 2.1 3.9 ± 2.13 1 P=0.12
2 P=0.09
3 P=0.90
TE V2 (ms) 105.3 ± 34.7 98.2 ± 17.0 82.1 ± 25.3 1 P=0.41
2 P=0.02
3 P=0.04
TE V5 (ms) 99.1 ± 31.6 89.6 ± 36.9 65.2 ± 18.0 1 P=0.46
2 P=0.01
3 P=0.0009
Table 6.2: 12-lead ECG determinants of repolarization. (STDQT = QT Standard de-
viation; TE = T-Wave peak to T-Wave end. P-value 1 = VT Group vs. non-VT Group;
P-value 2 = non-VT Group vs. Control Group; P-value; 3 = VT Group vs. Control Group)
6.4 Results
6.4.1 12-lead ECG determinants of repolarization
Repolarization parameters derived from the standard 12-lead ECG are given for
all three groups in table 6.2. Mean QT duration was longer in the VT Group and
non-VT Group as compared to the Control Group (P=0.04 and P  0.0001, respec-
tively), but not when the VT Group was compared to the non-VT Group (P=0.73).
The QTd was not significantly different between groups. Temporal variation in
QT duration per lead (QT standard deviation) was not significantly different be-
tween groups either. (P= 0.12 to P=0.90). T-wave peak to T-wave end in lead V2
and V5 were both in VT Group and non-VT Group significantly different from the
Control Group, but no significant differences between infarction patients with VT
(VT Group) and postinfarction patients without VT (non-VT Group) was noted.
6.4.2 BSM determinants of repolarization properties
Table 6.3 shows the results of repolarization parameter estimation utilizing the
BSM electrode array. Mean QT duration was longer in the VT Group and non-VT
Group as compared to the Control Group (P=0.05 and P  0.0001, respectively), but
not when the VT Group was compared to the non-VT Group (P=0.71). The QTd
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VT non-VT Control P-Values
Group Group Group
(N=13) (N=25) (N=19)
QT duration (ms) 398 ± 83 406 ± 39 355 ± 30 1 P=0.71
2 P  0.0001
3 P=0.05
QTd (ms) 98 ± 31 101 ± 22 79 ± 22 1 P=0.77
2 P=0.003
3 P=0.04
STDQT (ms) 4.7 ± 3.3 3.1 ± 1.6 2.3 ± 1.3 1 P=0.06
2 P=0.08
3 P=0.008
QRSTi Non-dipolar 26.9 ± 14.1 17.9 ± 16.4 9.2 ± 3.7 1 P=0.09
content (% ) 2 P=0.03
3 P  0.0001
Mean ARTG 2.0 ± 0.7 2.4 ± 0.7 1.7 ± 0.7 1 P=0.12
(ms/degree) 2 P=0.004
3 P=0.25
ARTG SD 0.35 ± 0.33 0.35 ± 0.14 0.26 ± 0.11 1 P=0.95
(ms/degree) 2 P=0.03
3 P=0.31
Max. ARTG 10.5 ± 5.3 11.2 ± 3.8 8.7 ± 3.1 1 P=0.65
(ms/degree) 2 P=0.03
3 P=0.23
ARTG range 7.7 ± 4.5 6.6 ± 2.2 5.0 ± 1.8 1 P=0.35
(ms/degree) 2 P=0.03
3 P=0.01
Table 6.3: BSM determinants of repolarization (ARTG = Activation Recovery Time Gra-
dient; QRSTi = QRST integral; STDQT = QT Standard deviation; P-value 1 = VT Group
vs. non-VT Group; P-value 2 = non-VT Group vs. Control Group; P-value; 3 = VT Group
vs. Control Group )
was not significantly different between VT Group and non-VT Group (P=0.77), but
did differ significantly between VT Group vs Control Group (P=0.04), and non-VT
Group vs Control Group (P=0.003). STDQT tended to reach significance between
the VT Group vs non-VT Group (P=0.06), and the non-VT Group vs Control Group
(P=0.08), but the difference was highly significant between the VT Group and Con-
trol Group (P=0.008). Non-dipolar content of the QRST integral was significantly
different between VT Group and Control Group as well as between non-VT Group
and Control Group (P  0.0001 and P= 0.03). Differences in mean ARTG, ARTG
standard deviation and maximal ARTG were consequently significantly different
between non-VT Group and Control Group, but not between VT Group and non-
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Mean STD Range Mean STD
ARI ARI ARTG ARTG ARTG
Mean QT 0.96 † 0.90 † 0.38 0.78 † 0.30
(P  0.0001) (P  0.0001) (P=0.22) (P=0.0029) (P=0.34)
STDQT 0.30 0.42 0.01 0.52 0.59 †
(P=0.35) (P=0.18) (P=0.98) (P=0.08) (P=0.044)
QTd 0.35 0.50 0.03 0.59 † 0.58 †
(P=0.27) (P=0.10) (P=0.92) (P=0.046) (P=0.047)
TE V2 0.56 0.83 † 0.18 0.72 † 0.19
(P=0.058) (P=0.0007) (P=0.58) (P=0.0082) (P=0.55)
TE V5 0.33 0.52 0.79 † 0.72 † 0.78 †
(P=0.31) (P=0.096) (P=0.0041) (P=0.012) (P=0.0041)
Table 6.4: Pearson’s correlation between endocardial and12-lead parameters in the VT
Group. Columns represent endocardial repolarization parameters. Rows represent body
surface measures of repolarization. In each cell, the R-square value and significance level
are denoted. † = Statistically significant; (ARI = Activation Recovery Interval; TE =
T-wave peak to T-wave end interval)
VT Group or Control Group. Only the range between minimal ARTG and maxi-
mal ARTG was significantly different between non-VT Group and Control Group
(P= 0.03) and VT Group and Control Group (P= 0.01).
6.4.3 Endocardial vs. 12-lead ECG determinants of repolarization
characteristics.
In the VT Group, an analysis was made to identify endocardial parameters that
cause dispersion in 12-lead ECG estimates of repolarization. First, for each 12-
lead ECG variable the correlation with endocardial measurements was calculated.
The results are shown in table 6.4. To determine the independent predictive value
of between each pair of variables, which showed correlation with a P-value of
less than 0.05, forward selection linear regression models were constructed. The
P value for entry into the model was set at 0.10. The results are shown in table
6.5. A strong correlation between mean QT interval and mean ARI was found
(r=0.85). Weaker associations were found between QTd and endocardial ARTG
standard deviation (r=0.39) and temporal QT standard deviation and endocardial
ARTG standard deviation (r=0.41).
6.4.4 Endocardial vs. BSM estimates of repolarization
characteristics.
Pearson’s correlation coefficients between parameters derived from the BSM elec-
trode array and endocardial parameters are shown in table 6.6. Results of the
130 Chapter 6. Repolarization properties
Mean STD Range Mean STD
ARI ARI ARTG ARTG ARTG
Mean QT rc=1.17 N/A N/A rc=6.86 N/A
r=0.85 r=0.080
(P  0.0001) (P=0.016)
STDQT N/A N/A N/A N/A rc=4.48
r=0.41
(P=0.035)
QTd N/A N/A N/A N/A rc=12.71
r=0.39
(P=0.040)
TE V2 N/A N/A N/A N/A N/A
TE V5 N/A N/A rc=0.62) N/A rc=16.50
r=0.62 r=0.25
(P=0.0039) (P=0.0043)
Table 6.5: Linear regression parameter estimates of endocardial and 12-lead ECG param-
eters in the VT Group. Columns represent endocardial repolarization parameters. Rows
represent 12-lead ECG measures of repolarization. In each cell, the linear regression pa-
rameter estimate (rc), partial R-square value (r) and significance level (P) are denoted.
N/A indicates that the variable was not selected for entry in the model. (ARTG = Ac-
tivation Recovery Time Gradient; ARI = Activation Recovery Interval; STDQT = QT
standard deviation per lead; TE = T-wave peak to T-wave end interval)
linear regression models are shown in Table 6.7. Non-dipolar content of QRST in-
tegral maps correlated inversely in the linear regression model (r=0.64) with mean
ARI. Mean QT interval was also independently predicted by mean ARI, combined
with the ARI standard deviation over all endocardial leads (r=0.88 and r=0.048,
resp.). Temporal standard deviation of the QT interval per lead, QTd and mean
surface ARTG were independently predicted by the endocardial ARTG standard
deviation (r=0.67, r=0.52 and r=0.51, respectively). Finally, surface ARTG standard
deviation, ARTG range and maximal ARTG were all predicted by the endocardial
ARTG range (r=0.53, r=0.63 and r=0.62, respectively).
6.5 Discussion
This is the first study that provides spatially high-resolution data on repolariza-
tion properties, obtained simultaneously from endocardium and body surface in
the intact, normothermic human ventricle on a beat-to-beat basis. Although us-
ing the 12-lead ECG can derive some information on intracardiac repolarization
properties, its use appears limited. Extending the surface ECG lead set to cover
the entire thorax by means of a BSM array offers better detection of endocardial
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Mean STD Range Mean STD
ARI ARI ARTG ARTG ARTG
QRSTi NDC -0.79 † -0.52 -0.17 -0.33 -0.15
-0.79 (P=0.084) (P=0.60) (P=0.30) (P=0.63)
Mean QT 0.96 † 0.89 † 0.34 0.74 † 0.27
(P  0.0001) (P  0.0001) (P=0.28) (P=0.0054) (P=0.39)
STDQT 0.26 0.30 0.12 0.43 0.81 †
(P=0.41) (P=0.35) (P=0.72) (P=0.16) (P=0.0015)
QTd 0.41 0.51 0.27 0.56 0.70 †
(P=0.19) (P=0.090) (P=0.39) (P=0.054) (P=0.012)
Mean ARTG 0.09 0.23 0.11 0.36 0.70 †
(P=0.78) (P=0.45) (P=0.73) (P=0.24) (P=0.011)
STD ARTG 0.52 0.69 † 0.61 † 0.71 † 0.56
(P=0.085) (P=0.013) (P=0.036) (P=0.0093) (P=0.058)
Range ARTG 0.45 0.58 † 0.75 † 0.63 † 0.70 †
(P=0.13) (P=0.0498) (P=0.0047) (P=0.028) (P=0.12)
Max. ARTG 0.44 0.56 0.61 † 0.71 † 0.56
(P=0.15) (P=0.058) (P=0.036) (P=0.0093) (P=0.058)
Table 6.6: Pearson’s correlation between endocardial and BSM parameters in the VT
Group. Columns represent endocardial repolarization parameters. Rows represent body
surface measures of repolarization. Each cell contains Pearson’s correlation coefficient and
the level of significance (P). † = Statistically significant; (ARI = Activation Recovery In-
terval; ARTG = Activation Recovery Time Gradient; NDC = Non-dipolar content; QRSTi
= QRST integral)
repolarization properties.
To compare repolarization parameters derived at the endocardium to body
surface differences in QT interval, a new parameter (ARTG) was defined that is
capable of identifying spatial gradients in repolarization duration. ARTG is inde-
pendent of variation in interelectrode distances or electrode distance to the heart.
ARTG appears therefore to be a useful parameter that provides information on lo-
cal spatial dispersion in repolarization and allows comparison of these parameters
between different, unevenly distributed, lead systems.
6.5.1 QT dispersion
Predicting vulnerability for ventricular arrhythmias by using QTd derived from
the 12-lead ECG is hampered by several problems. First, as has been elegantly
demonstrated by Willems et al, it appears that measurements of the QT interval
using surface ECG leads (or BSM) is subjected to a large intra- and interobserver
variability, despite the development of dedicated computer algorithms [28]. Inter-
observer differences of measurements mount up to 30 ms, which is approximately
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Mean STD Range Mean STD
ARI ARI ARTG ARTG ARTG
QRSTi rc=–0.27 N/A N/A N/A N/A
Non-dipolar r=064
content (P=0.0031)
Mean QT rc=1.12 rc=1.21 N/A N/A N/A
r=0.88 r=0.048
(P  0.0001) (P=0.054)
STDQT N/A N/A N/A N/A rc=5.45
r=0.67
(P=0.0021)
QTd N/A N/A N/A N/A rc=22.49
r=0.52
(P=0.012)
Mean ARTG N/A N/A N/A N/A rc=0.50
r=0.51
(P=0.013)
STD ARTG N/A N/A rc=0.02 N/A N/A
r=0.53
(P=0.011)
Range ARTG N/A N/A rc=0.14 N/A N/A
r = 0.63
(P=0.0038)
Max. ARTG N/A N/A rc=0.14 N/A N/A
r=0.62
(P=0.0042)
Table 6.7: Linear regression parameter estimates of endocardial and BSM parameters in
the VT Group. Columns represent endocardial repolarization parameters. Rows represent
body surface measures of repolarization. In each cell, the linear regression parameter esti-
mate (rc), partial R-square value (r) and significance level (P) are denoted. N/A indicates
that that variable was not selected for entry in the model. (ARI = Activation Recovery
Interval; ARTG = Activation Recovery Time Gradient; STDQT = QT standard deviation
per lead)
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in the same range as the QTd one is trying to establish. This QT measurement
problem is predominantly caused by the unclear determination of the T-wave end,
especially in the presence of U-waves. Fuller et al. tried to solve the problem of es-
timating the offset of the T-wave, in an electrolyte torso-shaped tank model with
a suspended canine heart in it, by means of a curvature analysis of the T-wave
shape [29]. Although this method appears promising, it should be noted, that this
method requires minimum noise as can only be obtained in a torso-shaped elec-
trolytic tank model with ideal electrode-torso contact. We found that – in vivo –
it appears to be impossible to reach the required signal-to-noise ratio needed for
this approach. Therefore, in our study we selected a more conventional method
for determination of the offset of the T-wave followed by visual inspection. Vari-
ation in the QT interval on a beat-to-beat basis (STDQT) was 2.3 to 4.7 ms in the
entire 62-lead BSM array, suggesting a stable determination of the QT interval in
this study.
The second problem that emerges when QTd is used for determination of re-
polarization dispersion is that the QT interval is not reflecting myocardial char-
acteristics of repolarization only. The QT interval is the summation of the entire
depolarization and repolarization process in the myocardium underlying a partic-
ular surface electrode. The QT interval is therefore not only determined by local
repolarization, but also by local depolarization characteristics, such as speed of
wave front conduction and direction. Therefore one cannot state that differences
in QT interval at the body surface will always reflect increased heterogeneity of re-
polarization in the heart, since this may also be caused by altered local activation
in the heart.
The third issue is that QTd is currently calculated as the longest minus the
shortest QT interval that can be recorded in a given electrode array system. Al-
though this does provide some information on the QT interval distribution over
the thorax, it is probably not the best measure to detect non-uniform local recovery
from excitation in the heart. It is conceivable that large differences in QT interval
that are found between electrode pairs that are far apart on the thorax do not bear
much clinical relevance since they do not necessarily indicate large regional dif-
ferences in repolarization in the heart. Increased local differences in repolarization
predispose for functional re-entry potentially resulting in malignant tachyarrhyth-
mias.
Finally, it should be noted that QTd estimation from the standard 12-lead ECG
is limited by the paucity of electrodes. In this study it was shown that only 15
% of the variance in QTd (partial r=0.39 in the linear regression model in Table 5,
therefore r2=0.15) could be independently explained by endocardial ARTG stan-
dard deviation. This illustrates that some of the information on local endocardial
differences in repolarization duration is preserved when the QTd is derived using
only the 12-lead ECG. This percentage increases slightly to 27% (partial r=0.52 in
table 6.7) when the entire BSM array is utilized.
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6.5.2 Non-dipolar content of BSM QRST integrals.
The concept of the QRST integral or ventricular gradient was first introduced by
Wilson et al, who suggested that the “deflection area of the QRST complex was
determined by differences in the duration of repolarization” [1]. Subsequent the-
oretical models confirmed this relation [30, 31]. Abildskov et al provided direct
evidence for this concept in an experimental study in dogs [32]. In their study,
they concluded that QRST integrals represent primary repolarization character-
istics, which are independent of the site of ventricular activation, as opposed to
secondary repolarization characteristics, which are dependent on the activation
site as well as on a disturbed activation sequence due to bundle-branch block or
prior infarction. Later, clinical evidence was found that linked non-dipolar con-
tent with left ventricular dilatation following myocardial infarction [17] and var-
ious forms of intrinsic electrical heart disease [19] and cardiomyopathy [18]. In
the presented study, a significant difference in non-dipolar QRST integral map
content was found between VT Group vs. Control Group and non-VT Group vs.
Control Group, respectively. The difference found between VT Group and non-VT
Group did not reach significance (P=0.09). The relatively small patient groups may
have caused this. Furthermore, one should realize that, although patients in the
non-VT Group had never suffered from sustained ventricular arrhythmias, they
potentially have the same arrhythmogenic postinfarction substrate. For instance,
although anecdotal, the patient in the non-VT Group with the largest non-dipolar
QRST map content (0.87) died suddenly 2 months after the BSM.
When non-dipolar QRST content was compared with direct endocardial repo-
larization measurements, it was found that the mean ARI duration was an inde-
pendent predictor, explaining 41% (r=–0.64 in the linear regression model) of the
non-dipolar QRST map content variance. Pearson’s correlation coefficient proves
that non-dipolar content is inversely related (r=–0.79) with mean ARIs. This im-
plies that patients with significant non-dipolar QRST content will have short en-
docardial refractory periods. Short endocardial electrical recovery intervals may
give rise to shorter reentry circuits thereby exposing the patient to more malignant
ventricular arrhythmias.
Major advantages of the QRST integral map are its relative independence of
noise and the exact determination of the T-wave end. Since stationary noise has
zero mean and unity variance, its contribution to the integral value can be ne-
glected. If the markers comprising the QRST interval can be set at the instant near
the offset of the T-wave where instantaneous voltages are low (in our study  0.02
mV), only a small contribution to the QRST integral value will be missed at most.
Major disadvantage of the QRST integral map is its relative sensitivity to baseline
drifting. Therefore, a good baseline correction algorithm should be used.
6.5.3 Transmural dispersion
More recently, the concept of transmural dispersion in repolarization was intro-
duced by Antzelevitch et al [33, 34]. They postulated the presence of specialized
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cells, so-called M-cells, in the deeper layer of the ventricular myocardium, pos-
sessing specific repolarization properties. From their experimental work it ap-
pears that the J-T-peak interval is determined by the repolarization duration of
the epicardial cells, whereas as the T-peak to T-end is determined by the difference
in repolarization between M-cells and the epicardial layer, thereby representing a
transmural repolarization gradient [35–37]. Most of the work by Antzelevitch et
al was done in an arterially perfused myocardial wedge model with an electrode
configuration resembling standard precordial lead V5 [35].
In the currently presented study the relation between the T-wave peak to T-
wave end interval in the precordial leads V2 and V5 and endocardial repolar-
ization estimates was determined. In both infarction patient groups (VT Group
and non-VT Group) the TE interval in V2 and V5 was significantly larger than in
the healthy controls (Control Group), but between VT Group and non-VT Group
no significant differences were found. When compared to the invasive estimates
of repolarization, TE V5 correlated strongly with the ARTG range and the ARTG
standard deviation. Both parameters combined explained 76 % (r=0.62 and r=0.25,
respectively) of the TE V5 variance. Interestingly, none of the endocardial param-
eters sufficed the P=0.10 threshold for entry in the linear regression model for TE
V2. These data suggest that TE V5 is indeed a powerful predictor of dispersion in
repolarization.
6.5.4 Activation Recovery Time Gradients
Since it was presumed that merely looking at differences in QT interval over the
entire thorax was probably not the best measure to express local differences in
repolarization, a new parameter was introduced in this study. ARTGs can be cal-
culated both for ARIs as for QT intervals, allowing direct quantitative correlation
between the two. ARTGs give information on the rate of local change in repolar-
ization duration, expressed as ms per degree between 2 electrodes. We postulated
that larger ranges in ARTG either at the endocardium or at the body surface rep-
resents increased dispersion in refractoriness. Indeed, correlations between en-
docardial ARTGs and TE V5 and the 12-lead QTd (Table 5), were found as well
as between endocardial ARTGs and the BSM QTd, and between endocardial and
BSM ARTGs (Table 6.7).
6.5.5 The ‘ideal’ non-invasive parameter to estimate repolarization
dispersion
The ideal parameter for detection of repolarization dispersion and therefore for
identification of patients prone to malignant ventricular arrhythmias would be a
parameter that 1) can be reliably and reproducibly detected at the body surface
2) gives information on local differences in repolarization independent of the de-
polarization characteristics and 3) is able to discriminate patients with potentially
the same arrhythmogenic substrate, who are not subjected to increased risk for
sudden death, from those who are. From all parameters used in this study, non-
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dipolar content of the QRST integral map appears to fit this description the best.
Only the difference between VT Group vs. non-VT Group did not reach signifi-
cance although a trend towards significance was present. The best way to resolve
this issue would be to conduct a prospective study comprising a larger number
of patients. The TE V5 interval is a simple to obtain parameter in daily clinical
practice and also appears to correlate well with endocardial dispersion in refrac-
toriness. In this study, TE V5 had less discriminative power between infarction
patients, but again larger prospective studies will be needed to establish this.
6.5.6 Limitations of the study
The repolarization process in the human ventricle is a complicated 3D (or maybe
even 4D when temporal dispersion is considered) process with possibly very dif-
ferent behavior in different layers of the myocardium. To investigate the repo-
larization in the heart an endocardial basket catheter was used as well as a BSM
array. This means that no direct information could be obtained from the intra-
mural myocardial and epicardial layers. Assumptions on transmural dispersion
will therefore have to be made with caution. Furthermore, since the basket is not
guaranteed to cover the entire endocardium, repolarization aspects of parts of the
endocardium – and especially the apex of the left ventricle – may have been un-
derestimated.
Finally, it should be noted that patients in the VT Group and non-VT Group
were incomparable with respect to left ventricular ejection fraction and time since
infarction. This was caused by the fact that the goal of this study was to compare
postinfarction patients without ventricular arrhythmias with those who suffered
from VTs. The concept that VTs develop late after myocardial infarction when
left ventricular dilatation has progressed, appears well in line with the correla-
tion between left ventricular dilatation and non-dipolar QRST content found by
Dambrink et al [17].
Since infarction patients in the VT Group and non-VT Group all potentially
are at risk for developing postinfarction ventricular arrhythmias, whether those
are already manifest or not, further prospective data are needed to evaluate the
discriminative powers of the variables between infarction patients that are and
infarction patients that are not at risk for sudden cardiac death.
6.6 Conclusion
QT dispersion can be detected at the body surface by means of the 12-lead ECG
to some extent. T-peak to T-wave end in precordial lead V5 appears to be a more
promising parameter. Extending the lead set to cover the entire chest area in-
creases the yield of QTd estimation for detection of disparity in repolarization, but
several problems intrinsic to the nature of QTd persist. Non-dipolar content of the
BSM QRST integral can identify patients with short mean endocardial repolariza-
tion duration, which are at risk for tachyarrhythmias with shorter cycle length.
Finally, ARTG can be used to detect differences in duration of repolarization in
References 137
confined chest areas, indicative of spatial disparity of repolarization, instead of
global difference in repolarization duration estimated over the entire thorax like
QTd. To further evaluate the clinical use of body surface ARTG, the TE V5 interval
and non-dipolar content of the QRST integral map, prospective trials are needed.
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142 Chapter 7. Physical considerations
7.1 Introduction
Ventricular tachycardia (VT) late after myocardial infarction requires a substrate of
surviving myocardial fibers within the infarcted area. Areas of slow conduction,
revealing itself as late potentials at the body surface [1], and non-uniform recov-
ery from excitability, possibly expressed by increased QT dispersion [2], appear
to be indices of vulnerability for ventricular arrhythmias. Surface ECG data can
be obtained with a body surface mapping (BSM) electrode array, whereas recently
multi-electrode systems that are capable of obtaining instantaneous multi-site en-
docardial maps – such as a ‘basket’ catheter – have become available to study
arrhythmogenic mechanisms in the human heart in vivo.
A number of issues will have to be resolved when trying to geometrically link
late potentials from endocardial areas of slow conduction to signals that can be
recorded at the body surface. First, the signal-to-noise ratio (SNR) is not high
enough for these signals to be detected directly on a beat to beat basis at the body
surface. This problem can be solved by signal averaging. Second, the amplitude
of ECGs depends on the location of the recording electrodes. Signals are largest
in the precordial region and smaller in regions more distant from the heart. To es-
timate the relative contributions of all surface leads, a correction for this distance
effect is necessary. Third, standard criteria used in the context of late potentials are
sensitive to the SNR. General criteria must be developed that identify late poten-
tials less dependent on SNR, since SNR changes with the electrode position at the
body surface. Fourth, electrodes of a basket catheter will be in a different position
for each patient. It is therefore not possible to use a general forward or inverse
solution. A tailor-made matrix that maps potentials at electrodes in the heart to
potentials at the body surface, has to be estimated for every patient. Finally, the
BSM electrode array and the basket catheter electrode system are quite different
unevenly distributed electrode systems. When comparing data (e.g. repolariza-
tion estimates) from both electrode systems, a measure will have to be developed
that not only corrects for different interelectrode distances within a lead system,
but also has the same dimension and similar magnitude in both lead systems, al-
lowing comparison between them.
7.2 Signal averaging of late potentials
When the signal-to-noise ratio of a repetitive signal is not large enough to reliably
detect this particular signal, one can use its repetition to increase the SNR. Repe-
tition can be used if it is possible to evoke the signal as a response to an external
stimulus, like e.g. in the case of evoked potentials in neurology or endocardial
paced ventricular activation in cardiology. Signal averaging can also be applied
if the signal of interest has a causal relation with a signal that has a SNR large
enough to be detected. The latter is the case for ‘late potentials’. These are small
deflections with a SNR below 1, occurring at the end of the QRS complex. They
have, however, a fixed relation in timing with the much larger QRS complex. By
deriving the timing from the QRS complex and averaging the entire signal, the
7.2. Signal averaging of late potentials 143
Figure 7.1: Reconstructed histological slices from the infarcted area of a human heart.
Grey and black areas depict surviving strands of myocardium. White areas denote fibrous
tissue. Picture from De Bakker et al. [3].
SNR of the late potentials can be increased.
7.2.1 Electrophysiological basis for signal averaging
Late potentials are generated by activation in myocardial bundles that survive in
the infarcted area. As can be seen in figure 7.1 surviving ‘bundles’ are in fact a
complex substrate consisting of tracts of preserved conduction within the infarc-
tion scar. These tracts tend to form a complex 3D structure with all sorts of twists
and turns. Because activation in these bundles will not travel in a straight line, an
ECG lead at the body surface will record the activation coming towards this lead
at some instant – and hence show a positive signal – while the next moment the
activation turns away and the signal diminishes and may even become negative.
This will cause surface leads to record a quickly changing (high-frequency) signal
from this substrate.
From the properties of these bundles we can derive the properties of signals at
the body surface that may indicate such a substrate. First, because propagation is
slower in surviving bundles these potentials will occur during sinus rhythm late
in depolarization, hence the name ‘late potentials’. Second, late potentials are of
small amplitude because they are generated by small myocardial areas and third
they are more prominent in the higher frequencies than the bulk of the ventricular
activation.
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These properties suggest the following method for detection: increase the SNR
by signal averaging, use a high-pass filter to remove large, low-frequency signals
and look at the end of the QRS complex. Of course, high frequency potentials gen-
erated by the arrhythmia substrate will also be present during the QRS complex
but in this interval they will be masked by the much larger normal ventricular
activation.
7.2.2 Coherent and weighted averaging
Coherent averaging
Usually, the standard procedure for signal averaging is to simply time-align all
complexes. Beats with artifacts and excessive noise are rejected and the mean of
the signal is used as an estimate of the signal. This is called coherent averaging.
The fundamental assumption when using coherent averaging to average  signals
is that the noise in the signal is stationary. The signal model, for stationary noise,
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In biological signals the noise is generally not stationary. For non-stationary
noise coherent averaging is not the optimal technique. Consider the case where
two QRS complexes are averaged and one complex contains twice as much noise
as the other complex. In this particular case coherent averaging will result in a






2 ≈ 1  12 times the lowest noise level. In this case,
the resulting noise level is even more than that in the most optimal original mea-
surement.
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For our example with one signal having twice the noise level of the other, after











 ≈ 0  9  , which is indeed
lower than the noise in either signal.
7.2.3 Definition of parameters
Simson has proposed a method to detect late potentials in body surface signals
and many variations on his scheme have since been proposed, all with basically
the same ingredients. First all complexes in a long recording, often 300 complexes
or more, are time-aligned. Then the X, Y, and Z leads are (coherently) averaged
to increase the SNR. These X, Y, and Z are ’bidirectionally’ filtered and combined
in a vector magnitude. In this context ‘bidirectionally’ means that the first part
of the signal is filtered forward to a point in the middle of the QRS complex and
then the last part is filtered backwards up to this same point. The result is that the
QRS duration is not overestimated as a result of leaking of energy out of the QRS
complex into the adjacent isoelectric segments as a result of the filtering. From the
vector magnitude the (filtered) QRS duration (QRSD, sometimes fQRSD) is deter-
mined by estimating the noise and subsequently setting the beginning of the QRS
complex at the instant when the signal exceeds for 5 ms the noise plus 3 times its
standard deviation. Then, the end of the QRS complex is determined by searching
backwards from a point well beyond the J-point for the instant when the signal for
the first time exceeds the noise plus 3 times its standard deviation for this same
interval. After determining the end of the QRS complex, two more parameters can
be computed viz. the RMS of the signal in the last 40 ms (the RMS40) and the time
between the moment the signal drops below 40 µVand the end of the filtered QRS
complex (LAS40).
All three parameters (QRSD, LAS40, and RMS40) are measures of late activa-
tion in the ventricles. For signals filtered with a low-pass of 25 Hz, clinical inves-
tigations show that QRSD Ò 120 ms, RMS40  23 Ñ V, and LAS40 Ò 38 ms are associ-
ated with patients prone to ventricular arrhythmias. When two out of the three
parameters are different from the normal population the patient is said to have
late potentials. For two patients, one with and one without late potentials data are
shown in figure 7.2.
7.2.4 Limitations of standard method
The Simson method for signal averaging only determines whether late potentials
are present. Since late potentials are detected on one single (compound) ECG
trace, anatomical localization of late potentials is impossible. Moreover, because
late potentials are defined as persistence of energy content of a specified ampli-
tude during a specified period of time at the end of the QRS complex, instead of
a specific deflection in the ECG representing the late potential, it is not possible to
identify the corresponding deflection in invasively obtained intracardiac record-
ings.
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Figure 7.2: Definition of parameters in the standard signal averaging procedure. QRSD
is the total QRS duration of the filtered vector magnitude. RMS40 is the RMS energy
in the last 40 ms of the QRS complex. LAS40 is the duration at the terminal part of the
signal that is below 40 Ñ V. The SAECG on the left is positive for late potentials (QRSD =
156.5 ms, RMS40 = 11.1 Ñ V, LAS40 = 69 ms). The SAECG on the right contains no late
potentials (QRSD = 104 ms, RMS40 = 76.9 Ñ V, LAS40 = 10.5 ms).
The requirement that the signal must cross the threshold for 5 ms is not con-
sistent with the 250 Hz bandwidth. A 100 Hz signal will cross the zero line every
5 ms. So any substantial (interference) signal of 100 Hz or higher will not be above
threshold for more than 5 ms in the vector magnitude. As is shown in figure 7.3
where a 150 Hz signal is artificially added to one of the leads, the QRS offset will
be detected more or less at the same instant, whereas the 150 Hz signal is clearly
present beyond that point. Therefore, the detection interval should be 2 ms and
not 5 ms to accommodate the 250 Hz bandwidth or the bandwidth should be re-
duced to 100 Hz. The current method will not detect high-frequency late poten-
tials in the 100–250 Hz range, but the frequencies between 100 and 250 Hz will still
contribute to the noise.
7.3 Lead dependent late potential criteria
When a multi-lead electrode system with variable heart – electrode distances is
used to detect late potentials instead of a 3-lead orthogonal lead system, a new cri-
terium for the presence of late potentials will have to be defined. All parameters
used in the standard procedure to detect late potentials depend on SNR. The end
of the filtered QRSD is defined as the instant in the electrogram when the instanta-
neous voltage drops below the mean plus three times the standard deviation of the
estimated noise. In effect, this implies that if the noise level decreases, the QRSD
will increase and as a result the LAS40 will also increase, while the RMS40 will
decrease. The SNR is larger in the precordial region than in the posterior regions
of the chest. Using any of these parameters in the aforementioned multi-lead elec-
trode system will underestimate the presence of late potentials originating from
e.g. the posterior wall of the left ventricle.
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Figure 7.3: High frequency interference in pass band. A train of 150 Hz sinuses is added
to an averaged signal from a patient to the positive X-lead (panel A). Although this is
in the pass band of the standard averaging procedure this signal will cross the zero-line
every 3.3 ms. The vector amplitude (panel B) will therefore not be above the threshold
(horizontal line) for more than 5 ms and the ‘end of QRS complex’ (vertical line) will be
detected at the approximate same time as in the panel A.
Another reason for not using LAS40 or RMS40 is that their determination also
depends on the signal amplitude. Signal amplitude varies with the distance of the
electrode to the heart, i.e. the position of the electrode on the thorax, whereas noise
will be mainly determined by local skin-electrode conditions. This will cause the
SNR to be less favorable in the areas of the thorax more distant from the heart.
Since the QRSD has an unknown distribution over the thorax, it is not possible
to use this parameter by itself to quantify late potentials in the heart at the body
surface.
Because criteria that depend on the signal can not be used, the only parameters
left are those that use a fixed time interval. This interval should not depend on
the presence or absence of late potentials, in fact ruling out the use of the filtered
ECG’s for defining this interval.
Therefore, we propose to use the interval from the J-point — as determined in
the unfiltered QRS complexes from the precordial leads V1 to V6 — to 50 ms after
the J-point to include all late potentials. The J-point was defined as the time when
a tracing changes slope abruptly at the end of the S-wave [4].
7.4 Distance Effect
The amplitude of late potentials in averaged signals in any lead will not only be
influenced by the size and orientation of the underlying electrical wave front but
also by the distance of the source to the electrode. The amplitude of a signal gen-
erated by a dipole will diminish rapidly with the distance between source and
recording electrode. This means that irrespective of the location of the substrate
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in the heart the maximum amplitude of late potentials will usually be recorded in
the precordial region. To avoid underestimation of the significance of late poten-
tials in other chest areas, a correction for the effect of electrode-source distance is
needed. Actually, the standard late potential analysis uses uncorrected X, Y, and Z
leads. This analysis therefore also overestimates late potentials from the anterior
wall and underestimates those from other sites of the heart.
The potential ( ¤¦¥ ) measured at point

on the surface is a result of the potential




















A implicitly includes the distance effect and torso inhomogeneities. This can be












For any lead set with leads at positions
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we can now estimate the potential distri-
bution corrected for the distance effect ¤
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The distance matrix can be computed from volume conductance theory and
information derived from MR images. For practical purposes, however, a measure
that can be derived from the data itself is preferable.
7.4.1 Methods for distance correction
We recorded 65 leads at the body surface (62 leads according to the Amsterdam
lead system plus three extremity leads) simultaneously with 64 endocardial leads
from a ConstellationTM basket catheter (Boston Scientific Inc.) in 16 patients. Bi-
plane X-ray images were acquired and digitized to obtain 3D positions of all en-
docardial electrodes.(See § 7.5)
Standard X, Y, and Z leads were reconstructed from the three best matching
electrode pairs selected from the 65 body surface electrodes. The standard SAECG
was obtained from these X, Y, and Z leads to compare SABSM with the signal aver-
aging method that is currently applied clinically. In the literature various criteria
for the detection of late potentials have been proposed, depending among other
things on the cut-off frequency used in the high-pass filter [5,6]. In this study, late
potentials were defined as a QRSD Ò 120 ms, RMS40  23 Ñ V, and LAS40 Ò 38 ms in
accordance with commercially available equipment used in our hospital for tradi-
tional SAECG.
As a time reference for all surface leads the J point in the unfiltered QRS was
chosen as described above. The energy in the 50 ms following this point was inte-
grated and plotted as a body surface map.
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Figure 7.4: Isopotential maps obtained at 5 ms intervals in the filtered signal averaged
QRS complex of sinus rhythm in one patient.
The following physical reasoning was adopted to derive the correction factors
for heart – electrode distance. During left ventricular depolarization every cell
generates a small current, the summation of which results in the QRS complex at
the body surface. It would seem that for every point at the surface, the average
energy during the QRS complex can be used as an estimate of the distance effect
matrix D(~

) (see equation (7.6) ), because it depends on the average distance of all
points in the heart to the recording electrode. This assumption, however, should
be treated with caution since most dipoles during cardiac activation point more or
less in the same direction. So the energy content at positions at the body surface
that are perpendicular to the heart axes, will then be underestimated. For a better
estimate of the distance effect we need a collection of dipoles instead of a single
dipole. Pacing at multiple sites in the ventricle could be employed, but this is
rather time consuming and only possible during catheterization. Another option
would be to remove the preferential direction of the heart axis by high-pass filter-
ing. After filtering, the surface distribution consists of rapidly changing, nearly
dipolar patterns (see figure 7.4). Based on these physical considerations it was ex-
pected that high-pass filtered activation during the QRS complex may serve as a
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The distance corrected late potentials are therefore computed as:
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Figure 7.5: For the same patient as in figure 7.4, filtered QRS integral maps obtained by
ectopic stimulation at 50 endocardial sites using the basket catheter are shown. From left
to right are the 8 splines of the basket catheter and from top to bottom the 8 electrodes on
each spline.
To illustrate that high-pass filtering of the QRS complex indeed removes the
preferential direction, filtered QRS integral maps obtained by pacing 50 of the 64
basket electrodes where capture could be obtained in the same patient are shown
in figure 7.5. Similar filtered QRS integral maps are obtained, regardless on the
site of origin of endocardial activation. The correlation coefficient (r) between each
individual paced map and the mean paced QRS integral map is 0.98. There is also
excellent correlation between the mean paced filtered QRS integral map and the
filtered QRS integral map of sinus rhythm in this patient (r=0.97)
Since detection of late potentials is done using high-pass filtered electrocardio-
graphic data, using these same signals for the correction procedure seems very
efficient. To be able to compare maps from different patients, the correction vector
should have an amplitude that does not depend on the total energy in the QRS
complex for that patient. This can be achieved by normalizing the correction fac-
tor.
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V1 V1
Figure 7.6: Left panel: the uncorrected energy distribution in the 50 ms interval following
the J-point for a patient without late potentials in the standard SAECG. The approximate
positions of the X, Y, and Z electrodes are shown as open circles. The darkest area has 3.6
times as much energy as the lightest. Right panel: the mean energy distribution during
the QRS complex in the same patient. The darkest area has 6.0 times as much energy as
the lightest. In both panels the positions of precordial leads V1–V6 are indicated by dots.
7.4.2 Results of distance correction
The patient in the right panel of figure 7.2 on page 146 has no late potentials on
the standard SAECG although this patient had documented VT. In the left panel
of figure 7.6 the uncorrected energy of the late potentials is shown for this patient.
In this panel also the approximate positions of the standard X, Y, and Z electrodes
are shown. The standard SAECG procedure did not show late potentials probably
because the area is relatively small and the electrodes are just outside this area.
The right panel shows the average energy during the QRS interval. It is obvious
that, as expected, the amplitude is largest in the precordial region.
In the upper panel of figure 7.7, the corrected energy i.e. the energy in the
50 ms following the J-point (left panel in figure 7.6) divided by the normalized
energy during the QRS complex (right panel in figure 7.6) is shown. Darker areas
correspond to higher energies. For clarity, the left part of the map is repeated
on the right. This map shows that the energy above the V2–V3 area in the left
panel of figure 7.6 is not a result of late potentials in local heart tissue, but that
the maximum around V5 does reflect late potentials. Note that there is now also
an area high on the back of the patient that shows a high energy contribution.
These two areas correspond to the two areas of the basket catheter (lower panel)
that show late potentials (dark areas) during sinus rhythm. The basket is shown
in four views, one from the front, one from the right, one from the back and one
from the left. They are positioned under the map at positions that correspond to
these views from that aspect of the thorax.
In figure 7.8, data from a patient in whom all three SAECG late potential crite-
ria are positive are shown. The standard SAECG analysis for this patient is shown
in the left panel of figure 7.2. Like in figure 7.7 the upper panel of figure 7.8 shows
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V1
Figure 7.7: Top panel: energy distribution in the same patient as in figure 7.6 after cor-
rection for the distance effect. Lower panel: the late potentials as recorded with the basket
catheter. Dark colors indicate electrodes with late potentials. The darkest area has 4.0 times
as much energy as the lightest. Note that the two areas with late potentials correspond to
the dark areas in the top panel.
the energy distribution over the body in the 50 ms after the J-point, corrected for
the distance. The lower panel shows the late potentials as recorded by the basket
catheter.
7.5 Spatial correlation of basket and surface leads
7.5.1 Reconstruction of 3D position of basket electrodes
During catheterization simultaneous biplane x-ray images were acquired using
right (RAO) and left anterior oblique (LAO) digital cine fluoroscopy (Philips Med-
ical Systems Integris). The same end-diastolic frames from both fluoroscopic pro-
jections were selected. Starting at the A and B spline, which are easily identified by
one resp. two extra radiopaque markers at the proximal end, all electrodes were
labelled in both views. Correct labelling was checked by a team of experienced
cardiologists.
If the positions of individual electrodes in the two perpendicular views are
known, it is possible to compute their 3D positions within the left ventricle. In
both views a line can be drawn from the pixel of the image in the detector to the
corresponding x-ray source. These two lines must intersect at the 3D position of
the object under consideration. In practice because of measurement errors the two
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V1
Figure 7.8: Late potentials in a patient with positive SAECG. Layout is the same as in
figure 7.7. Again, two endocardial as well as two body surface areas of late potentials are
found.
lines will not intersect but cross at a certain distance. For the 3D position of the
electrodes of the basket the midpoint of the shortest line segment connecting the
two crossing lines was taken. The length of this line segment is an indication of
the accuracy of the reconstruction. For the basket electrodes the mean length of
this segment was 3 mm.
7.5.2 3D positions of surface electrodes
For each patient the position of the surface electrodes relative to the heart was de-
rived computationally. For this purpose, cross-sectional images of a human tho-
rax, as can be found on the internet, were utilized [7]. The image at the level of the
center of the left ventricle was used (figure 7.9). The approximate positions of the
14 BSM straps and the center of the left ventricle were determined on this selected
slice. By repeatedly translating the surface positions over a vertical distance of
3 cm, a simple model of the torso was constructed.
This 3D information was used in combination with the computed 3D posi-
tions of the basket electrodes, placing the basket virtually in the same image while
making the center of the basket and the center of the left ventricle coincide. This
allowed investigation of the spatial relations of surface ECGs and endocardial sig-
nals.
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Figure 7.9: Left Panel: Cross-sectional image of the human thorax at the level of the center
of the left ventricle. Right panel: The approximate position of the 14 straps on the body
surface as determined from the left panel. At the positions where the straps ‘B’ and ‘O’
would be the Amsterdam Lead set does not contain electrodes. The asterisk denotes the
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Figure 7.10: Computation of distance (D) of the basket electrodes from the line connecting
a surface electrode with the center of the basket catheter.
7.5.3 Matching surface and endocardial electrodes
Electrodes at the body surface are most sensitive to regions in the heart that are
nearest to them. When interested in the value of a parameter in a certain region of
the heart one should select an electrode that observes this region and subsequently
compare its value with those obtained at other sites. To determine which regions
on the heart project to which regions on the body surface a forward computation
can be employed if the exact geometry of the patient is known. No MRI or other
3D information were available in our study, however.
To be able to make the comparison between recorded endocardial late poten-
tials and late potentials that were detected after signal averaging, a matrix should
be constructed that indicates the weighted contribution of each basket electrode
to all of the BSM electrodes in each individual patient.
For all 62 BSM and all 64 endocardial electrodes the 3D positions can be calcu-
lated utilizing the aforementioned techniques. We postulated that every electrode
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at the surface is most sensitive to those parts of the heart that lie close to the line
connecting this electrode to the center of the left ventricle. We therefore computed
for each pair of surface electrode and basket electrode the distance of the basket
electrode to the line that connects the surface electrode to the center of the basket
(see figure 7.10). Since electrodes at the opposite side of the center of the basket
may also be close to this line through the center of the basket, these distances were
rendered negative to distinguish these electrodes from the electrodes close to the
line on the same side of the basket as the surface electrode. Because basket elec-
trodes closest to this line contribute most to that particular surface electrode, the
inverse of these distances was used to establish a weighted contribution. The in-
verse distances were then normalized such that the maximal contribution of each
endocardial electrode to the surface was 1 (arbitrary unit). Final result of these
calculations is a 62 × 64 transfer matrix. The total distribution of late potentials
at the surface that can be expected from recorded endocardial late potentials can
now be computed by summation of all contributions of basket electrodes where

























inverse of the distance of basket electrode » from the line that connects the surface
lead ± to the center of the basket.
In equation (7.10) there is still a choice to be made for the set of » ’s that is used
in the forward computation. To optimize discriminating power of the computed
maps, the optimal number of electrodes in the neighborhood of the connecting
line that should be used was investigated. As can be seen in figure 7.11 the resolv-
ing power of the forward computed late potential map increases with decreasing
number of contributing electrodes. Using all electrodes results in a smooth dipo-
lar pattern without specific details. Restricting the electrodes to those that are on
the same side of the center of the basket as the surface electrode results in a little
more detail. When the six nearest electrodes are used, the pattern resolves to that
of two areas of the heart that do contain late potentials. Reducing the number
of electrodes further will result in a patchier pattern that is harder to interpret.
It was concluded that about 4 to 8 closest electrodes yielded the best resolution
without being too patchy. An example of the patterns for one electrode are shown
in figure 7.12. Figure 7.11 is the result of the sum of such maps from the 15 basket
electrode leads with late potentials in this patient.
Restricting the selected basket electrodes by a threshold on the maximal dis-
tance from the line instead of reducing the number of electrodes also resulted in ei-
ther too smooth or too patchy patterns, depending on the threshold chosen. How-
ever, a maximum distance that gave satisfactory results for all patients could not
be found.
It should be noted that in each patient the basket catheter is deployed differ-
ently. This causes the electrodes of the basket to be in a different position for every
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Figure 7.11: Effect of number of contributing endocardial electrodes on localizing power.
From left to right and from top to bottom, maps constructed by using all basket electrodes
(with negative values for electrodes at the other side of the center of the basket), using only
basket electrodes on the same side of the basket as the surface electrode, using the 6 closest
basket electrodes, and using only the closest one are shown.
patient. Therefore, the matrix ¼
®ffi½
£
in equation (7.10) was calculated for each pa-
tient. Figure 7.13 displays the results in four patients for an arbitrarily selected
basket electrode.
In principle, also the inverse approach could have been used to estimate late
potentials at the left ventricular endocardium from those at the surface. Superiorly
and inferiorly positioned electrodes in the heart do not project well on the surface
electrodes, however. This tends to give rise to systematic errors in the compari-
son. The basket electrodes cover more of the space angle than the body surface
electrodes. Therefore, this problem of unequal coverage did not complicate the
forward computation, but would have posed a problem in the inverse computa-
tion.
7.6 Spatial gradients in unevenly distributed electrode
systems
When, for instance measures of spatial inhomogeneity in repolarization such as
QT intervals or endocardial activation recovery intervals (ARIs) are computed, it
may be useful to take the geometrical relation between measuring positions into
account. Measuring a difference of 30 ms in QT interval between sides that are
located at opposite sites of the chest will probably not be as indicative of arrhyth-
mia vulnerability as the same difference in electrodes 2 mm apart. We therefore
considered methods to compute in an identical way the repolarization difference
corrected for interelectrode distance in quite different lead systems. If physical
interelectrode distances would have been used such an index would have very
different values at the body surface as compared to values obtained from endo-
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Figure 7.12: Contribution of arbitrarily selected basket electrode B4 to the surface distri-
butions for four numbers of contributing endocardial electrodes. From left to right and
from top to bottom, maps constructed by using all basket electrodes (with negative values
for electrodes at the other side of the center of the basket), using only basket electrodes on
the same side of the basket as the surface electrode, using the 6 closest basket electrodes,
and using only the closest one are shown.
Figure 7.13: Map showing the contribution of an arbitrarily selected basket electrode (B4)
to the surface distribution of late potentials for four patients. Since the endocardial location
of basket electrode B4 will be different in individual patients, due to the nature of the basket
catheter used, different maps are obtained.
cardium or epicardium. This would have complicated quantitative comparison.
A measure, however, that is independent of physical interelectrode distances and
can be defined both at the body surface and in the heart is the timing difference





at the surface, the angle between the lines connecting them to the center of the left















Figure 7.14: Calculation of angle  between electrodes V4 and V5 in the torso model as
described in § 7.6. CLV = Center of the left ventricle.
Figure 7.15: Map of minimal angles between pairs of electrodes in the Amsterdam lead
set. Dark areas indicate large angles (maximum about 29 degrees) light colors small angles
between neighboring electrodes (minimum about 6.3 degrees).
The principle is shown in figure 7.14. Again, the 3D torso model is derived from
the ’Visible Human Project’ internet site as described earlier (§ 7.5.2).
Plotting the minimum angle between each lead and any other lead (i.e how far
the nearest electrode is) as a body surface map confirms that the Amsterdam lead
set is reasonably homogenously distributed over the thorax (see figure 7.15).

























This will result in a N x N matrix containing the difference in repolarization, di-
vided by the angle between electrodes for each possible electrode pair in the elec-
trode array. The maximum of every row in the matrix, signifies the largest dis-
persion gradient for every electrode. This is the activation recovery time gradient
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Figure 7.16: Area within 45 degrees from electrode. For precordial lead V2 and for lead
N6 located on the patient’s back (indicated with asterisks), all electrode positions of the
Amsterdam lead set (solid dots) that are within 45 degrees of these electrodes are indicated.
For clarity also the electrodes in the 16 by 12 grid, from which the Amsterdam lead set is a
subset, are shown with open circles.
(ARTG).
It appears to be better to restrict the analysis per electrode to a more confined
neighborhood of electrode pairs. Comparing electrodes that are far away does not
result in physiological relevant data. On the other hand using a too small area may
mean that only a few electrodes are compared and that not all directions will be
covered. For the body surface mapping system used in this study, using a cut-off
angle of 45 degrees means that there are at least 6 neighbors for each electrode.
For two arbitrarily selected leads (precordial lead V2 and lead N6 located on the
back of the patient) all electrodes that were within a 45 degree angle are depicted
in figure 7.16. The areas appear elongated. This is because the aspect ratio of the
map is not the same as on the actual body surface. Average distances between
straps vary between patients and is about 5 to 7 cm whereas the vertical distance
is fixed at 3 cm.
7.7 Conclusions
Comparing spatially high resolution electrocardiographic body surface data with
simultaneously derived multi-lead endocardial data poses specific technical prob-
lems. Specific signal averaging methods, filter techniques, correction for inequal-
ity in electrode heart distances, 3D reconstruction of electrode arrays and trans-
lation schemes between different electrode systems as currently presented allow
direct comparison between intracardiac and body surface data thereby increasing
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8General discussion
This study was designed to explore new technologies for analysis of the substrate
of postinfarction ventricular arrhythmias with respect to prevention and treatment
of these arrhythmias. Until now, most of our knowledge of the human postinfarc-
tion arrhythmogenic substrate has been gathered by performing endocardial map-
ping during ventricular tachycardia (VT) [1–5]. In addition, endocardial mapping
performed during ventricular antiarrhythmic surgical procedures has contributed
invaluably to the current scientific concept of postinfarction VT [6]. Traditionally,
endocardial mapping was focused on delineation of the exit site of VT. In the last
decade, the potential of BSM to localize the site of origin of VT (representing the
VT exit site) prior to antiarrhythmic surgery or radiofrequency ablation was ex-
plored [7, 8].
Until the advent of radiofrequency catheter ablation, ventricular antiarrhyth-
mic surgery was the only curative approach for ventricular tachycardia. Most cen-
ters have abandoned antiarrhythmic surgery because of its invasive nature and
disappointing results as compared to ICD therapy with regard to survival. Our
evaluation in chapter 2 demonstrates that antiarrhythmic surgery performed by
a skilled surgeon in an experienced electrophysiologic center still results in clin-
ical outcome that is at least comparable to the results of radiofrequency catheter
ablation of postinfarction VT [9, 10]. Furthermore, little evidence is presented in
the literature on the long-term follow-up and success rate of radiofrequency ab-
lation of postinfarction VT. Therefore, antiarrhythmic surgery remains an addi-
tional optional therapy in a selected subset of postinfarction patients who are due
for open-heart surgery, such as left ventricular aneurysm remodeling, coronary
artery bypass grafting or valve surgery [11, 12].
Body surface mapping (BSM) is evaluated for its clinical value and accuracy
for localization of sites of origin of the postinfarction VT in chapter 2. The major
advantage of knowing the exit site of VT is that at least for one part of the reentrant
circuit (that is obligatory connected to the critical isthmus of slow conduction), the
approximate location is known. Our results show that, despite the fact that BSM
offers many advantages (such as ease-of-use and capability of mapping of non-
sustained and hemodynamical poorly tolerated arrhythmias) the clinical value of
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BSM for antiarrhythmic surgery or radiofrequency catheter ablation of postinfarc-
tion VT is limited. This is caused primarily by the limitations of exit site guided
VT ablation. Histology of the postinfarction scar taught that the arrhythmogenic
substrate is in fact a too complicated structure for mere exit site ablation. It con-
tains multiple potential tracts of slow conduction (only some of which are critical
to the reentrant circuit), which can lead to multiple exit sites [13]. Therefore, exit
site guided ablation results in abolishment of parts of the reentrant circuit that are
critical to that specific VT morphology. It does not imply elimination of the critical
part of the reentrant circuit. Therefore the occurrence of VTs with different mor-
phology, utilizing in part the same critical pathways, may persist in this patient.
Furthermore, exit site directed VT ablation will only be able to eliminate exit sites
that are revealed by induction of the corresponding VT morphology which not
necessarily needs to be a spontaneous clinical VT morphology.
Second reason why BSM is of limited use for ablation of postinfarction VT is
that its localization performance is also influenced by histologic and electrocardio-
graphic characteristics of the arrhythmogenic substrate in the individual patient.
As has been demonstrated in chapter 3, differences in extent of conduction block,
inhomogeneous distribution of endocardial electrogram amplitudes and the pres-
ence of sometimes multiple exit sites in the active VT circuit, all complicate the
task of reference database oriented localization of VT sites of origin. Although
Sippens Groenewegen et al. introduced BSM reference databases that are specific
for anterior or inferior myocardial infarction, this can never account for differences
among patients in infarction size, intramural extension of the infarct, shape of the
left ventricle and involvement of the interventricular septum. This also explains
the difference in accuracy reported between body surface mapping in patients
with and patients without structural heart disease [14, 15].
All factors mentioned above urge us to develop methods for localization of
confined, critical parts of the reentrant circuit such as the tracts of slow conduction.
At present, concealed entrainment during VT is a clinically evaluated methodol-
ogy that functionally differentiate critical tracts of slow conduction from bystander
tracts and that has proven to yield satisfactory clinical outcome [16]. Still, in order
to apply the principle of concealed entrainment, sustained VT should be inducible,
and the patient should be able to tolerate prolonged periods of arrhythmia.
Ideally, the critical parts of the arrhythmogenic substrate should be detected
during sinus rhythm. Tracts of delayed conduction displaying fractionated elec-
trograms, continuous electrical activity or isolated diastolic potentials can be lo-
calized during sinus rhythm. Major impediment, however, is that their functional
significance for the emergence and perpetuation of VT cannot be established by
mere localization mapping [17]. Furthermore, in chapter 5, it was shown that only
at 24 % of the sites that display late potentials during sinus rhythm also contain di-
astolic potentials during VT, whereas at 68 % of sites that show diastolic potentials
during VT, no late potentials are found during sinus rhythm. Finally, the relation
between sites containing late potentials (i.e. whether or not they are located along
an interconnecting strand) is not known by performing activation mapping alone.
Therefore, in chapter 4, new ways were explored to analyze the substrate dur-
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ing sinus rhythm. Functional properties of the arrhythmogenic substrate during
sinus rhythm can possibly best be studied - in analogy to concealed entrainment
during VT - by delivering a perturbation (for instance by means of ventricular
pacing) and subsequent study of the response of the substrate. In the past, the sig-
nificance of the relation of delay between pacing stimulus and onset of the body
surface QRS complex during sinus rhythm was studied, but this did not provide
discrimination between critical and non-critical sites [18]. In our study, we not
only observed the delay between stimulus and body surface QRS complex, but
also reconstructed the tract of conduction between stimulus site and border of the
scar. This further clarifies the contribution of tracts of surviving fibers in the in-
farcted area to arrhythmogenesis, but does not discriminate between critical and
bystander tracts.
Novel developments, however, that allow instantaneous multi-site mapping of
the entire left ventricle are currently available. This means that the methodology
and signal processing algorithms that were developed in chapter 4, can be used in
the catherization laboratory [19,20]. Instantaneous multi-site pace mapping of the
postinfarction substrate combined with beat-to-beat multi-site mapping will iden-
tify surviving bundles within the postinfarction scar. Since other authors have
shown that it is feasible to perform radiofrequency ablation of VT by means of
creation of linear lesions across these tracts of slow conduction, it appears to be
possible to eliminate the arrhythmia substrate during sinus rhythm [21, 22]. This
approach resembles the technique suggested by data reported by Ciaccio et al in
an experimental study [23]. If the area for pace mapping (e.g. the postinfarction
scar) during sinus rhythm could be confined, more detailed pace mappings could
be obtained in less time. In chapter 5 it was shown that signal averaged BSM gives
regional information on endocardial localization of areas with late potentials. The-
oretically, the same signal averaging and localization methodology can be applied
for mapping of VT. If this same procedure could be ported to mapping of sus-
tained, hemodynamical well-tolerated VT, information could already be obtained
of the clinical VT at the bedside of the patient. Mathematical analysis in chapter
7 suggests that weighted signal averaging lowers the noise with the approximate
square root of the number of complexes even when the noise level changes during
the recording. The difference between the noise that you can expect in a clinical
ECG recording setting and the noise level required for analysis of a signal aver-
aged ECG is only a factor of about 5. This would mean that weighted averaging of
an interval of only 8 seconds could be enough to enable anatomical delineation of
diastolic potentials during a non-sustained VT of cycle length 300 ms. This needs
to be confirmed in a prospective study.
Not all survivors of myocardial infarction will develop life-threatening ar-
rhythmias. Identification of patients at risk for potentially fatal cardiac arrhyth-
mias becomes of utmost importance, both for primary and secondary prevention
of postinfarction ventricular arrhythmias. From the arrhythmogenic mechanisms,
it has been shown that both anisotropy in conduction and disparity in ventricular
repolarization are an index of vulnerability to postinfarction ventricular arrhyth-
mias. Signal averaged electrocardiography has proven to be an easy to perform
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diagnostic tool that has a reliable specificity for identification of patients at risk
for sudden death, especially when other clinical variables are incorporated in the
decision making process [24]. It should be noted that for purposes of prevention, a
diagnostic tool should especially be sensitive to a specific event. In chapter 5 it was
shown that sensitivity for late potentials can be well increased, while specificity is
still excellent, by extending the number of surface leads used. Signal averaged
BSM may play a role in the near future in identifying postinfarction patients need-
ing further electrophysiological work-up, but this remains to be confirmed by a
prospective study.
Much work has been devoted in recent years to techniques for identification of
repolarization dispersion, but clinical studies evaluating their use are controver-
sial [25–27]. Several factors, which can be held responsible for the poor predicting
value of currently available non-invasive repolarization estimates, are discussed
in chapter 6. Major impediment in clinical research directed at non-invasively
identifying nonuniform recovery of excitation is the lack of a “golden standard”.
To overcome this problem, spatially dense body surface electrocardiograms and
multi-lead endocardial data obtained in the intact human left ventricle were com-
pared in chapter 6. It is for the first time that data derived from the entire chest
area combined with left ventricular endocardial multi-site data are presented that
were recorded simultaneous on a beat-to-beat basis in a human being. Since the
main interest in dispersion in repolarization stems from the role it plays in the
emergence of functional conduction block, local differences in refractory period
in the heart appear to be more meaningful than differences in QT interval over
the entire thorax. Therefore, a new parameter for non-invasive expression of lo-
cal dispersion in refractoriness was introduced. This parameter - activation time
recovery gradient - expresses local differences in repolarization in a similar way
for endocardial end surface electrode systems. It emerged from these data that
T-wave peak to T-wave end duration, non-dipolar content in BSM QRST integral
maps and activation recovery time gradients all correlated well with intracardiac
estimates of repolarization. It is conceivable that these findings have clinical rel-
evance. T-wave peak to T-wave end in precordial lead V5 as well as the range of
surface activation recovery time gradients were found to be associated with in-
creased dispersion in endocardial repolarization. This is a condition that favors
the occurrence of functional arcs of block. Non-dipolar content of BSM QRST inte-
gral maps was shown to indicate short endocardial activation-recovery-intervals.
Since the wavelength of functional reentry is determined by conduction speed and
repolarization duration, ventricular arrhythmias in patients with high non-dipolar
QRST content can expected to be exposed to more malignant ventricular arrhyth-
mias. Therefore, these parameters should be analyzed in a prospective study.
Finally, it should be noted that many physical science issues arise when cor-
relating endocardial data with body surface electrocardiography, all of which will
have to be solved. Some of these problems are connected with the inverse solu-
tion problem of electrocardiography, which nearly is as old as electrocardiography
itself [28]. In this thesis, solutions for 3D reconstructions of electrode arrays, sur-
face Laplacian techniques for endocardial electrograms, extraction of meaningful
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electrograms from pacing artifacts, correction for differences in heart-surface elec-
trode distance, optimal signal averaging techniques, projections between surface
and endocardial lead systems, and methods to compare spatial gradients within
a lead system and between different unevenly distributed electrode systems, are
presented. Our main goal was to search for solutions that could be derived from
the data itself, since this would make application of these solutions in daily clinical
practice possible. The methodology described in chapter 7 increases our insight
in the genesis of the electrocardiogram.
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Hart- en vaatziekten vormen nog steeds de voornaamste doodsoorzaak in de Wes-
terse wereld. Een groot gedeelte hiervan komt voor rekening van onbehandelbare
ritmestoornissen of pompfalen in de acute fase van het hartinfarct. Echter ook
een gedeelte van de patie¨nten die de acute fase van een hartinfarct overleven blijft
een verhoogde kans op overlijden houden in de jaren hierna. Het overgrote deel
van dit late overlijden is te wijten aan het optreden van zo geheten late kamerrit-
mestoornissen. De oorzaak voor deze kamerritmestoornissen is gelegen in het in-
farctlitteken. Het infarctlitteken is een complex substraat waarin spiervezels kun-
nen overleven, die een waar doolhof kunnen vormen in het littekenweefsel (zie
figuur 7.1). Deze kleine, overlevende bundels van spiervezels die vaak een veran-
derde, trage geleiding hebben kunnen onder specifieke omstandigheden een aan-
eengesloten circuit vormen waarin de elektrische prikkelsblijven ‘rondzingen’ en
zo tot ongewenste, zeer snelle kamerritmestoornissen aanleiding kunnen geven.
Tevens zal door het infarctlitteken het niet geı¨nfarceerde deel van het hart functi-
oneel zwaarder belast worden. Deze zwaardere belasting uit zich vaak in een ge-
leidelijk verwijding van de linker hartkamer. Deze verwijding van de hartkamer
leidt via een reeks van processen tot veranderde elektrische hersteleigenschappen
(repolarisatie), welke op hun beurt de patie¨nt op den duur ook blootstellen aan
het optreden van levensbedreigende kamerritmestoornissen.
Voor de behandeling en voorkoming van kamerritmestoornissen na het hartin-
farct zijn de laatste jaren diverse therapiee¨n ter beschikking gekomen. Deze thera-
piee¨n kunnen in 3 categoriee¨n onderverdeeld worden. Geprobeerd kan worden bij
een verder ongemoeid gelaten substraat het optreden van kamerritmestoornissen
te voorkomen door de elektrische eigenschappen van de hartspier te veranderen
met behulp van medicijnen (antiaritmica). Daar deze antiaritmica in sommige ge-
vallen juist echter het optreden van ritmestoornissen kunnen bevorderen kan het
resultaat hiervan zeer teleurstellend zijn.
De tweede categorie van behandeling wordt gevormd door therapiee¨n die de
fatale afloop van het optreden van een ritmestoornis voorkomen. Met behulp
van deze zogenaamde implanteerbare cardioverter/defibrillator (ICD) worden le-
vensbedreigende ritmestoornissen automatisch herkend en middels een elektri-
170 Hoofdstuk 9. Samenvatting
sche schok bee¨indigd. Met deze therapie worden uitstekende resultaten bereikt
voor wat betreft overleving. Implantatie van een ICD kan ook consequenties heb-
ben voor de kwaliteit van leven van de patie¨nt, omdat hij immers blootgesteld
blijft aan ritmestoornissen welke op een onvoorspelbaar moment aanleiding kun-
nen geven tot bewustzijnsverlies. Tevens bestaat de mogelijkheid, dat de patie¨nt
onterechte ontladingen ervaart van de ICD voor snelle, maar niet levensbedrei-
gende ritmestoornissen, welke niet uit de hartkamer komen of terechte ontladin-
gen tijdens kamerritmestoornissen zonder dat hij het bewustzijn verloren heeft.
De laatste behandelingscategorie wordt gevormd door therapiee¨n die het in-
farctlitteken zodanig modificeren dat late kamerritmestoornissen niet meer op
kunnen treden. Derhalve behoren tot deze categorie behandelingen, die curatief
zijn in opzet. Tot deze therapiee¨n moeten ritmechirurgie en catheterablatie gere-
kend worden. Tijdens ritmechirurgie wordt een ablatie van de aritmogene zone
uitgevoerd, terwijl bij catheterablatie op percutane wijze via cathetertechnieken
getracht wordt de bron van ritmestoornissen uit te schakelen. Willen deze be-
handelingen succesvol zijn dan is kennis van de lokalisatie van het substraat bij
de individuele patie¨nt noodzakelijk. De tot dusver beschikbare methoden om rit-
mestoornissen in kaart te brengen (‘mapping’) kunnen onderverdeeld worden in
invasieve en niet-invasieve methoden. Met invasieve methoden (zoals catheter-
mapping en intraoperatieve mapping waarbij e´e´n meerkanaals ballonelectrode
tijdens een operatie in de linker hartkamer geplaatst wordt, zie figuur 4.1) wordt
kartering van ritmestoornissen bereikt door op meerdere plaatsen in het hart het
moment van plaatselijke activatie te meten. Zodoende wordt niet alleen de oor-
sprongsplaats van de ritmestoornis, maar tevens ook het gehele circuit dat de rit-
mestoornis binnen de hartkamer aflegt, gevisualizeerd. Om reeds voor de catheter
ablatie of de operatie geı¨nformeerd te zijn over de lokatie van het aritmogene sub-
straat worden reeds voor de operatie ook mapping van de kamerritmestoornissen
gedaan. Met niet-invasieve methoden (zoals ‘body surface mapping’), wordt —
door op vele plaatsen op het lichaamsoppervlak elektrocardiogrammen tijdens
de ritmestoornis te meten — de oorsprongsplaats van kamerritmestoornissen ge-
vonden door de metingen te vergelijken met bibliotheken van elektrocardiogram-
men van kamerritmestoornissen met bekende oorsprongsplaats (figuur 3.1 en 3.2).
Voordeel van niet-invasieve mapping methoden zijn, dat ze voor de patie¨nt min-
der belastend en in het ziekenhuis makkelijk toepasbaar zijn.
9.1 Bepaling van de oorsprongsplaats van
kamerritmestoornissen
In het hier gepresenteerd promotieonderzoek zijn methoden ontwikkeld om het
substraat van late kamerritmestoornissen na het infarct beter in kaart te brengen.
In hoofdstuk 2 werd de invloed op het success van een ritme-operatie van de tot
dan toe gebruikelijke technieken om de oorsprongsplaats van ritmestoornissen
voorafgaand aan en tijdens een operatie in kaart te brengen, geanalyseerd. Hier-
toe werden bij de eerste groep van 54 patie¨nten achtereenvolgens alle beschik-
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bare karteringsmethoden gebruikt (catheter-mapping, body surface mapping en
ballon-mapping tijdens de operatie) en de mapping resultaten onderling vergele-
ken. Het bleek dat de overeenkomst tussen de lokalisatie van de oorsprongsplaats
van 128 verschillende kamerritmestoornissen met mapping tijdens de operatie,
die als gouden standaard gebruikt werd, en body surface mapping en catheter-
mapping redelijk was. Het bleek verder, dat met body surface mapping veruit de
meeste kamerritmestoornissen gekarteerd konden worden. Overeenkomst in oor-
sprongsplaats plaats tussen catheter-mapping en body surface mapping bedroeg
79 %, terwijl enerzijds de overeenkomst tussen ballon-mapping en body surface
mapping en anderzijds die tussen ballon-mapping en catheter-mapping respec-
tievelijk 58 % en 56 % bedroeg. Gekeken werd of de catheter-mapping voortaan
weggelaten kon worden in de pre-operatieve voorbereiding voor ritmechirurgie.
De overleving na 4 jaar (70 % vs 87 %, figuur 2.4) en vrijheid van ritmestoornis-
sen na 4 jaar (74 % vs 90 %, figuur 2.5) verschilde niet in patie¨nten onderzocht
met of zonder catheter-mapping. Geconcludeerd kon worden, dat patie¨nt be-
lastende catheter-mapping veilig weggelaten kon worden voorafgaand aan een
ritme-operatie. Opvallend was, dat de correlatie tussen body surface mapping
en intraoperative ballon-mapping niet hoger was dan ± 60 % bij de onderzochte
patie¨nten. Overwogen werd, dat veranderingen van elektrische geleiding over
de hartspier, welke door het voorafgaande hartinfarct veroorzaakt waren en bij
iedere individuele patie¨nt anders kunnen zijn, hiervoor verantwoordelijk waren.
Om dit te onderzoeken werd in hoofdstuk 3 bij 14 patie¨nten met kamerritmestoor-
nissen na het hartinfarct gelijktijdig gedetailleerde metingen in de linker hartka-
mer tesamen met body surface maping gedaan. Met een speciale 64-polige cathe-
ter (basketcatheter, figuur 3.3) en voor dit onderzoek ontwikkelde computerpro-
grammatuur, konden op minimaal invasieve wijze van hartslag tot hartslag gede-
tailleerde kaarten van activatie van de linker hartkamer gemaakt worden tijdens
de ritmestoornis en elektrische stimulatie van de linker hartkamer. Door het ver-
loop van elektrische activatie over de hartspier te visualiseren, kon meer inzicht in
het substraat van de kamerritmestoornissen verkregen worden. Daarmee werden
de redenen waarom er soms discrepantie was tussen de door body surface map-
ping aangewezen oorsprongsplaats en de met de ingebrachte catheter gevonden
oorsprongsplaats opgespoord. In totaal werd voor 17 kamerritmestoornissen en
322 geconstrueerde kaarten tijdens elektrische stimulatie op diverse plaatsen van
het hart een overeenkomst van de oorspongsplaats van 59 % en 70 % gevonden.
Er werden vier verklaringen voor verschil in lokalisaties gevonden: (1) gebieden
van niet elektrisch activeerbaar hartspierweefsel, waardoor het elektrisch activa-
tie front gedwongen werd een ander beloop te nemen; (2) regionale verschillen
in grootte van de in het hart gevonden elektrogrammen; (3) het feit, dat e´e´n rit-
mestoornis tegelijkertijd meerdere oorsprongsplaatsen kon hebben; (4) sommige
ritmestoornissen hadden mogelijk een oorsprongsplaats, die dieper in de spier
gelegen is, waardoor de metingen met de catheter aan de binnenkant van het
hart slechts de doorbreekplaats van de ritmestoornis aan de binnenkant van het
hart registreerde. Uit dit onderzoek bleek dat het elektrocardiogram van kamer-
ritmestoornissen gemeten aan het lichaamsoppervlak sterk beı¨vloed wordt door
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structurele veranderingen in het hart, veroorzaakt door het eerdere hartinfarct.
9.2 Lokaliseren van het substraat van
kamerritmestoornissen tijdens normaal sinusritme
Idealiter zou het substraat van kamerritmestoornissen gelokaliseerd moeten kun-
nen worden tijdens normaal hartritme (sinusritme). Dit zou immers de patie¨nt de
belasting van het opwekken van ritmestoornissen kunnen besparen. Bovendien
blijkt het in een aantal gevallen technisch niet mogelijk een kartering van de ka-
merritmestoornis uit te voeren, omdat de ritmestoornis niet opwekbaar blijkt of
omdat de patie¨nt de ritmestoornis niet kan verdragen en het bewustzijn verliest.
Daarom werd in hoofdstuk 4 onderzoek gedaan naar de mogelijkheden om het
substraat van ritmestoornissen in kaart te brengen zonder de ritmestoornis op te
wekken. Hiertoe werd bij 13 patie¨nten, die ritmechirurgie ondergingen, stimulatie
met een pacemaker op zoveel mogelijk plaatsen in het infarctlitteken uitgevoerd
met behulp van een veelkanaals ballonelektrode. Door vervolgens activatiekaar-
ten te registreren van de volgorde van activatie vanaf het stimulatiepunt kon het
beloop van het activatie front vanaf de plaats van stimulatie naar de uitgang van
het doolhof aan de rand van het infarctlitteken bestudeerd worden. Vervolgens
werden de kamerritmestoornissen opgewekt en de oorsprongsplaatsen bepaald.
Het bleek, dat 46 % van de oorsprongsplaatsen van kamerritmestoornissen mid-
dels de stimulatietechniek tijdens sinusritme gelokaliseerd konden worden. Te-
vens bleek, dat de geleiding in het infarctlitteken op dezelfde wijze in kaart ge-
bracht kan worden als tijdens de kamerritmestoornis. Hiermee kan nu gedetail-
leerd het circuit van de ritmestoornissen bestudeerd worden. Tevens kunnen in
dit circuit plaatsen worden aangewezen welke geschikt zijn voor het verrichten
van de ablatie.
Omdat mapping van ritmestoornissen op niet-invasieve wijze minder belas-
tend is voor een patie¨nt werden in hoofdstuk 5 de mogelijkheden bestudeerd
om met body surface mapping de paden van langzame geleiding in het infarct-
litteken op te sporen. Het gaat bij deze paden van langzame geleiding vaak om
vezelbundels van geringe omvang. Daarom kunnen deze elektrische signaaltjes
(late potentialen), die door deze bundels gegenereerd worden niet direct aan het
lichaamsoppervlak gemeten worden, omdat deze signaaltjes niet van ruis te on-
derscheiden zijn. Met behulp van een speciale signaalbewerkingstechniek (signal-
averaging) kunnen deze signalen echter toch gedetecteerd worden. Daarom werd
bij 16 patie¨nten met een eerder hartinfarct gelijktijdige metingen met een basketca-
theter aan de binnenzijde van het hart en body surface mapping (‘buitenzijde’ van
het lichaam) verricht. Aan de hand van de signalen gemeten met de basketcathe-
ter werden gebieden met vertraagde geleiding gedetecteerd. Voor de body surface
mapping registraties werd met signal-averaging technieken versterking van ‘late
potentialen’ bewerkstelligd en werd hun aan- en afwezigheid op het lichaamsop-
pervlak vastgesteld. Middels projectietechnieken werd gekeken of er een relatie
in anatomische zin bestond tussen oppervlakte gebieden met ‘late potentialen’ en
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gebieden met vertraagde geleiding in het hart. Het bleek dat bij 12 van de 13
patie¨nten er visueel een goede correlatie was tussen binnenkant van het hart en li-
chaamsoppervlak. Kwantitatieve vergelijking van direct gemeten signal-averaged
body surface mapping kaarten en kaarten, die middels projectietechnieken van in
het hart gemeten signalen geconstrueerd waren, leverde een correlatie op van 0.6
± 0.12. UIt de studie blijkt, dat met signal-averaged body surface mapping ge-
bieden met vertraagde geleiding in het hart geı¨dentificeerd kunnen worden en
dat op die manier het gebied dat tijdens catheterablatie onderzocht moet worden,
verkleind kan worden.
9.3 Herkenning van patie¨nten met een verhoogde kans
op ritmestoornissen na het hartinfarct
Naast behandeling van patie¨nten met late kamerritmestoornissen na het hartin-
farct, is de identificatie van patie¨nten met een verhoogd risico op deze ritmestoor-
nissen van wezenlijk belang. Traditioneel worden hier klinisch twee elektrocardi-
ografische technieken voor gebruikt. Signal-averaged elektrocardiografie en me-
ting van regionaal verschil in duur van repolarisatie van de hartspier middels
meting van dispersie in het QT-interval op het elektrocardiogram.
Bij signal-averaged elektrocardiografie worden met behulp van drie standaard
afleidingen en speciale signaalverwerkende technieken gebieden met vertraagde
geleiding aangetoond in het hart. Dit betekent, dat bij patie¨nten na het hartinfarct
aannemelijk gemaakt kan worden dat het substraat voor ritmestoornissen poten-
tieel aanwezig is. Hoewel de specificiteit van signal-averaged elektrocardiografie
goed is, lijkt de sensitiviteit teleur te stellen (hoofdstuk 5). Gedacht werd, dat dit
te wijten was aan de beperkte elektrode resolutie van een 3 afleidingen systeem.
Daarom werd in hoofdstuk 5 gekeken naar invloed van het uitbreiden van het
aantal elektroden op de sensitiviteit en specificiteit. Signal averaged body surface
mapping werd vergeleken in twee groepen patie¨nten: een groep van 16 patie¨nten
met een eerder hartinfarct en 12 controlepersonen zonder structurele hartafwij-
kingen. Het bleek, dat de sensitiviteit van signal-averaged body surface mapping
toenam van 0.19 tot 0.88, terwijl de specificteit slechts daalde van 1.0 naar 0.92.
Thans is gebruikelijk om veranderingen in dispersie in repolarisatie te meten
met behulp van het QT interval in het 12-kanaals elektrocardiogram. Tot dusver
zijn er weinig gegevens voorhanden van metingen in het intacte menselijke hart,
die kunnen bevestigen of dispersie in het QT interval daadwerkelijk dispersie in
repolarisatie aangeven. Daarom werd in hoofdstuk 6 in 3 patie¨ntengroepen me-
tingen gedaan: een groep van 13 patie¨nten met een eerder hartinfarct en bewezen
spontane kamerritmestoornissen; een groep van 23 patie¨nten met een eerder hart-
infarct, die nog nooit kamerritmestoornissen hadden gehad; en een groep van 19
gezonde vrijwilligers. Bij de patie¨nten met bewezen hartritmestoornissen werd
tevens een basketcatheter ingebracht.
Ten slotte dient opgemerkt te worden, dat een groot aantal methoden ontwik-
keld moest worden om invasief verkregen data te kunnen vergelijken met me-
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tingen gedaan aan het lichaamsoppervlak. Hiertoe behoren technieken zoals 3D
reconstructie van de positie van de basketcatheter, signaalverwerkingstechnieken
zoals berekening van de oppervlakte Laplaciaan en subtractie van stimulatiear-
tefacten en correctie voor afstand van huidelektroden tot het hart. De fysische
achtergrond van deze technieken wordt verantwoord in hoofdstuk 7.
9.4 Toekomstig onderzoek
Een groot aantal vragen blijft open staan bij het begrijpen van late kamerritmestoor-
nissen na het infarct. Zo treden deze ritmestoornissen niet bij alle infarct patie¨nten
op. En ook is het niet altijd mogelijk om een bij een patie¨nt — die spontane ka-
merritmestoornissen heeft — deze op te wekken. Een groot aantal factoren kun-
nen deze opwekbaarheid beı¨nvloeden. Een beter begrip van de omstandigheden
die het ontstaan van ritmestoornissen mogelijk maken of uitlokken geeft meer
houvast om voor de individuele patie¨nt de geschikte therapie te selecteren en te
controleren of een ingestelde therapie zoals geneesmiddelen of catheterablatie ef-
fectief is. Met de in dit onderzoek ontwikkelde methoden om gelijktijdig ana-
tomische informatie te krijgen over repolarisatie eigenschappen van het hart en
zones van langzame geleiding is het wellicht mogelijk meer inzicht te krijgen in
de opwekbaarheid van kamerritmestoornissen. Dit dient prospectief onderzocht
te worden.
In hoofdstuk 5 worden technieken gebruikt om zones van trage geleiding tij-
dens sinusritme anatomisch in kaart te brengen. Dezelfde techniek zou toege-
past kunnen worden tijdens de kamerritmestoornis, zodat het pad van trage gelei-
ding dat daadwerkelijk gebruikt wordt inzichtelijk gemaakt zou kunnen worden.
Deze informatie zou gebruikt kunnen worden tijdens catheterablatie van kamer-
ritmestoornissen.
Ten slotte is een methode ontwikkeld om tijdens sinusritme het doolhof van
het infarctlitteken in kaart te brengen. Met elders ontwikkelde technieken, waar-
mee activatie van de linker hartkamer van slag op slag in beeld gebracht kunnen
worden, zou het in hoofdstuk 4 ontwikkelde protocol toegepast kunnen worden
op de catheterisatiekamer.
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Dankwoord
Het wezen van wetenschappelijk onderzoek doen naast een volledige baan in een
perifeer ziekenhuis werd al getypeerd door A.A. Milne in 1926. Op de eerste pa-
gina van “Winnie-The-Pooh” schreef hij immers: “Op het eerste plaatje zie je Eduard
Beer de trappen afkomen, boem, boem, boem, boem op zijn achterhoofd, achter Janneman
Robinson aan. Hij weet niet beter, of dit is de enige manier om een trap af te gaan; maar
hij krijgt to`ch wel eens even een gevoel alsof hij er nog wel wat anders op zou kunnen
vinden, als hij er maar e´e´n enkel ogenblikje rustig over na kon denken. Maar dan voelt
hij toch ook weer, dat er geen andere manier is.” Promovendi behoren echter tot de
categorie mensen, die de laatste zin van dit citaat zeker niet zomaar over hun kant
laten gaan. Uiteraard dient opgemerkt te worden, dat daarbij de onmisbare steun
van velen nodig is. Daarom wil ik in het algemeen iedereen bedanken die op wat
voor manier dan ook behulpzaam is geweest bij het tot stand komen van dit proef-
schrift en een aantal mensen in het bijzonder :
Eerst en vooral mijn promotor en voormalig opleider, prof. dr. N.M. van He-
mel. Beste Norbert, jou bedanken zou eigenlijk heel wat meer ruimte vragen dan
kan binnen het kader van een proefschrift. Niet alleen was jij de eerste om de
geheimen van de electrofysiologie voor me te ontsluieren, niet alleen ben je mijn
opleider in de Cardiologie geweest: het is een cliche´ om te zeggen, dat deze thesis
zonder jouw enthousiasme, gedrevenheid en warme belangstelling niet tot stand
gekomen zou zijn. Met veel genoegen denk ik aan de regelmatige ‘zondagsavond-
telefoontjes’ en de vele discussies die we hebben gevoerd over onderwerpen die
de Electrofysiologie vaak ruim ontstegen. Hoewel er op een bepaald moment een
schaduw van onzekerheid over onze samenwerking trok, ben ik om meerdere re-
denen heel dankbaar dat we deze klus samen hebben mogen afronden. Marijke
van Hemel, bedankt dat ik zo vaak beslag mocht leggen op je man (of andersom?)!
Mijn tweede promotor, prof. dr. ir. J.M.T. de Bakker. Beste Jacques, ook jouw
inbreng in dit proefschrift was van onschatbare waarde. Ook jij hebt je altijd alles-
behalve een contrafessor getoond. Je grote bescheidenheid dwingt een promoven-
dus om de literatuur goed bij te houden en zich zodoende jouw grote bijdrage aan
de wetenschap op het gebied van ritmestoornissen te realiseren. Waar ik soms de
neiging had om teveel hooi op mijn vork te nemen, was jij er altijd om me op het
belang van het bedrijven van onderzoek op een meer pragmatiche manier te wij-
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zen en zodoende mijn vizier scherp te houden. Ik ben zeer dankbaar, dat ik van
je inspiratie, eruditie en visie op het gebied van de electrofysiologie heb mogen
profiteren.
Mijn co-promotor en naaste mede-onderzoeker dr. A.C. Linnenbank. Beste Andre´,
wat nu nog te zeggen? De software die je voor me ontwikkelde, de illustraties die
je voor me maakte en de stof voor vele inhoudelijke discussies worden in kwali-
teit slechts gee¨venaard door de vanzelfsprekendheid waarmee jij die leverde. Ik
denk dat we een sterk team geweest zijn en dat de kracht van onze samenwer-
king vooral het plezier is geweest dat we er allebei aan beleefd hebben. De vele
avonden samen doorgebracht achter de computer waarbij het programmeren en
signaal analyse doorspekt waren met citaten uit Monty Python en de Hitchhiker’s
Guide maakten promoveren bijna tot een genoegen....
De leden van de beoordelingscommisie: prof. dr. ir. C.A. Grimbergen, prof. dr.
R.N.W. Hauer, prof. dr. H. Jongsma, dr. W.G. Stevenson en prof. dr. H.J.J. Wellens,
dank ik voor hun bereidwilligheid om naast hun drukke werkzaamheden tijd vrij
te maken ten einde dit proefschrift kritisch te beoordelen.
I’d like to express my special thanks to dr W.G. Stevenson for the fact that he
came all the way from Boston to honor our pre-dissertation symposium and my
actual dissertation with his presence.
Mijn paranimfen dr. H.P.A. van Dongen en ir. V.L.J. Karthaus. Beste Eric en
Vincent: het schrijvcn van een proefschrift is e´e´n, het orchestreren van alles wat
daarna komt is twee. Ik dank jullie dan ook voor jullie morele ondersteuning tij-
dens het promotieproces en jullie hulp bij het afhandelen van alle organisatorische
kwesties.
Mijn naaste collega’s van de afdeling Klinische Electrofysiologie van het St. Anto-
nius Ziekenhuis te Nieuwegein: dr. E.F.D. Wever en dr. E.R. Jessurun. Beste Eric
en Emile, ik ben jullie dankbaar voor jullie bijdrage aan mijn opleiding tot Electro-
fysioloog, jullie hulp bij het plaatsen van de basket catheters voor mijn onderzoek
en het geduld bij het doen van mijn metingen. Ook dit is onmisbaar geweest bij het
schrijven van dit proefschrift. En, Emile, kamergenoot en vriend, hoewel het beeld
van je rokende zwijgzaamheid, naast me, aan ons gemeenschappelijk bureau, on-
uitwisbaar op mijn netvlies gebrand staat, zal ik toch vooral de wijze lessen, die
je altijd voor me had op de momenten dat je niet zwijgzaam was, blijven onthou-
den....
De leden van de maatschap Cardiologie van de locatie St. Antonius Ziekenhuis
van het Heart Lung Center Utrecht: dr C.A.P.L. Ascoop, drs. E.T. Bal, drs. J.M.
ten Berg, dr. J.M.P.G. Ernst, drs. E.G. Mast, dr. W. Jaarsma, dr. H.W.M. Plokker,
dr. M.J. Suttorp, dr. E.F.D. Wever en de recentelijk tot de maatschap toegtreden dr.
B.J.W.M. Rensing alsmede zijn voorganger prof. dr. J.H. Kingma, dank ik voor de
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opleiding tot cardioloog en het feit dat ik van het patie¨ntenmateriaal van het St.
Antonius Ziekenhuis gebruik kon maken voor mijn onderzoek.
De maatschap Thoraxchirurgie van het St Antonius Ziekenhuis te Nieuwegein,
in het bijzonder drs. J.J.A.M.T. Defauw, voor hun expertise op het gebied van rit-
mechirurgie en – opnieuw – voor hun geduld tijdens de metingen die ik bij de
door hen uitgevoerde operaties kwam doen.
drs. M. Potse van de afdeling Medische Fysica van het Academisch Medisch
Centrum te Amsterdam. Beste Mark, je behulpzaamheid om software op maat te
schrijven, je ontwikkeling samen met Andre´ Linnenbank van het prachtige soft-
ware pakket MapLab en de vele illustraties die je altijd bereid was om voor me
te maken, waardeer ik bijzonder. Dat jouw ‘s’ over twee weken ook maar mag
sneuvelen.
dr. A. Sippens Groenewegen wil ik bedanken voor de vele potloden die hij versle-
ten heeft bij het zwart arceren van mijn artikelen. Beste Arne, ik heb veel geleerd
van je enorme kennis van body surface mapping en de kritisch manier van lezen
van mijn stukken.
Mevrouw G.J. van der Kuijl en mevrouw E. Hoogteijling-van Dusseldorp. Gerda,
het feit, dat je menig vrije dag opofferde om ons van jouw kunde op het gebied
van het maken van dia’s, posters en het verzendklaar maken van artikelen te laten
genieten is niet onopgemerkt gebleven. Bedankt hiervoor! Beste Elly, ik ben je
dankbaar voor de gedrevenheid en precisie waarmee je altijd onze database on-
derhouden hebt en de follow-up gegevens van onze patie¨nten hebt verzameld.
De medewerkers van de afdeling Cardiomeettechniek van het St. Antonius Zie-
kenhuis te Nieuwegein: Erik Stel, Peter van Hartingsveld, Barbara Maat-Poot en
Rob Thijssen. Jullie ondersteuning bij het maken van de body surface mappings
en het verrichten van de electrofysiologische metingen op de catheterisatiekamer
en operatiekamer waren cruciaal bij het schrijven van dit proefschrift.
Van mijn collega assistenten tijdens de Cardiologie opleiding, wil ik met name
Rob van Tooren en Braim Rahel danken, die zo vriendelijk waren om mijn klini-
sche afdeling waar te nemen als ik een paar uur uit de roulatie was om al mijn
metingen op de elctrofysiologie kamer te kunnen doen. Hans Kelder en Monique
Stofmeel : bedankt voor jullie epidemiologische terugkoppelingen en het kritisch
uitvoeren van de laatste syntax check.
E´e´n-na-laatst-maar-niet-lest wil ik mijn zus, broers, schoonzussen, neefjes, nicht-
jes, klimmaatjes, vrienden en vriendinnen bedanken voor het begrip en het geduld
dat ze opbrachten als ik het weer eens te druk had om op regelmatige tijden con-
tact te houden of op het laatste moment weer eens een vakantie af zegde omdat ik
toch moest “typen”.
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Lieve Vader en Moeder, de zekerheid, dat ik altijd kan terugvallen op een warm
nest, heeft de afgelopen jaren een project als het schrijven van dit proefschrift voor
mij haalbaar gemaakt. Maar alles, wat ik opgestoken heb bij het werken aan deze
dissertatie, verbleekt bij wat ik allemaal al van jullie heb mogen leren. Als ik de
normen en waarden half zo goed mag uitdragen als jullie die me bijgebracht heb-
ben, prijs ik mij een gelukkig mens. Ik dank jullie voor alles.
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